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Drug-induced seizure is a major reason for compound attrition during drug development, hence 
testing the potential of novel agents to induce such neurotoxic events is a vital process. 
Currently, in vivo and in vitro animal assays are used for seizure-liability studies; yet controversy 
over the relevance, efficacy and cost of these methodologies has led to interest in the 
development of human based models, for increased translatability and data extrapolation. 
Human induced pluripotent stem cells (iPSCs) are a revolutionary platform for neurotoxicity 
testing. However, considerable variation in culturing protocols, growth media and analytical 
techniques exists, with no validated standard for drug-induced seizure-liability testing.  
In this thesis, this cutting-edge iPSC technology, in combination with concurrent morphological 
and functional analysis has considered several methods for generation of a robust, reproducible 
human seizure-liability model, capable of responding to ionic and pharmacological stimuli. 
Spontaneously differentiated neural cultures display electrical activity, but sporadic 
epileptiform activity, as observed with fluorescent calcium imaging. Moreover, weak functional 
activity and longevity and the absence of characteristic seizure-like activity was observed in 
isolated monocultures of neurons and astrocytes. Various co-culture protocols were developed 
and tested, displaying greater baseline activity, network interconnectivity and responses to pro-
convulsant conditions than spontaneously differentiated cultures; highlighting the absolute 
requirement for both cell types to be present in culture. Final experiments introduced 
interneuronal populations to the established co-culture protocol; with preliminary results highly 
suggestive of providing a robust system which can be used for widespread seizure-liability 
assessment. 
This thesis provides the first comparison of iPSC-derived culture methods for seizure-liability 
testing, whilst factoring in several variables which currently exist in the literature; including 
growth medium, duration of differentiation and methods to control cell proliferation. In 
addition, a proposal for a validatory panel of pro-convulsant conditions for the inclusion of 
human iPSC-derived platforms in safety pharmacology studies is presented.  
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1: GENERAL INTRODUCTION 
1.1 Introduction  
The human brain is the most complex organ in the body, controlling our highest functions, as 
well as regulating myriad processes which incorporate the entire physiological system. The brain 
is vulnerable to damage by physical trauma and a multitude of injurious agents, including 
pathogens, pharmaceuticals and toxins. Physiological and anatomical protection and regulation 
for the controlled environment of the brain is provided by the blood-brain barrier (BBB). This 
consists of brain endothelia, astrocytes and pericytes, providing a system of tight endothelial 
junctions where selective permeability to water, some gases and fuel sources such as glucose 
and amino acids can be modulated (Daneman & Prat, 2015). The presence of glial cells in 
particular regulates the ionic and nutrient composition of fluid surrounding neurons (Prat et al., 
2001). Should these mechanisms fail, brain functionality can be compromised. Indeed, seizure 
is one such severe neurological complication that can present from several circumstances, 
ranging from an adverse drug reaction (ADR), to infection or as a result of trauma (Koseki et al., 
2014; Vaughan & Delanty, 2003). 
1.2 Definitions: Seizures and Epilepsy 
A seizure is the defining symptom of epilepsy, which is one of the most common chronic 
neurological disorders, estimated to affect 65 million individuals worldwide (Thurman et al., 
2011). ‘Epilepsy’ encompasses multiple syndromes which predispose the individual to 
generation of epileptic seizures (Fisher et al., 2005). A seizure itself is defined as an abnormal, 
transient discharge of neurons in the brain (Fisher et al., 2005), and is broadly characterised by 
neuronal hyperexcitability and hypersynchrony (Jiruska et al., 2013). If an individual suffers a 
single event with no recurrence, they are said to have suffered a seizure. If multiple consecutive 
12 
 
and/or recurring seizures are experienced, the patient may be diagnosed with epilepsy 
(Scharfman, 2007).  
In a clinical/research context, seizures are referred to as ‘ictal events’, with the period leading 
up to seizure termed pre-ictal, the period following seizure termed post-ictal and for individuals 
with recurrent seizures, the period between each event is known as the interictal state (Fisher 
et al., 2014). Epileptogenesis describes the processes which render a healthy system capable of 
generating seizures, whilst also establishing the condition, hence making recurrent seizures 
more likely (Blauwblomme et al., 2014; Pitkänen, 2010). Ictogenesis refers to the transition 
between the interictal state to the ictal state in an already hyperexcitable brain (Dichter, 2009). 
This thesis makes frequent reference to ‘seizurogenesis’, which in this context describes the 
generation of seizures in reference to pharmacological/ionic stimuli.  
Patients suffering from seizures experience different effects depending on the brain region 
involved. The International League Against Epilepsy (ILAE) classify seizures into four categories: 
focal, generalised, those of an unknown onset (formerly classified as epileptic spasms) and 
unclassified – where insufficient data exists to categorise the seizure (Fisher et al., 2017). Focal 
seizures originate in neuronal networks in one part of the cerebral hemisphere, whereas 
generalised seizures begin and spread bilaterally to incorporate the entire brain, explaining the 
variety of symptoms and often loss of consciousness which results (Stafstrom & Carmant, 2015). 
It is worth highlighting that the classification of seizures and epilepsy is a very dynamic process, 
with revisions to the terminology published almost annually. An expanded description of the 
most recent classification is shown in Figure 1.1. Symptoms of seizures may include changes in 
cognition, paraesthesia, or the experience of flashing lights or unusual odours. Convulsions are 
commonly observed, which can be accompanied by various combinations of muscle rigidity 
(tonic) and jerking limb (clonic) activity. Atonic seizures, also called ‘drop attacks’ are associated 
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with a sudden loss of muscle tone, with patients often collapsing. They are characteristic of focal 















Figure 1.1: ILAE classification of seizures and their major symptoms. Adapted from Fisher et 
al., (2017). 
 
Although seizure is the defining symptom of the epilepsies, only about 25% of patients who 
suffer seizure have an epilepsy syndrome (Stasiukyniene et al., 2009). The remaining patients 
suffer seizures from the major causes listed above, as well as neonatal occurrences amongst 
14 
 
infants. These seizures may be described as provoked or acute symptomatic, as they are not the 
result of established or enduring brain alterations; but rather occur in an acute and transient 
manner (Fisher et al., 2005; Thurman et al., 2011). The potential severity of induced seizures 
makes them an important metric for the necessity for predictive neurotoxicity assays. 
1.3 Mechanisms of Seizure Induction 
Seizurogenesis falls under the broad umbrella of epileptogenesis – modifications in the brain to 
support seizure development. It is likely that epileptogenic mechanisms occur before, 
throughout and following seizurogenesis to support seizure propagation, leading to changes 
within the brain which are receptive to seizurogenesis before a seizure occurs (Blauwblomme 
et al., 2014). However, neither of these processes are entirely understood and both 
seizurogenesis and epileptogenesis can arise from multiple mechanisms, which adds increased 
complexity. On the most elementary level, one can consider seizurogenesis to be the result of 
perturbation to the delicate balance between neuronal excitation and inhibition, mediated by 
ion flux and ion channels. Indeed, suppressing inhibition and enhancing excitation are both 
criteria for epileptic discharges (Lerche et al., 2001).  
1.3.1 Healthy neuronal activity  
Neurons are excitable cells. At rest, a membrane potential of roughly -70 mV is established by 
the ionic gradient which exists between sodium (Na+), potassium (K+), chloride (Cl-) and organic 
cations in the cellular environment. This resting membrane potential (RMP) arises from higher 
intracellular K+ and higher Na+ in the extracellular space and is maintained by a series of voltage-
gated channels, the sodium-potassium ATPase active transporter (Na+-K+ pump) (Chrysafides & 
Sharma, 2019) and leak channels, of which the neuron has considerably more, allowing the  
passage of K+ (Lesage, 2003). When excited, the membrane potential is depolarised, primarily 
due to the opening of sodium channels and influx of Na+ to reach the action potential (AP) firing 
threshold. The repolarisation phase involves the efflux K+ to return to the RMP and prevent 
repetitive stimulation (Raimondo et al., 2015).  
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As the Na+-K+ pump plays such a vital role in maintaining resting neurons, if dysfunctional, the 
RMP may not be established. As a result, the neuron can depolarise to the point where the 
electrochemical balance becomes unstable and hence, neurons become hyperexcitable (Funck 
et al., 2015). Indeed, it has been shown that partial inhibition of the Na+-K+ pump induces 
epileptiform burst-firing (Vaillend et al., 2002). Dysfunction of the Na+-K+ pump may also be 
associated with provoked neonatal seizures in infants, based on evidence that in rodents, the 
development of this protein is delayed after birth. It may be possible that the same process, or 
alteration to the corresponding protein occurs in humans who are predisposed to neonatal 
seizure (Scharfman, 2007).  
1.3.2 Potassium  
Neuronal cells are highly permeable to K+ movement through membrane ion channels, making 
K+ the principle regulator of neuronal excitability. Action potentials lead to increased 
extracellular potassium concentrations ([K+]e), which are returned to a resting state following 
the opening of potassium channels, the Na+/K+ pump and glial cell K+ uptake (Larsen et al., 2016). 
Normally, the accumulation of K+e is prevented to avoid widespread depolarisation, which can 
lead to increased firing and burst-firing, facilitating seizurogenesis. Exceeding an extracellular 
concentration of 2.7 – 3.5 mM can have effects on either nerve terminals (whose depolarisation 
results in neurotransmitter release) or neurons themselves (whose depolarisation leads to AP 
discharge). Mild depolarisation increases excitability by moving towards the more positive firing 
threshold. If the [K+]e exceeds 10 mM, ‘persistent’, slowly inactivating Na+ currents increase the 
likelihood of recurrent seizure (Somjen, 2002). Baseline K+e has been shown to be approximately 
25-fold lower than intracellular K+, which means a small efflux of K+ can generate large changes 
in the transmembrane K+ gradient (Jiang & Haddad, 1991) and furthermore, significant 
membrane depolarisation (Lesage, 2003).  
As K+ plays such an integral role in excitability and the movement of K+ is enabled by various 
channels and transporters, it is not surprising that mutations in and dysfunction of ion channels 
16 
 
can directly affect brain excitability and induce seizure activity (Steinlein et al., 2001). Potassium 
channels are the most widely distributed neuronal and glial ion channels in the nervous system, 
comprising voltage-gated (VG), calcium-dependent and sodium-activated channels (de Curtis et 
al., 2018). VG channels are involved in repolarisation following AP (Gutman et al., 2005), 
calcium-dependent are sensitive to changes in intracellular [Ca2+] following AP and are involved 
in setting the RMP (Marrion & Tavalin, 1998) and sodium-activated potassium channels mediate 
the outward current, regulating neuronal excitability during repetitive AP’s (Bhattacharjee & 
Kaczmarek, 2005). Unregulated activity in any of these channels can provide an ionic basis for 
the generation of hyperexcitability and repetitive AP discharge, which is typical of a seizure. 
Indeed, the inherited epileptic syndrome ‘benign familial neonatal convulsions’ is associated 
with the mutation of two potassium channels: KCNQ2 and KCNQ3, which normally contribute 
to repolarisation of the neuron during action potentials (Lerche et al., 1999).   
Whilst perturbation of normal ionic gradients can lead to seizurogenesis, seizures themselves 
also affect the ionic environment and can generate conditions which promote seizure 
recurrence. During seizure, [K+]e increases and extracellular sodium and calcium ([Na+]e/[Ca2+]e) 
decreases, due to neuronal release and uptake, respectively (Feldberg & Sherwood, 1957; 
Somjen, 2002). This can create a cycle of depolarisation, promoting further AP discharge from 
continuous excitation (Sypert & Ward, 1974). Experiments with canine and feline models as 
early as the 1940’s showed the seizurogenic effects of elevated K+e and that neurons release 
excess K+ during electrical stimulation and seizure (Cicardo & Torino, 1942; Feldberg & 
Sherwood, 1957). The accumulation of K+e as a result of seizure is undisputed, however, whether 
this alone causes seizure is a topic of debate. The ‘potassium accumulation hypothesis’ theory 
(Fröhlich et al., 2008) suggests that seizure-induced K+e accumulation triggers the onset of 
seizure and leads to a positive-feedback cycle, only slowed when a depolarisation block occurs. 
Depolarisation blocks are a result of Na+ channels becoming inactivated following severe 
depolarisation (Raimondo et al., 2015). Irrespective of the debate, it is widely accepted that K+ 
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is an integral ion in maintaining neuronal ionic homeostasis and conditions of hyperexcitability. 
In Chapter 4, experimental means of modulating K+e are discussed in detail. 
1.3.3 Sodium  
Alongside the undisputed importance of K+ flux, neurons would be unable to initiate or 
propagate AP’s without Na+. Similarly to K+ flux, Na+ currents are established by the passage of 
Na+ via a series of ion channels which open, close or inactivate, depending upon the membrane 
potential. Na+ currents can participate in epileptiform firing (Stafstrom, 2007) due to their effect 
on membrane depolarisation and hence, excitability. Such effects can result through modulation 
of sodium ion channels. Decreased inactivation and increased activation and opening times, for 
example, would all support the influx of Na+ and the subsequent continued depolarisation of 
the neuron.  
Mutations in three genes encoding sodium channels (SCN1A, SCN2A and SCN1B) can result in 
various epilepsy syndromes (Escayg & Goldin, 2010). Mutations to SCN1/2A leads to genetic 
epilepsy with febrile seizures plus (GEFS+), characterised by febrile seizures in infants, persisting 
beyond 6 years of age (Wallace et al., 1998). In addition, mutations to SCN1B have also been 
reported in GEFS+ patients (Wallace et al., 2001).  
Dravet’s syndrome (DS, Severe myoclonic epilepsy of infancy) is another inherited epilepsy 
syndrome, the hallmarks of which include febrile seizures during the first year of life and 
impaired psychomotor development (Dravet & Bureau, 1981). Furthermore, seizures observed 
in DS often do not respond to anticonvulsant treatment (Lossin, 2009). Mutations in SCN1A are 
observed in 33%-100% of patients with DS (Tonekaboni et al., 2013). Mutations of sodium 
channels have been shown to promote a gain-of-function effect, leading to hyperexcitability of 
neurons, however whether this mechanism is consistent between mutations to other sodium 
channels is yet to be determined (Lossin, 2009). 
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In combination with section 1.3.2, mutations to sodium-activated potassium channel ‘KCNT1’ 
can result in severe epileptic encephalopathies, via faster recovery from AP discharge, leading 
to rapid firing (Quraishi et al., 2019). 
1.3.4 Chloride 
Chloride (Cl-) is the most abundant negatively charged ion in the body, and its homeostasis is 
regulated predominantly by membrane Cl- channels and transporters, particularly the Cl- 
extruder: potassium-chloride co-transporter (KCC2) (Chamma et al., 2012). Cl- in the CNS plays 
crucial roles in neurotransmitter uptake and moderating neuronal excitability by determining 
the responses of the inhibitory neurotransmitters γ-aminobutyric acid (GABA) and glycine on 
post-synaptic cells (Ben-Ari et al., 2007). In particular, Cl- modulates inhibitory responses from 
activation of GABAA receptors to reduce neuronal excitability via the maintenance of 
hyperpolarising GABAergic transmission (Di Cristo et al., 2018; Rahmati et al., 2018). With 
relevance to epilepsy, KCC2 mutations have been found to attenuate Cl- movement and hence, 
impairs inhibition, leading to neuronal excitation (Duy et al., 2019).  
1.3.5 Neurotransmitter involvement in seizure 
Synaptic transmission involves the release of neurotransmitter from a pre-synaptic nerve 
terminal across a synapse to receptors on the post-synaptic neuronal membrane. 
Neurotransmitters are an absolute requirement for brain function at every level, hence they can 
play integral roles in seizurogenesis. Glutamate and GABA are the major excitatory and 
inhibitory neurotransmitters in the mammalian CNS, respectively. 
1.3.5.1 Glutamate and excitation 
Glutamate is the main excitatory neurotransmitter in the human brain. Put simply, 
depolarisation (excitation) is mediated by synaptic currents resulting from glutamatergic 
transmission. Glutamate and its associated receptor agonist subtypes can stimulate a variety of 
ionotropic and metabotropic receptors to exert its excitatory effects. The N-methyl-D-aspartate 
(NMDA) and amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors are 
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particularly important in seizure and activation of multiple NMDA receptors (NMDAR) further 
depolarises the cell and promotes increased Ca2+ influx (Vaughan & Delanty, 2003). At resting 
potential, NMDAR are blocked by magnesium (Ruppersberg et al., 1994), which can be rapidly 
removed via depolarisation (Mayer et al., 1984). Increased depolarisation during seizure can 
lead to increased NMDAR activation and hence, NMDA and AMPA receptor antagonists are well-
known to suppress seizurogenesis (Blauwblomme et al., 2014). AMPA receptor activation 
enables K+ and Na+ flux into the cell, generating a fast excitatory postsynaptic current (EPSC). 
The flow of ions from the EPSC generates an excitatory postsynaptic potential (EPSP), which 
increases the likelihood of reaching the threshold for AP firing. EPSCs are also generated by 
NMDA and kainate receptor agonism, however, the kinetics of NMDAR pore unblocking are 
complex and consist of both rapid and slower components, resulting from the magnesium pore 
block (Vargas-Caballero & Robinson, 2003). The strength of the EPSCs can vary between 
receptors, however, small EPSCs can integrate excitatory inputs over a large time period so 
could still lead to AP discharge (Lerma, 2003). 
1.3.5.2 GABA and inhibition 
γ-aminobutyric acid (GABA) is the principle inhibitory neurotransmitter and as such, plays an 
important role in counterbalancing neuronal excitation and excessive AP discharge. GABA 
antagonism is a major mechanism of seizurogenesis, as the inhibition of GABA’s inhibitory mode 
of action results in excitation. This is supported by common GABA agonists such as 
benzodiazepines and barbiturates, which are known to be anti-convulsive and function by 
enhancing the inhibitory effect of GABA (Wong et al., 2010). Similarly, antagonistic agents which 
block GABA synthesis (such as isoniazid) are documented pro-convulsants (Treiman, 2001). In 
this context, GABA acts upon either the GABAA or GABAB receptor (GABAR), regulating Cl- entry 
or increasing K+ conductance, respectively. GABAA are postsynaptic receptors, whereas GABAB 
are found presynaptically (Bromfield et al., 2006). GABAergic transmission mostly results in 
hyperpolarisation (making AP discharge less likely) and GABAergic synapses are most abundant 
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in GABAergic interneurons (discussed below). Cl- currents hyperpolarise neurons as they enter 
the cell, reducing the likelihood that threshold will be reached for AP discharge. Stimulation of 
metabotropic GABAB receptors decreases Ca2+ entry to the presynaptic cell, reducing 
neurotransmitter release (Treiman, 2001).  
1.3.6 Interneurons and their role in seizure 
Despite the seemingly well-understood evidence of inhibitory neurotransmission, the effects of 
GABAA receptor-mediation are paradoxical. GABAergic interneurons (GIN) are a diverse subset 
of neurons, widely expressed throughout the CNS, which function predominantly as inhibitory 
cell types. However, depending on the brain region and disease conditions, the effects of GIN 
may also be excitatory (Snodgrass, 1992; Ye & Kaszuba, 2017). Whilst interneurons 
hyperpolarise roughly 80% of pyramidal neurons in the cortex (Benes & Berretta, 2001), the 
remaining 20% become depolarised (Blauwblomme et al., 2014; Neske et al., 2015), challenging 
the popular tenet that GIN are consistently inhibitory in nature.  
The past decade has seen an increase in evidence that GABAA receptor-mediated mechanisms 
and GIN in particular, are involved in seizurogenesis (Huberfeld et al., 2015) and that the onset 
of seizure correlates with reduced neuronal firing and enhanced GABAergic interneuronal 
network activity (Librizzi et al., 2017). Moreover, in the absence of ionotropic glutamatergic 
transmission, enhanced GABAergic activity alone is sufficient to result in epileptiform activity in 
in vitro experimental slice preparations and synchronised burst firing of pyramidal neurons 
(Lévesque et al., 2016; Uusisaari et al., 2002). Interestingly, depolarising effects of GABA are 
seen in developing cortical networks alongside chronic epileptic brains, due to reduced 
capability of the neuronal Cl- transporter KCC2 (discussed above), which renders neurons with 
a high intracellular chloride concentration. A different transporter (NKCC1), imports Cl- into the 
immature cells, resulting in Cl- efflux, which depolarises the membrane and leads to excitation 
(Wang & Kriegstein, 2009). During seizure, excessive inhibitory currents may overload KCC2’s 
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Figure 1.2: Ion transmission at excitatory and inhibitory synapses. Glutamate release from 
excitatory presynaptic cells binds to various glutamate receptors (GluR) on the postsynaptic 
membrane, resulting in sodium influx and subsequent calcium increase and depolarisation. 
Potassium efflux occurs via potassium receptors (KR), leading to an overall increase in potential 
in the postsynaptic cell. GABA release from inhibitory neurons binds GABAA subtype receptors 
(GABAR), leading to chloride influx, resulting in a decrease in membrane potential and 
hyperpolarisation. The potassium chloride transporter 2 (KCC2) facilitates flux of chloride and 
potassium to restore baseline potential.  
 
Whilst the precise mechanisms of GIN-mediated excitatory effects are not entirely understood, 
several suggested mechanisms have been postulated. Firstly, GIN can excite post-synaptic 
neurons due to the raised reversal potential of GABAR in post-synaptic cells. Secondly, the 
continuous activity of GIN could lead to reduction in GABA levels, preventing their inhibitory 
mode of action on excitatory pyramidal cells. Excessive depolarisation of GIN can result in a 
depolarisation block and subsequent failure to fire AP (Trevelyan & Schevon, 2013). Thirdly, GIN 
can synchronise network activity during seizure activity and in addition, GIN can disinhibit other 
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GIN, leading to excitation (Ye & Kaszuba, 2017; Zhu et al., 2018). Furthermore, GABAR 
antagonism results in more rapid spread of seizure activity suggesting interneurons provide an 
inhibitory restraint on seizure propagation (Wenzel et al., 2017) and breakdown of feed-forward 
inhibition occurs during the spread of seizure activity across the cortex (Trevelyan et al., 2006, 
2007), which is likely due to membrane depolarisation of GIN (Cammarota et al., 2013). As such, 
the roles which GIN function and dysfunction play in seizure are myriad, complex and not fully 
understood.  
Synchronisation of neurons is essential for seizure activity, and interconnectivity between 
neuronal subtypes in the cortex supports network synchronisation, mediated by GIN (Magloire 
et al., 2019). It has been demonstrated that synchronisation and hyperexcitation observed in 
seizures can result from altered GIN activity (Avoli & de Curtis, 2011; Dinocourt et al., 2003; 
Hedrich et al., 2014). Pyramidal cells in all layers of the cortex project locally and distally to other 
pyramidal cells, as well as GIN. Each cortical neuron receives thousands of excitatory synaptic 
inputs, and as functionally related areas are particularly highly interconnected, neuronal activity 
can spread very rapidly between these densely unified regions (McCormick & Contreras, 2001). 
GIN such as the basket cells innervate pyramidal neurons and as they are distributed throughout 
the cortex and cerebellum and are multipolar, they connect to many surrounding cells. As a 
result, discharge of a single GIN can result in the synchronous hyperpolarisation of the 
surrounding population of pyramidal cells and characteristic epileptiform activity.  
The effects of GIN-mediated seizure activity can also affect ion currents. As the inhibition 
depletes and the cell begins to depolarise, currents such as the T-type Ca2+ current become 
active, which are regarded as pivotal mechanisms underlying the generation of neuronal burst-
firing (Cain & Snutch, 2013). Whilst relatively inactive at RMP, hyperpolarisation relieves 
inhibition and influx of Ca2+ occurs. T-type Ca2+ channels require only low-threshold 
depolarisations for bursts of action potentials and are the first to respond to small 
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depolarisations, with their activity leading to further depolarisation of the cell. Indeed, blockade 
of the voltage-gated Ca2+ channel can prevent burst-firing activity of neurons, which normally 
result in seizure. In fact, this is the mechanism of action of ethosuximide, which is used as an 
anticonvulsant (Leresche et al., 1998). Finally, gap junctions facilitate low-resistance movement 
of current between cells; particularly between GIN in the cortex and other GABAergic cell types. 
This promotes rapid and effective synchronisation between local networks (Scharfman, 2007). 
In summary, the roles of interneurons in controlling and indeed, in generating seizures are a 
highly significant complicating factor in epilepsy and seizure, hence, their inclusion is essential 
for a heterogenous epileptic model.  
1.3.7 Astrocytes and their role in seizure 
Many studies of seizures describe properties of excitatory and inhibitory neurons and the 
resulting networks which form from their interaction. However, glial cells such as astrocytes, 
oligodendrocytes, microglia and Schwann cells perform vital tasks in the nervous system. It has 
been shown that the neuron:glia ratio varies considerably throughout areas of the brain (von 
Bartheld et al., 2016). In the cerebellum, glial cells make up only 18.9% of cells, whilst in the rest 
of brain this figure can increase to 91.7% (Herculano-Houzel, 2014). Despite this very significant 
quantity, it is only relatively recently that astrocytes have been studied in sufficient depth to 
appreciate the full diversity of their roles in the brain and seizure.  
There are several ways in which astrocytes are actively involved in transmission at synapses and 
consequent excitation of neurons and as such, their typical neuronal-supportive function is to 
protect against hyperexcitation and seizure activity (Volman et al., 2012). Excessive 
glutamatergic excitation of neurons can cause excitotoxicity, resulting in damage to, and the 
eventual death of the neuron (Maragakis et al., 2004). Astrocytes take up excess ammonia and 
glutamate from the synaptic cleft via the GLT1 (EAAT2) transporter (Maragakis et al., 2004) and 
use glutamine synthetase to convert it to glutamine via a condensation reaction (Choi, 1987). 
Inhibition of astrocytic glutamine synthetase has been implicated in multiple neurodegenerative 
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disorders, including epilepsy (Eid et al., 2013). Furthermore, GLT1 knockout rats have an 
increase in neuronal cell death and in extracellular glutamate concentration, characteristic of 
excitotoxicity (Rothstein et al., 1996). Alongside glutamate, astrocytes can affect extracellular 
GABA levels. Increase of GAT3, the astrocytic GABA transporter, reduces extracellular GABA 
prior to seizure onset (Lee et al., 2006).  
In addition to neurotransmitter levels, healthy astrocytes also regulate the extracellular 
concentration of Na+, K+, Cl- and Ca2+, determining the reversal potentials of these ions in 
neighbouring neurons. Indeed, alteration to the reversal potential has a direct effect on cell 
excitability (Annunziato et al., 2013). In particular, astrocyte membranes are highly permeable 
to K+, as they contain many potassium channels along with sodium/potassium ATPases, which 
together normally prevents hyperexcitability of neurons (Carmignoto & Haydon, 2012). In 
rodent models, these transporters are responsible for maintaining low extracellular K+ levels 
and importantly, restore resting levels of K+ following epileptiform activity (Coulter & 
Steinhäuser, 2015). Dysfunction of astrocytic uptake of extracellular K+ and astrocytic 
uncoupling can lead to the generation and propagation of seizure (Bedner et al., 2015). 
Interestingly, astrocytes can regulate osmotic homeostasis via selective membrane water 
channels called aquaporins (AQP). AQP4 is highly expressed in the end-feet of astrocytes, 
surrounding capillaries and the BBB, and is highly abundant at sites of fluid transport (Hubbard 
et al., 2015). There is an increasing body of evidence for the ability of astrocytes to affect K+-
mediated epileptiform activity by regulating extracellular cerebrospinal fluid (CSF) volumes. This 
was hypothesised following the observation that astrocytic AQP4 is often co-localised with 
Kir4.1 potassium channels (Nagelhus et al., 2004) and that in AQP4 knockout mice, decreased 
water permeability (Solenov et al., 2004) and significantly impaired K+ clearance was reported 






Figure 1.3: Excitatory tripartite synapse and the role of astrocytes in excitability. The tripartite 
synapse is formed between the pre and postsynaptic nerve terminals and the close proximity of 
astrocytic end feet. Upon depolarisation and release of neurotransmitter at the presynaptic 
terminal (blue dots), some glutamate can diffuse to metabotropic glutamate receptors (mGluR) 
on astrocytes. Stimulation of astrocytic mGluR results in elevation of inositol trisphosphate (IP3) 
and subsequent calcium release (pink dots). This increased astrocytic calcium can cause release 
of astrocytic glutamate (orange dots). Release of intracellular astrocytic calcium can lead to 
glutamate release, affecting presynaptic mGluR and postsynaptic NMDA receptors, enhancing 
presynaptic release or postsynaptic excitability, respectively.  
 
Moreover, in these knockout models, the duration of seizure activity was increased (Binder et 
al., 2006). The evidence suggests that astrocytic regulation of fluid in the extracellular 
environment can lead to depolarisation of astrocytes from K+ accumulation, activating a sodium-
bicarbonate cotransporter, which leads to a surge in intracellular osmolarity. As a result, water 
intake into the astrocytes via AQP4 increases, leading to swelling of the cell and shrinkage of its 
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surrounding extracellular space. The decrease in extracellular space reduces the distribution 
area for extracellular K+, lowering the seizure threshold and promoting excitability (Volman et 
al., 2012).  
Astrocytes can release glutamate and ATP via calcium-dependent gliotransmission, which in 
turn, can regulate neuronal activity (Hubbard & Binder, 2016), including synchronisation of 
neurons in the hippocampus (Angulo et al., 2004). Furthermore, application of ATP analogues 
has been shown to evoke neuronal excitation and promote seizure activity (Rassendren & 
Audinat, 2016). Alongside gliotransmitter release and ion buffering and uptake, connectivity 
between astrocytes and neurons can influence seizure dynamics. It is now accepted that 
neurons and astrocytes communicate bidirectionally, and that their interaction is achieved by 
close physical proximity of the pre-synaptic membrane, post-synaptic membrane and glia, 
termed the ‘tri-partite synapse’ (Figure 1.3). Whilst neurons are synaptically connected, 
astrocytes communicate through gap junctions, via calcium signalling, which enables them to 
redistribute neuro/gliotransmitters and ions released by neurons in the tripartite synapse 
(Perea et al., 2009). During preictal activity, astrocytes are highly active and display synchronised 
activity across large brain distances, independent of neuronal activity. In addition, glial activity 
surges during seizurogenesis, and consequently produces a strong increase in neuronal network 
activity (Nikolic et al., 2019) via a rapid increase in extracellular glutamate and gap junction 
signalling (Diaz Verdugo et al., 2019). The roles of astrocytes in a healthy system and in seizure 
activity warrant their inclusion in studies of disease and epileptogenesis. Their ability to 
influence neuronal excitation and integrate into healthy and epileptic networks highlights their 
absolute relevance to seizure activity and may provide previously unconsidered contributions 





1.4 Anti-epileptic drugs 
Despite the prevalence of epilepsy globally, the same anti-epileptic drugs (AED) have been used 
for several decades (Dichter & Brodie, 1996). Although there are roughly 25 AED licensed for 
clinical use, many patients find themselves on a combination of established medication, termed 
‘rational polytherapy’, as roughly 30% of patients have drug refractory epilepsy (Perucca et al., 
2007). In turn, rational polytherapy increases the occurrence of ADR. Recent years have seen 
the development and clinical use of numerous new AEDs, which are superior in their reduction 
of ADR and teratogenicity and have increased target specificity. However, despite these obvious 
benefits, the new classes of drugs offer no improved anti-epileptic effect compared with 
traditional AEDs (Hanaya & Arita, 2016), even though newer AEDs presented with novel 
mechanisms of action (Shih et al., 2013).  
Many first-generation agents, including phenytoin and benzodiazepines, modulate sodium 
channels to prevent neuronal depolarisation and excitability, or function as GABA agonists to 
increase inhibition, respectively. Whilst new agents would seem a welcome inclusion to 
treatment of seizure and epilepsy, Perampanel (Fycompa), a clinically approved novel inhibitor 
of AMPA-induced intracellular Ca2+ increases, has potential for abuse and addiction (Shih et al., 
2013). There exists a delicate balance between anti-epileptic effect and ADR for even the newer 
AEDs, suggesting that the development of AEDs with a high safety profile that is also efficacious 
is a significant challenge.  
A compound gaining significant media attention and notoriety is cannabidiol (CBD), that has 
demonstrated anticonvulsant properties via modulation of G protein-coupled receptor 55 at 
excitatory synapses. It is believed to reduce intracellular Ca2+, alongside adenosine-mediated 
signalling (Nichols & Kaplan, 2020). Its notoriety arises from its derivation from cannabis plants, 
currently categorised as a Class B controlled substance in the UK, however, CBD can also be 
produced synthetically and does not act directly upon the cannabinoid receptors (Lattanzi et al., 
2018). As such, the psychoactive side effects reported from illegal cannabis use is not of concern 
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when taking CBD therapeutically. Whilst currently licensed for use in severe epilepsy cases, 
further study into this seemingly safe, efficacious compound is required before widespread 
prescription can be expected.  
The exact mechanisms of action of all AED are beyond the scope of this thesis, with the 
exception of the first-generation AED sodium valproate, which is discussed in detail in Chapter 
6.1. Figure 1.4 briefly summarises the action of many AED.  
Figure 1.4: Mechanisms of action of anti-epileptic drugs. AEDs display diverse mechanisms of 
action, affecting both inhibitory and excitatory nerve terminals. GAT-1: sodium and chloride-




1.5 Current animal models of seizure-liability 
CNS toxicity testing of any new pharmaceutical is a vital procedure and a legal requirement for 
safety pharmacology studies (ICH, 2000). A drug-induced seizure is an example of a potentially 
fatal ADR and is the most commonly encountered CNS-related issue during the drug 
development process (Authier et al., 2016). Pre-clinical seizure liability (PSL) testing is essential 
to identify such ADRs, however these tests usually occur late in the drug development process 
(Figure 1.5) (Easter et al., 2007). Despite the severity of drug-induced seizure, there are no 
official guidelines outlining how this issue should be tested and regulated (Easter et al., 2009; 
Will et al., 2016). In vitro and in vivo models enable potential side effects to be discovered 
earlier, thereby saving time, cost and resources. However, current models are hindered by 
limitations such as low-throughput capabilities, heavy reliance on animal studies and arguable 
relevance to man, whilst often incurring considerable financial expense. Furthermore, with 
relevance to in vivo PSL testing, the severity of assays frequently requires specialist 
practitioners, further increasing costs and decreasing throughput. In 2018, the UK performed a 
total of 474,000 procedures on animals for regulatory testing, of which toxicity testing 
comprised 31%. In addition, over 200,000 procedures were carried out for basic nervous system 
research (21% of all basic research) (Home Office, 2018). There is increasing pressure to reduce 
the numbers of animals used, without sacrificing on the quality of information provided by such 
tests.  
Current effective in vitro models include rodent brain tissue slices and CNS cell cultures. These 
have been employed for decades and are credited with the discovery of mechanisms pertinent 
to seizure, epilepsy and neurobiology in general. Animal-based models of seizure are important 
for defining epileptogenic and ictogenic activity, as well as providing a reference point for the 
more recent human-based research. Whilst seizure describes a full ictal event in vivo, the term 
‘seizure-like event’ (SLE) more accurately describes the effects seen in in vitro and predictive in 
silico models.  
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There are many animal-based in vitro and in vivo models for seizure-liability testing. For 
simplicity, the following section will focus on the models most commonly used in toxicity 
screening. Most current models employ rodents, as the rodent brain develops incredibly rapidly, 
with a gestation period of 18-24 days and tissue can be ready for neurological experimentation 
from Day 7-10 postnatal; compared with 9 months gestation for humans, followed by years of 
maturation (Murray et al., 2010; Semple et al., 2013). 
1.5.1 In vivo methods 
It has been estimated that a single compound requires several hundred rodents and 
approximately £1 million for complete assessment of neurotoxicity and seizure liability (Moser, 
2011; OECD, 2006; Smirnova et al., 2014), due in part to the low-throughput capabilities and 
specialised tests performed on whole animals. Whilst the range of species used is considerable, 
varying from zebrafish to baboons, there exists no standard platform for which all methods of 
inducing seizure in vivo can be applied. 
Despite this considerable expense, there are many established in vivo models for modelling 
epilepsy and PSL, ranging from the cortical implantation of metals known to induce seizure, to 
drugs known to modulate GABA inhibitory activity, to electroshock and implanted electrode 
models (Rubio et al., 2012). These models were classified according to their method of 
epileptogenesis (Fisher, 1989), summarised in Table 1.1. Discussion of these is beyond the scope 
of this thesis, however an excellent review into in vivo models of epilepsy and seizure is available 





























Figure 1.5: The drug development process (Grainger et al., 2018). Taking anywhere up to 15 
years and a cost of ~$1.7 Billion, the process can be separated into pre-clinical and clinical 
testing. Pre-clinical studies consist of in silico, in vitro and in vivo animal and cell-based assays. 
Post-market surveillance continues indefinitely (Paul et al., 2010). Reducing these studies or 





Table 1.1: Classification of in vivo models of epileptogenesis, based on ILAE guidelines (Fisher, 
1989; Rubio et al., 2012). 
Simple partial seizure models 
Cortically implanted metals 
Aluminium, Cobalt, Zinc 
Complex partial seizure Model 
Kainic Acid administration 
Repetitive electrical stimulation 
(Kindling) 
Tetanic Toxin administration 








Generalised absence seizure models 
Audiogenic seizures in mice 
Genetic: Photosensitive baboons 
Status epilepticus Pilocarpine 
 
1.5.2 In vitro methods 
Whilst in vivo methods ensure a living, complete system and provide insights not only into the 
cellular effects of seizure induction, but also behavioural and physical aspects, they are not high-
throughput systems, are very expensive and raise considerable ethical concerns. In vitro models 
are often used as complements to whole animals, beneficial for their increased throughput and 
less specialised tests. A comparison of the most common methods of PSL using in vitro models 





1.5.2.1 Acute slice assays 
In a 2016 industrial survey of nervous system safety pharmacology, the rat ex vivo hippocampal 
slice assay was found to be most commonly used for seizure-liability testing (Authier et al., 
2016). Slices can be obtained from any region of any species with a complex brain. Hippocampal 
slices (HS) are useful in vitro models as they retain a defined cytoarchitecture and relevant 
receptors and constituents of the full brain system, including inter-area connectivity. This is of 
great importance, as the cause of seizures and epileptiform activity can be complex and 
interlinked with multiple hierarchical levels of the CNS (Scharfman, 2007). External conditions 
can be precisely controlled and manipulated with HS. Indeed, slice assays typically involve 
manipulation of the extracellular ionic milieu to induce SLE, discussed in Chapter 4.1. 
Furthermore, the mechanisms by which different agents induce SLE is highly variable. With 
tissue slices, it is more likely that all necessary cell types and receptors to respond to diverse 
pharmacological agents are present. Acute slices are harvested from adult rodent brain, 
intended for experimentation on the same day to study individual neurons or neuronal circuits 
(Lein et al., 2011). However, difficulties in inter-species extrapolation reduces the utility of the 
platforms and inevitably, slice preparations undergo important cellular and environmental 
changes including ischaemia and severing of projection neurons that would have connected the 
slice to the rest of the system. 
Obviously, human brain tissue is problematic to obtain (except for limited excised epileptic 
tissue), so efforts to refine the commonly used rodent HS or replace with non-human primates 
have been attempted (Easter et al., 2007). Once removed from the animal, slices rapidly begin 
to deteriorate, making them an expensive and low-throughput model system; however, a semi-
automated platform has been validated for use in pre-clinical testing, allowing multiple slices 
per animal to be perfused simultaneously, thus, increasing the throughput capabilities of the 




1.5.2.2 Organotypic slice assays 
In contrast to acute slice preparations, organotypic slices (OS) are derived from neonatal 
rodents and are maintained in vitro for several weeks (Lein et al., 2011). Compared with acute 
slices, OS require more time and resources; in particular, culture medium which can provide 
essential growth factors, hormones and metabolites; which may or may not include serum. As 
variability between culture media can frequently be attributed to serum, chemically defined 
media have also been developed and have been shown to support OS culture and more 
importantly, facilitate seizurogenesis (Liu et al., 2017).  
Organotypic slices are representative of their respective in vivo counterpart. They contain most 
of the neuronal subtypes present in the brain and retain local intrinsic connective properties of 
the tissue. As previously mentioned, excision of acute slices leads to cellular damage, ischaemia 
and an altered metabolic state, however OS can recover from these insults during culture and 
have been shown to exhibit synaptogenesis and early studies demonstrated the formation of 
new functional contacts (Chen et al., 2008; Robain et al., 1994; Sato et al., 2007). Furthermore, 
any necrotic cells or debris disappears after several weeks in culture (Lein et al., 2011). OS are 
particularly useful for assessing long-term effects of agents or SLEs, as they can be further 
incubated following experimentation. 
Despite the supposed benefits of OS, there are limitations in using them as models, cf acute 
slices. There is concern that as the tissue is harvested from neonates, that this is not entirely 
representative of adult tissue. Whilst any acute damage to OS rectifies itself, synaptic 
reorganisation and axonal/dendritic remodelling can occur from destruction of afferent 
connections of neurons – a process termed deafferentation (Gutiérrez & Heinemann, 1999). The 
trauma of slicing can also activate glial cells, leading to the formation of an astrocytic scar, which 
was believed to prevent axon regeneration; although this is now disputed (Anderson et al., 
2016; Lein et al., 2011).  
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1.5.2.3 Primary cell culture assays 
The second most commonly used model system for seizure-liability studies is primary neuronal 
cell cultures (Authier et al., 2016). Similarly to slice models, primary rodent CNS cultures can 
contain most, if not all, of the components of intact cortex, which bear a true resemblance to 
the cells in vivo. However, the structure and three-dimensional nature of the brain is lost. Unlike 
slice assays, cell cultures are typically higher throughput, but do take several weeks in culture 
to reach maturity, as is the case with OS.  
Whilst neurons are an absolute requirement for seizure activity, they are not the only cell type 
involved (Section 1.3.7). Indeed, omitting other cell types, or culturing ratios of subtypes not 
representative of in vivo ratios could affect the validity of such models. There is also concern 
that certain receptors or channels may not appear in cultured neurons, which may or may not 
influence the outcome of experiments (Dichter & Pollard, 2006). Despite this, primary cell 
culture assays can reliably and consistently predict seizure-liability. Recent literature has 
produced a comprehensive in vitro screen for seizure-liability using primary rat cortical neurons, 
including ratios of neurons and astrocytes observed in the intact rat brain (Bradley et al., 2018). 
In addition, the predictive capability of rat cortical models from cultures containing both 
excitatory and inhibitory neuronal subtypes has been demonstrated (Kreir et al., 2018). In both 
instances, rodent cells were shown to be able to respond to a large group of agents known to 
induce SLEs, with consideration of multiple neural activity markers. However, like OS, there is 
controversy over when the cultured cells reach maturity and at which point they should be used 
for seizure-liability studies so that they are as representative of the living system as possible. 
Arguably, the most important consideration for epileptiform studies is the capability of cells to 






1.6 Human neurotoxicity models  
Just as many animal-based models have been developed and widely used for disease modelling 
and drug testing, there exists several human cell models which have been used as animal 
alternatives for some time. Whilst these models have the benefit of being human derivatives 
and are rapidly cultured with relatively low expense, these methods are outdated and inferior 
compared to animal models. Two particular human cancer cell-derived models are most well-
known: the neuroblastoma SH-SY5Y cell line and the embryonal carcinoma NT2/D1 line.  
1.6.1 SH-SY5Y Neuroblastoma line 
The subclone of neuroblastoma line SK-N-SH, SH-SY5Y neuroblast-like cells can be differentiated 
in the presence of retinoids, to form neuronal-like cultures, possessing a similar karyotype to 
human cells (Biedler & Schachner, 1978; Yusuf et al., 2013). SH-SY5Y cells are mostly used for 
studies with dopaminergic pathologies, such as Parkinson’s disease, owing to their tendency to 
generate dopaminergic neurons (Shipley et al., 2016). Despite the publishing of protocols to 
differentiate SH-SY5Y into adrenergic-like and cholinergic-like subtypes (Shipley et al., 2016), 
the author is unaware of any reliable protocol for the generation of cortex-specific neurons; 
likely a result of SH-SY5Y not being precursors to any specific cell fate. Moreover, functional 
studies have been performed using SH-SY5Y cultures, wherein changes in K+ conductance to 
known seizurogenic agents were not observed and electrophysiological properties were highly 
variable (Tosetti et al., 1998). SH-SY5Y are not an appropriate system for studying seizure-
liability, owed to their lack of heterogeneity, their functional inactivity and the display of several 
genetic aberrations, typical of a cancer cell origin (Xicoy et al., 2017).  
1.6.2  NT2/D1 Embryocarcinoma cell line 
In contrast, the NTERA-2 cl. D1 (NT2/D1) cell line has been widely used to generate both neurons 
(Andrews, 1984) and functional astrocytes, following retinoid treatment and mitotic inhibition 
(Bani-Yaghoub et al., 1999). Compared with SH-SY5Y, the individual cell types are functional, 
displaying complex network activity including wave propagation and respond to various 
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compounds with increases or cessation of calcium-mediated activity, where appropriate (Hill et 
al., 2012). Further research in our laboratory has confirmed these culture models are effective 
as platforms for toxicological investigations and pharmacological interrogation (Hill et al., 2012; 
Tarczyluk et al., 2015; Woehrling et al., 2006, 2007, 2010, 2011, 2013). 
NT2 D1 differentiate to form co-cultures of functional neurons and astrocytes within 2 months, 
without the need for expensive or specialised growth medium considerations. The 
differentiation process is reproducible and faster than other stem cell models, making them an 
attractive model system. However, as with SH-SY5Y cultures, NT2 cells originate from a cancer 
cell, which can preclude their usage when other, non-cancerous cell types are available. Indeed, 
NT2’s have been shown to contain a highly variable karyotype of up to 60 chromosomes in a 
large percentage of cells (Mostert et al., 1996).  
1.6.3 Human tissue 
Current research into the mechanisms and treatment of drug-refractory epilepsy is using 
resected human tissue from patients. This condition is diagnosed when seizures cannot be 
controlled by at least two or three anti-convulsants appropriate for the epilepsy syndrome (Tang 
et al., 2017). The possibilities for human tissue range from histopathological analyses, to 
modulation of SLE in drug-resistant tissue and the testing of novel anti-convulsant compounds 
and electrophysiological investigation (Gabriel et al., 2004; Hsiao et al., 2015; Klaft et al., 2016). 
Furthermore, several methods are now available that increase the longevity of the resected 
tissue, enabling increased throughput of investigations (Schwarz et al., 2017; Wickham et al., 
2018). However, it is unlikely that enough human tissue will ever be available for high-
throughput compound screening. Furthermore, the tissue is often in a diseased state, which 
may demonstrate different responses to otherwise healthy tissue.  
Ethical considerations and consent also need to be obtained to use human tissue, further 
complicating an already limited process. Human stem cells could provide a viable alternative to 
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human tissue, allowing researchers to generate functional neuronal networks for high 
throughput drug testing. 
It is also possible to obtain human cerebrospinal fluid (hCSF) from patients, which has been 
shown to have a protective effect on resected human tissue, promoting longevity compared 
with culture medium (Schwarz et al., 2017). Furthermore, preservation of electrophysiological 
properties, including network-level activity is observed. Whilst it appears unlikely that hCSF 
would be readily available in the quantities necessary to culture and assess iPSC-derived neural 
models, it would nevertheless be interesting to determine what effects, if any, this composition 
has on the electrophysiological activity of the cultures. 
1.7 Requirements for a human in vitro model of seizure-liability testing 
As discussed above, an ideal model system for in vitro PSL testing should therefore be able to 
recapitulate the information existing models provide and address some of their limitations. The 
most obvious shortcoming for current platforms used for seizure-liability testing is that they use 
animals. An ideal platform would therefore be relevant to humans, using cells which are 
phenotypically human, expressing human receptor proteins with which current convulsant and 
anti-convulsant compounds can interact. The cells should also be able to form functional 
neurophysiological networks, containing the various cell types seen in the intact brain, with 
brain region specificity, as opposed to current generic models. Importantly, the platform must 
be capable of pharmacological interrogation, of displaying phenotypic human seizure-like 
activity and of sensitivity to known therapeutic anti-convulsants. The system should also be 
robust and amenable to high-throughput testing and predictive of the effects of diverse 
neuroactive compounds. A human-based in vitro seizure-liability platform for pre-clinical 
neurotoxicity testing should in theory and practice, fundamentally perform as existing animal 
models do, whilst improving species translation with human seizure activity.  
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1.8 Human induced pluripotent stem cells  
Induced pluripotent stem cell (iPSC) technology (Takahashi & Yamanaka, 2006) is a ground-
breaking, revolutionary method, with considerable potential for toxicity testing and disease 
modelling, allowing the generation, growth and study of human cells without the need for 
invasive isolation procedures or extensive ethical approval. Previously, sources of human stem 
cells were primarily embryos, causing considerable political and moral controversy. In addition, 
the use of embryonic stem cells (ESC) in the clinic is limited by the rejection of the transplanted 
cells by the patient’s immune system (Park et al., 2008).  
Similarly to ESCs, human iPSCs can differentiate into any cell type generated by the three germ 
layers which develop in utero and retain the ability to propagate in culture indefinitely (Robinton 
& Daley, 2012). Pioneering work reprogrammed murine (Takahashi & Yamanaka, 2006) and 
human (Yu et al., 2007) fibroblasts via retroviral transduction of transcription factors: c-Myc, 
Oct4, Klf4 and Sox2; now referred to as the ‘Yamanaka Factors’.  Since the original methods of 
reverting adult cells to a state of pluripotency, there have been considerable advances and 
refinements in the process, moving from viral methods (which typically have large footprints, 
with viral vector sequences integrating into the genome) to episomal and mRNA-based 
reprogramming with typically lower footprints, which may be less efficient (Malik & Rao, 2013).  
The application of iPSCs extends from neurotoxicity testing and disease modelling to drug-
screening and cell-based therapies (Jung et al., 2012; Kumar et al., 2012). Neuronal cultures 
which are derived from human iPSC could be a suitable addition to PSL testing, as the systems 
are closer to humans than a primary rodent-derived cell line. In addition, a remarkable benefit 
of iPSCs is that they retain the genotype of the original fibroblast cell and indeed, any cell then 
generated from iPSCs also shares that genetic background. This is invaluable in disease research, 




1.8.1 iPSC-derived neural seizure-liability models 
The foremost aim of in vitro neurotoxicity tests, including iPSC-derived PSL models, should be 
to replicate the in vivo morphology and functionality as closely as possible. Diseases of the 
cerebral cortex are major causes of morbidity and mortality. Hence, iPSC-derived cortical 
neuronal systems could provide a reliable predictive base for PSL testing and are conceptually 
more relevant to toxicity testing than animal tissue, as they are human cells. Indeed, the cortex 
of primates is considerably different to that of rodents, with a marked increase in size relative 
to the rest of the CNS and its complexity (Shi et al., 2012a). Moreover, diversity of the neurons 
within the layers of the cortex and their respective developing stem cell populations means a 
truly representative model needs to use human stem cells to follow this pattern of 
differentiation.  
Protocols for the development of iPSC-derived cortical neurons and characterisation of cortical 
neurogenesis and terminal differentiation to achieve mature electrophysiological properties 
and functional excitatory synapses have been developed, as shown in Figure 1.6 (Chambers et 
al., 2009; Shi et al., 2012b). Neural induction methods for generating NPCs from iPSCs are 
classified into 3D spheroid-based and 2D monolayer protocols. Irrespective of the culture 
method used, the process is largely the same and it was found that both methods produce 
neurons with similar electrophysiological properties and similar morphological endpoints, with 
subtle differences in neurite length and proportion of progenitor cell expression 
(Chandrasekaran et al., 2017). 2D culture methods (Chambers et al., 2009; Shi et al, 2012b) 
produced more SOX1 positive cells, with smaller neurite extensions, whereas 3D floating sphere 
methods (Gunhanlar et al., 2017) produced cells with higher levels of PAX6 expression. In 
addition, 3D methods form neurons with longer neurite extensions, which may be advantageous 
for the production of forebrain cortical neurons (Chandrasekaran et al., 2017).  
In either case, the protocols are largely similar and involve the culturing of iPSCs on a gelatinous 
protein substrate, reminiscent of the basement membrane matrix. Neural induction involves 
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the suppression of epidermal fate, as opposed to the induction of a neural fate, meaning the 
default state of naïve ectoderm is neural (Colas & Schoenwolf, 2001). The inhibition of 
epidermal fate is achieved by the inhibition of SMAD signalling – which are a family of proteins 
that function as the main signal transducers for TGFβ and bone morphogenetic proteins (BMP) 
and are essential cytokines for development of the nervous system (Chambers et al., 2009). 
Inhibition is achieved via the synergistic action of two inhibitors (SB431542 and Noggin) which 
induces rapid and complete neural conversion of >80% of human stem cells under monolayer, 
adherent conditions (Chambers et al., 2009). Specifically, SB43142 is a small molecule which 
enhances neural induction via TGFβ inhibition and Noggin inhibits BMP.  
Figure 1.6: Neural induction of iPSCs to form neural subtypes. Patient fibroblasts are 
reprogrammed with the Yamanaka factors Klf-4, Sox2, c-Myc and Oct4 to a state of pluripotency. 
Dual SMAD inhibition of iPSCs via the small molecule SB431542 and Noggin/dorsomorphin can 
then induce the iPSCs to a neural fate, leading to the generation of neural precursor stem cells 
(NPCs), typically arranged in a cortical rosette structure. Defined growth medium and 
differentiation of NPCs leads to the generation of radial glia and glial progenitor cells, both of 
which can generate astrocytes. Neurons result following radial glia formation. Modified from 
Grainger et al., 2018. 
42 
 
Following the work of Shi et al., (2012a,b), it was found that vitamin A derivatives are crucial for 
induction of in vitro cortical neurogenesis, as is reported in vivo (Kim et al., 2010) and the use of 
retinoids, combined with an alternative small molecule SMAD inhibitor to Noggin 
(dorsomorphin) greatly reduces variation in cortical induction and increases efficiency of 
conversion to near 100% (Shi et al., 2012b).  
The development of iPSC-derived cortical cultures should demonstrate the presence of cortical 
neuronal markers, astrocytes and populations of excitatory and inhibitory neurons (which exist 
at roughly 80% to 20% in the human cortex, respectively (Shi et al., 2012a). Indeed, the cortical 
induction method proposed by Shi et al., (2012b) showed the generation of astrocytes following 
spontaneous differentiation. Moreover, it has been shown that human iPSCs can also be 
differentiated exclusively into astrocytes (Shaltouki et al., 2013) and interneurons (Kim et al., 
2014; Liu et al., 2013). This is of critical importance when considering the seizurogenic potential 
of novel compounds. An entirely excitatory or inhibitory culture is not a representative system 
and accurate drug responses may not be observed without inclusion of both major neural 
subtypes. Efforts have been made to determine the presence of excitatory and inhibitory 
neuronal populations and neuron/astrocyte ratios and it would appear that immunostaining for 
morphological assessment and pharmacological interrogation can suggest the 
presence/absence of such neuronal subtypes and astrocytes (Gunhanlar et al., 2017; Kuijlaars 
et al., 2016; Tukker et al., 2016). A complete, demonstrative, heterogenous system must include 
all subtypes and at ratios close to those observed in vivo. Furthermore, assessing the effects of 
compounds on astrocytes will provide increased accuracy and validity, particularly as astrocyte-
specific agents can be tested and monitored in mixed cultures (Hill et al., 2012). 
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Table 1.2: Comparison of current major seizure-liability testing platforms. Modified from Grainger et al., (2018). 
Model Benefits Limitations 
Acute slice assay • Representative of in vivo adult rodent brain • Difficulty in inter-species extrapolation 
• Same day experimentation • Preparations undergo cellular changes and damage 
• Validated for use • Projection neurons severed 
• Defined cytoarchitecture • Typically low throughput 
• Current ‘gold standard’  
• Forms functional network  
Organotypic slice culture • Representative of in vivo rodent • Difficulty in inter-species extrapolation 
• Retain connective properties of the tissue 
• Forms functional network 
• Derived from neonates, so may not be predictive of 
matured system 
• Can recover from damage from slicing • More time consuming than acute slices 
• Can assess long-term effects of neuroactive 
chemicals 
• Requires supportive culture medium 
• Synaptic reorganisation/remodelling 
Primary CNS culture • Representative of cell subtypes in vivo, as 
derived from intact system 
• Difficulty in inter-species extrapolation 
• Loss of structure and 3-dimensionality 
• Predictive model validated • More time consuming 
• Higher throughput than slices • Do cultured cells reach maturity? 
 • Often cultured in absence of astrocytes or other neural 
cells 
iPSC-derived culture • Human-based • Expensive 
• Exhibit humanoid morphology • Time consuming 
• No ethical considerations • Research still in infancy, lacking validation 
• Amenable to high throughput • No defined ultrastructure 
• Retain genotype of original fibroblast, so they 
can be used to model genetic components of 
human epilepsies 
• No standard protocol 




1.9 Functional analysis of iPSC-derived cultures 
Whilst there are now many emerging disease platforms and investigative models using iPSC-
derived neurons, research using human iPSC neural networks for the express purposes of drug 
screening is still in its infancy. It has been shown that iPSC-derived neurons respond 
appropriately to convulsant and pro-convulsant agents and could be utilised in PSL testing (Ishii 
et al., 2017; Odawara et al., 2014; Tukker et al., 2016). Whilst typical endpoints for current PSL 
tests include assessment of biochemical, morphological and physiological endpoints, the 
throughput capabilities of these assays are too low for toxicity screening. Changes to ion 
channels, calcium changes and network responses are implicated in many toxicity pathways and 
functional techniques used must be able to detect these changes. Convulsant compounds affect 
the nervous system and neuronal excitability as discussed in depth in Chapter 4. These 
disruptions in turn affect nervous system physiology, often preceeding or occuring in the 
absence of the typical morphological/biochemical changes. Furthermore, some existing 
methods fail to record the most rapid events, such as action potentials, or are not amenable to 
high-throughput testing, making them less desirable for toxicity screening. Therefore, methods 
used with iPSC-derived neural models must demonstate a relatively high-throughput capability, 
without compromising on the quality of the information obtained. Techniques enabling 
network-wide effects to be recorded and visualised would provide relevant endpoints to 
monitor drug induced SLEs. 
In many cases, gold-standard electrophysiological techniques such as patch clamping are 
employed to accurately monitor electrical activity and responses, however, these are invasive 
and are traditionally limited to measurement of a single cell. Individual manual patch clamping 
is also a very technically demanding and precise method and requires a high-level of expertise. 
However, there is potential to increase throughput capacity via automated patching systems, 
which can measure several neurons simultaneously (Kodandaramaiah et al., 2012) and indeed, 
recent developments have enabled multiple-cell patch clamping to be used in industrial 
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applications (Vardi et al., 2016). Whilst patch clamping is a particularly efficient and accurate 
method of studying ionic currents, its use for large-scale toxicity screening is not practical.  
1.9.1 Calcium Imaging  
Calcium imaging is a well-established technique which enables visualisation of free intracellular 
Ca2+ from populations of cells. Calcium indicators are sensitive to calcium movement and can be 
loaded in a non-invasive manner to neuronal cells, although, prolonged exposure to the dye is 
toxic. Fluorescent dyes can either be single wavelength or ratiometric. Fluorescent calcium 
imaging enables the researcher to explore  the role calcium is playing in the cell, due to specific 
calcium-mediated processes occuring over different time periods. For example, calcium-
mediated neurotransmitter release occurs much more rapidly than calcium-mediated gene 
expression in the nucleus (Grienberger & Konnerth, 2012).  
With regards to PSL, calcium imaging can be used to detect responses to electrical activity, 
oscillatory activity, synchrony and network activity, making it a very useful tool for assessing 
neural circuitry and drug responses (Smetters et al., 1999). This approach has been used in an 
effort to characterise the development and maturation of iPSC-derived neural calcium activity 
and to study network responses to neurotransmitters/drugs (Kirwan et al., 2015; Tukker et al., 
2016). These studies have demonstrated maturation of oscillatory calcium activity and 
increased activity when exposed to excitatory compounds. However, to the author’s knowledge, 
the use of calcium imaging as a method for PSL testing in iPSC-derived neural networks has not 
yet been demonstrated, despite preliminary work showing the capability of iPSC-derived 
neurons to respond to the GABA antagonist picrotoxin with increased synchronised activity 
(Kuijlaars et al., 2016). In contrast, the response of primary rodent neural cultures to a panel of 
neurotransmitters and convulsants has been shown by multi-well calcium imaging (Pacico & 
Meur, 2014), with large increases in repetitive calcium-mediated activity observed in the 
presence of pro-convulsants, suggesting that calcium imaging as a method for viewing SLE is 
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valid. Whilst the author in this case opted for a non-optical method of calcium imaging, the 
ability to visualise cell calcium activity in near real-time is extremely advantageous.   
Ultimately, optical fluorescent calcium imaging allows for greater resolution at a cellular level, 
as opposed to single cell patches which can miss considerable amounts of data and not 
necessarily inform on the activity of the entire network. Fluorescent calcium imaging of iPSC-
derived neural networks for seizure-liability testing has not previously been performed and as 
such, there is scope for this technique and platform to incorporate into the existing strategies 
for toxicity testing.  
1.9.2 Multi-electrode array recordings 
Multi-electrode array (MEA) systems are increasingly used with iPSC-derived cultures to assess 
spontaneous electrical activity, synchronous epileptiform bursting activity, drug-responses and 
network mechanisms, such as long-term potentiation and depression (Matsuda et al., 2018; 
Odawara et al., 2014, 2016a, 2016b; Seidel et al., 2017). MEAs take advantage of the generation 
of neuronal ion currents and membrane action potential firing. MEAs transduce this ionic 
voltage change to electronic current, which can then be detected and analysed by a wide range 
of commerically available and custom-made software.  
This cutting-edge technology is non-invasive, enabling the real-time analysis of activity in 
multiple locations in cultured neurons and recording of extracellular potentials and basic 
measures such as spiking and bursting activity and network responses (Johnstone et al., 2010). 
The use of primary rat cortical neurons on the MEA is well characterised, with extensive neural 
activity endpoints. The parameters and results from primary models are important for providing 
a comparative system for emerging iPSC-derived MEA data (Bradley et al., 2018). A number of 
studies have been carried out to determine whether MEA analysis of iPSC-derived neural 
networks is a viable option for toxicity screening. Furthermore, a broad panel of drugs have 
been evaluated, and results suggest that MEAs are a useful tool in screening compounds with 
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diverse mechanisms of action (Kasteel & Westerink, 2017; McConnell et al., 2012; Valdivia et 
al., 2014). In addition, over the past several years, multi-well MEAs have emerged, with capacity 
of upwards of 300-1000 recording electrodes. These systems significantly increase the 
throughput capabilities of primary cell culture and slice assays, further making them attractive 
systems for predictive toxicity tests and drug screening. 
As the throughput capabilities of MEAs increase and their usage in toxicity screening becomes 
more widespread, it will be important to generate standard protocols and definitions of SLEs in 
iPSC-derived models. A recent study by Bradley et al., (2018) has assessed a wide variety of 
endpoints to demonstrate epileptiform activity and network functionality, providing a 
comprehensive predictive primary rodent model. Whilst there are some commonalities 
between approaches, each group using MEAs for neurotoxicity screening assess different 
endpoints based upon their respective experimental design. For example, a common endpoint 
to consider is the number of spikes in a burst, with bursts being typical of epileptiform activity. 
However, the definitions set on burst parameters have large variation and as such, analysis is 
specific to particular cell lines, which makes standardisation difficult. Despite this, recent 
literature has suggested a stepwise method for detection of synchronised burst firings in iPSC-
derived neural cultures (Matsuda et al., 2018). This is a positive move towards standard 
protocols for assessing epileptiform activity using the MEA with human iPSC-derived cultures, 
with a particular emphasis on toxicity testing, especially as many difficulties in MEA analysis 
have presented themselves with this modern technique. Moreover, as this technology is a 
recent introduction to the field, there are challenges with culturing cells for experimentation, 
as historically MEA studies utilised slice assays, which do not require a specialised culturing 
protocol.  
Compared to traditional electrophysiological techniques, the MEA enables network electrical 
activity to be monitored, especially in the recent high-throughput systems. This means 
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substantially more data can be derived than for equivalent patch/ current clamp recordings, is 
more rapid and for epileptiform studies in particular, network activity visualisation is more 
beneficial than individual cells. A benefit of using these established techniques is that several 
software packages are available for data acquisition and analysis, many with user-friendly 
interfaces. However, for newer technology, software is limited and analysis is more complex.  
Presenting a novel method of seizure-liability testing of iPSC-derived neural cultures must 


















1.10 Aims and Objectives 
The current methods of pre-clinical seizure-liability testing are heavily reliant upon animal-
based platforms. Human induced pluripotent stem cell technology has revolutionised 
regenerative medicine, providing an essential tool for generating human cells in a non-invasive 
and ethically sound manner. The generation of morphologically distinct, functionally active, 
pharmacologically responsive neural cells from iPSC could supplement existing strategies in drug 
development, with more relevance to man, whilst removing doubts from inter-species 
extrapolation. To date, the inclusion of human-based platforms as models for seizure-liability is 
extremely limited, due to a lack of a complete, robust system. Furthermore, the methods used 
to assess seizure-liability in these cultures are developments in progress. Consequently, this 
thesis aims to contribute to the cutting-edge platforms of iPSC-derived toxicity testing.  
To that end, the overall aim of this thesis is to develop a protocol for the differentiation of 
human iPSC-derived cortical cultures which can respond to pro-ictogenic compounds with 
increased activity and synchrony and interface with a high-throughput analytical technique. 
In order to achieve this aim, the following objectives will be considered: 
1) To generate morphologically distinctive cortical cell types in culture, consisting of 
neurons, astrocytes, cortical layers and synapses, assessed via immunostaining and 
qPCR 
2) To produce electrically functional cultures, which can generate action potentials, 
network activity and respond to excitatory stimuli, via fluorescent calcium imaging and 
multi-electrode array analysis 
3) To induce hyperexcitable and hypersynchronous activity in culture, via addition of ionic 
and pharmacological manipulations widely used as convulsants in toxicity testing and 
observe said activity using optical and MEA approaches  




2: MATERIALS AND METHODS 
All reagents were purchased from Sigma-Aldrich (Poole, UK) unless otherwise stated.  
2.1 Cell culture  
2.1.1 Coatings 
Cultureware was pre-treated to improve the hydrophilicity of surfaces to enhance adherence of 
cells for long-term culture. All mentions of incubation refer to a humidified 5% CO2 incubator at 
37°C, unless otherwise stated. 
2.1.1.1 Plastic multi-well plates 
Plastic 6-well, 12-well and 96-well plates (Corning, CA, USA) were coated with 200 µL/cm2 of 20 
µg/mL poly-L-ornithine (PORN) and incubated for 4 hours, followed by two sterile dH2O washes. 
Laminin was dissolved in sterile dH2O to a 10 µg/mL working solution and coated at 200 µL/cm2, 
then incubated overnight. Prior to cell seeding, wells were washed with D-PBS without 
magnesium or calcium.  
2.1.1.2 Glass coverslips 
For immunocytochemistry and calcium imaging experiments, glass coverslips (13 mm thickness, 
VWR) were sterilised in 70% ethanol and dried overnight in the laminar flow hood to ensure 
evaporation. Coverslips were then placed in 6-well and 12-well plates and treated with PORN-
laminin as described in 2.1.1.1. 
2.1.1.3 Multi-electrode array planar chips 
Platinum and carbon-coated MED-P515A planar multielectrode array (MEA) chips were 
purchased from Alpha Med Scientific (Osaka, Japan). The arrays comprised a 10 mm culture 
depth with 64 electrodes in an 8 x 8 grid arrangement with 150 µm spacing between electrodes. 
Arrays were rinsed in sterile dH20 and gently submerged in 70% ethanol for a maximum of 15 
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minutes for sterilisation. Ethanol was aspirated and the array left to dry in the laminar flow hood 
under UV irradiation for 60 minutes. Arrays were coated with 100 µL 20 µg/mL PORN and 
incubated for 6 hours. PORN was aspirated and arrays were rinsed with sterile dH20, before 20 
µL of 10 µg/mL laminin was pipetted directly over the electrodes. Arrays were incubated for 30 
minutes and laminin aspirated ready for immediate cell seeding. After seeding, cells were left 
to adhere for 1 hour, before gently being flooded with cell culture medium (2.1.2.1).  
2.1.2 Neural precursor stem cell differentiation 
2.1.2.1 Cell culture medium 
Axol: Axol Neural Maintenance Medium and Supplement Kit, Ax0031 (Axol Bioscience, 
Cambridge, UK). 
SCT: BrainPhys™ Basal medium, 2% (v/v) SM1 supplement, 1% (v/v) N2A supplement, 100 
µg/mL brain-derived neurotrophic factor (BDNF), 100 µg/mL glia-derived neurotrophic factor 
(GDNF), 100 mg/mL cyclic adenosine monophosphate, sodium salt (cAMP) and 50 µg/mL L-
ascorbic acid (all components from StemCell Technologies, Cambridge, UK). 
Astrocyte medium: ScienCell Astrocyte medium, 2% (v/v) foetal bovine serum, 1% (v/v) 
penicillin-streptomycin and 1% (v/v) astrocyte growth supplement (all components from 
ScienCell Research Laboratories, CA, USA).  
Sync SCT: BrainPhys™ Basal medium, 2% (v/v) SM1 supplement, 1% (v/v) N2A supplement, 100 
µg/mL BDNF and 100 µg/mL GDNF.  
 
2.1.2.2 Spontaneous differentiation 
Cryopreserved Ax0013 neural precursor cells (NPCs) from cord blood CD34+ cells of a healthy, 
newborn male donor were purchased from Axol Bioscience (Cambridge, UK). Cells were fast-
thawed in a 37°C water bath, resuspended in Axol media and centrifuged for 5 minutes at 200 
x g. The cell pellet was resuspended in Axol and a sample taken for haemocytometer counting. 
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Cells were seeded at a density of 50,000/cm2 onto pre-treated PORN-laminin culture plates, 
glass coverslips and MEA chips as described in 2.1.1. Spontaneously differentiating cells were 
fed with Axol every other day, with a complete media change. Neuronal differentiation and 
confluency were monitored via daily phase contrast microscopy images using the EVOS XL Core 
Imaging System (Life Technologies, UK). Once cells reached ~80% confluency, they were 
passaged by discarding spent media from the culture and rinsing with D-PBS without magnesium 
or calcium.  
To detach the cells, 100 µL/cm2 accutase (Thermo Fisher, MA, USA) was distributed over the cell 
layer and incubated for 5 minutes. Four times the accutase volume of Axol was added to each 
well to neutralise the dissociation reaction. Dissociated cells were centrifuged at 200 x g for 5 
minutes and the cell pellet was resuspended in Axol, before a sample was taken for cell 
counting. Cells were seeded as above. Cells were expanded through 3-5 passages, for final 
plating for spontaneous differentiation experiments at passage 6.  
Passage 6 cells were fed with either Axol or SCT, as described in 2.1.2.1. Every other day, a 
complete Axol and half SCT media exchange was done. Cells were differentiated over various 
timepoints, being monitored daily using phase contrast imaging, as mentioned previously.  
2.1.2.3 Synchronised neural differentiation 
Cryopreserved Ax0013 were fast-thawed, plated and expanded to passage 6, as described in 
2.1.2.1.  However, for final plating to passage 6, cells were seeded at 100,000 cells/cm2 and 
cultured in Sync SCT media. Cells were incubated overnight and the following day, a full media 
change was performed, adding 10 µM N-[N-(3,5-Difluorophenacetyl)-L-alanyl]-S-phenylglycine 
t-butyl ester (DAPT; Abcam, ab120633) to enable all neurons to exit the cell cycle at the same 
time. Full Sync SCT media changes with 10 µM DAPT were done every other day, so the cells 
were incubated with DAPT for a total of 7 days. On day 8, cells were returned to Sync SCT media 
without DAPT and media replaced every other day until day 14. On day 14, BDNF and GDNF 
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were removed from the media and the cells were fed every other day with half media changes 
of SCT with SM1. Synchronised differentiating cells were cultured over 8 weeks, monitored via 
phase image microscopy as above.  
2.1.2.4 Astrocyte differentiation 
Cryopreserved, 11-week-old iPSC-derived astrocytes (Ax0015; Axol Bioscience) from cord blood 
CD34+ of a healthy newborn male donor were fast-thawed in a 37°C water bath, resuspended in 
astrocyte media (AM) and centrifuged for 5 minutes at 400 x g. The cell pellet was resuspended 
in AM and a sample taken for haemocytometer counting. Cells were seeded at a density of 
12,000/cm2 onto pre-treated PORN-laminin culture plates and glass coverslips as described in 
2.1.1. Astrocyte cultures were fed with AM every other day, with a half media change and 
passaged as described for 2.1.2.2 (albeit at 400 x g centrifugation).  
For synchronised astrocyte studies, following passaging, astrocytes were recovered for 24 hours 
in AM, then treated with 10 µM cytosine arabinoside (AraC) for 24 hours, before recovery in 
AM. Astrocytes were then cultured for 4 weeks for experimental study. 
2.1.2.5 Co-cultures of neurons and astrocytes 
Ax0013 neurons and Ax0015 astrocytes were synchronised using 10 µM DAPT and AraC, 
respectively, as described in 2.1.2.3/4.   
Final ratios of neurons to astrocytes were 20:1, respectively. Cultures were matured for 10 
weeks following astrocyte addition (co-cultured astrocytes final age 21 weeks).  




Table 2.1: Process of co-culturing neurons and astrocytes together, including media requirements and seeding densities.
Day Neurons procedure Astrocytes procedure 
0 Passage Ax0013 NPCs and plate at 100,000/cm2  
1 Recovery  
2 Sync SCT media with 10 µM DAPT  
3   
4 Sync SCT media with 10 µM DAPT Plate Ax0015 astrocytes at 12,000/cm2 
5   
6 Sync SCT media with 10 µM DAPT Astrocyte media 
7   
8 Sync SCT media with 10 µM DAPT Astrocyte media 
9 Remove DAPT. Sync SCT media. Passage Ax0015 astrocytes 
10  Recovery 
11 Sync SCT media Inhibit astrocytes with 10 μM AraC 
12  Recovery 
13  Passage astrocytes onto neurons 5,000/cm2 
14 Recovery 
15 Recovery 
16+ SCT + SM1 feed every 2-3 days 
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2.1.2.6 Co-cultures with interneurons 
Co-cultures of Ax0013 NPC’s and Ax0015 astrocytes were synchronised and differentiated as 
described in 2.1.2.5, with the addition of Ax0665 interneurons (Axol Biosciences, Cambridge, 
UK). Cryopreserved interneurons were fast-thawed in a 37°C water bath, resuspended in Axol 
media and centrifuged for 5 minutes at 200 x g. The cell pellet was resuspended in Axol and a 
sample taken for haemocytometer counting. A seeding density of 16,000 interneurons/cm2 
were added to the co-cultures at Day 9 (prior to the addition of astrocytes). 
2.2 Immunofluorescent staining 
Incubation periods for immunofluorescent staining were all performed at room temperature. 
2.2.1 General staining method 
Cultured cells for immunocytochemistry studies were fixed in an equal volume of culture media 
and 4% (v/v) paraformaldehyde (PFA) in PBS for 5 minutes at room temperature. The solution 
was removed, and cells were treated with PFA only for 5 minutes, then washed twice in PBS and 
incubated for 5 minutes in permeabilisation buffer (PBS with 0.2% (v/v) Triton X-100), then 
permeabilised again for 5 minutes. Cells were then blocked for 1 hour in block buffer (BB) (PBS 
with 0.2% (v/v) Triton X-100 and 2% (w/v) bovine serum albumin) on a stationary rocker at low 
speed. Cells were either single-stained or co-stained with a maximum of two primary antibodies 
dissolved in BB for 1 hour (see Table 2.2). Cells were washed 3 x 5 minutes in BB to remove 
excess antibody. For secondary antibody staining, coverslips were protected from light and 
secondary antibody dissolved in BB (1:500) was added for 1 hour (Table 2.2). The BB wash steps 
were repeated and the cells rinsed in dH20 before being inverted onto a droplet of mountant 
containing the nuclear stain DAPI (Vectashield, UK) on glass microslides. Coverslips were 






2.2.2 Synaptic staining method 
For staining of sensitive synapses, an amended protocol was used. Cells were fixed as described 
in 2.2.1. To quench auto-fluorescence, fixed cells were rinsed three times and incubated for 5 
minutes in 50 mM ammonium chloride in PBS. Cells were then incubated for 10 minutes in 
synaptic permeabilisation buffer (0.1% (w/v) saponin in PBS), followed by 30 minutes in synaptic 
block buffer (SBB) (0.1% (w/v) saponin, 3% bovine serum albumin in PBS). Primary antibodies 
(Table 2.2) were dissolved in SBB and the cells incubated for 1 hour, under gentle agitation. Cells 
were then rinsed twice and incubated for 10 minutes in SBB. Secondary antibodies were 
dissolved in SBB and incubated for 1 hour, followed by two rinses in SBB, two PBS washes and a 
rinse with dH2O. Cells were mounted and stored as described in 2.2.1.  
Table 2.2: Primary and secondary antibodies used for ICC experiments. Antibodies frequently 




























































1:500 Rabbit Goat Anti-Rabbit 
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2.2.3 Fluorescent microscopy acquisition and quantification 
Immunofluorescently-labelled cells were imaged using a Zeiss Axiovert 200M epifluorescent 
microscope using Leica Application Suite Advanced Fluorescence (LASAF) microscopy software 
(Leica Microsystems, Milton Keynes, UK). Filter cubes optimised for the excitation and emission 
spectra of each fluorophore were used, alongside a 20x objective (Nikon) for cell staining and 
63x oil-immersion objective (Nikon) for synaptic staining. Filter sets were as follows for all 
fluorescently imaged figures in the thesis:  
Green FITC:     excitation λ of 495 nm, emission λ of 519 nm,  
Blue:                 excitation λ of 345 nm, emission λ of 455 nm,  
Red DsRed:     excitation λ of 588 nm, emission λ of 649 nm. 
 
 
Several images were modified from green to grey post-acquisition to account for the author 
being colour vision-impaired and hence, unable to differentiate between pre-set colours.  
For quantitative image analysis (Ki67 proliferation studies), each coverslip was imaged in three 
random areas, creating an overlay of each fluorophore and the nuclear stain. Images were 
separated and imported into ImageJ (Fiji, NIH). An automatic cell counting macro, developed in-
house by Dr. Rachael Wood was used and optimised for cell sizes. Cell somas were automatically 
counted and the readout was extracted to Microsoft Excel (Microsoft, Redmond, USA). Averages 
of the three random regions were taken for each image. DAPI-positive cells were regarded as 
total cell number, and subsequent marker-positive data presented as a percentage of total cells.  
2.3 Cell Viability Studies – MTT assay 
3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) was diluted in sterile 
PBS to a stock of 2.5 mg/mL.  
Ax0015 astrocytes were seeded at a density of 3000 cells/well in 96-well plates (2.1) and treated 
with serial dilutions of AraC in astrocyte medium in triplicate and returned to the incubator for 
24 hours. Media was aspirated, and the cells washed in PBS. MTT stock was diluted in AM to a 
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working concentration of 0.5 mg/mL and added to the cells and control wells, before incubation 
for 2 hours.  
MTT was then aspirated and 50 μL dimethylsulfoxide (DMSO) added per well to permeabilise 
formazan crystals. DMSO was triturated and shaken at 500 rpm for 30 seconds, using a Stuart 
SSL3 gyro-rocker (Cole-Parmer, Staffordshire, UK), then returned to the incubator for a further 
15 minutes. Absorbance values were then measured at 590/690 nm using a Multiskan-EX 
spectrophotometer (Thermo).  
2.4 Gene expression analysis 
All reagents and kits were purchased from PrimerDesign (Hampshire, UK) unless otherwise 
stated.  
2.4.1 RNA extraction 
RNA was isolated from spontaneously differentiated cultures and co-cultures at various 
timepoints. RNA was extracted and purified in accordance with the manufacturer’s instructions 
from the Qiagen RNeasy mini kit (Qiagen, Manchester, UK; 74104). An additional DNAse 
treatment was also performed, to reduce the potential of detection of contaminating genomic 
DNA (Qiagen, 79254). Quantification was performed using the Nanodrop 1000 (Thermo). If qPCR 
was not to be performed immediately, samples were stored at -80 °C until needed.  
2.4.2 cDNA synthesis 
Isolated RNA was thawed on ice and 100 ng total RNA made up to 9 µL in sterile DNA/RNAse-
free water. 1 µL Oligo-dT primers were added to the RNA template.  
The mixture was then annealed at 65 °C for 5 minutes using a Thermocycler PCR machine (Bio 
Techne, Abingdon, UK) and immediately cooled on ice. 10 μL of reverse transcription mastermix 
(containing deoxynucleoside triphosphates (dNTP’s), reverse transcriptase, buffer and 
RNA/DNAse-free water) was added and the sample reverse transcribed using the Thermocycler 
with the following conditions: 20 minutes at 42 °C, 10 minutes at 75 °C and held at 4 °C. 
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2.4.3 qPCR  
Qualitative PCR was performed according to manufacturer’s instructions. Briefly, SYBR® green 
was added to cDNA samples alongside RNA/DNAse-free water to pre-validated primers for Pax6, 
Sox2, TUBB3, S100β and vGAT. The housekeeping genes GAPDH, ACTB, YWHAZ and 18S were 
assayed under the same conditions as for experimental primers. Samples were added to PCR 
plates with an optical film seal and spun in a plate spinner (Thermo) for 30 seconds to ensure 
the sample was sufficiently mixed. Plates were loaded into a Lightcycler (Thermo) and cycled as 
shown in Table 2.3.  
Table 2.3: qPCR protocol including steps involved, temperature, duration and number of 
cycles for reaction.  
Steps Temperature Time Cycles 
Initial Denaturation 95 °C 10 minutes 1 
Denaturation 95 °C 15 seconds 
40 
Annealing/Extension 60 °C 1 minute 
 
2.4.3.1 qPCR analysis 
Analysis of qPCR data was performed using Microsoft Excel and the ΔΔCt method. Both control 
samples (Week 0) and experimental samples were normalised to endogenous controls 
(Appendix Figure A9A) and ΔCt was calculated from the difference in CT value between the 
target gene and the endogenous control, by subtracting the average control CT value from each 
replicate.  
ΔΔCt was then calculated via ΔCt (experimental) – ΔCt (average control) and these values were 
used for statistical analysis (described in text). To generate a fold change in experimental gene 
expression relative to Time Week 0, 2-ΔΔCt was computed and this value was represented in the 
figures throughout the thesis. In-text values refer to the ΔΔCt values from which statistical 




2.5 Fluorescent calcium imaging 
2.5.1 Acquisition 
Acquisition of calcium-mediated activity was achieved using a single-wavelength calcium 
sensitive dye and fluorescence imaging. Calcium signals were recorded under baseline 
(spontaneous) conditions, and evoked ionic and pharmacological conditions. 5 µM membrane-
permeable Fluo4- acetoxymethyl ester (Fluo4-AM) (Molecular Probes, Eugene, Oregon, USA) 
dissolved in either Axol or SCT was added to the cells for 30 minutes and incubated at 37°C, 
followed by a recovery phase of media only, for 10 minutes. During incubation, respective media 
and artificial cerebrospinal fluid (aCSF) (containing, in mM: 126 NaCl, 26 NaHCO3, 2.5 KCl, 1.25 
KH2PO4, 10 MgSO4, 2 CaCl2, and 10 glucose) was heated to 37°C and bubbled with carbogen gas 
(95% O2, 5% CO2) to maintain pH.  
Cells were imaged at a rate of 0.33 - 1 Hz over 5-40 minutes using a submersible 20X lens (Nikon, 
UK) and filter cube for Fluo4 (Chroma VT, USA). An Orca CCD camera (Hamamatsu, Japan) was 
used to acquire the images, allowing for the shutter to be controlled without the need to 
manually handle the microscope. A 65 ms exposure time and a bin value of 2 was used for 
experiments. Excitation of the fluorophore was done at 470 nm using an automated OptoLED 
power supply LED (Cairn, UK) and Optomorph software (Molecular Devices, US) was used for 
image acquisition of changes in intracellular calcium. Cells were mounted and perfused with 
either Axol, SCT or standard aCSF for several minutes before beginning the recording to allow 
the cultures to recover from any disturbances. 
2.5.2 Evoked responses 
After recording baseline activity for each coverslip, cells were subjected to a series of 
pharmacological and ionic manipulations (Table 2.4). Ionic manipulations involved modification 
of the standard aCSF recipe from 2.5.1. Drugs were dissolved in aCSF and continuously perfused 
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on to cultures at a low rate of 1 mL/min, avoiding the need for the recording to be paused or 
interrupted and limiting disruption.  
Table 2.4: Variety of pharmacological and ionic manipulations used throughout the thesis.  
Treatment Class Concentration used 
Glutamate Excitatory neurotransmitter 100 µM 
Tetrodotoxin Sodium channel blocker 1 µM 
4-aminopyridine Potassium channel blocker 100 µM 
Picrotoxin GABAA antagonist 100 µM 
Valproate Anticonvulsant 2 mM 
Magnesium-free aCSF Excitatory perfusate 0 mM MgSO4 
High potassium aCSF Excitatory perfusate 7.5 mM KCl 
 
2.5.3 Calcium Analysis 
2.5.3.1 Video preparation and region of interest determination 
Images were stacked, aligned and processed into video files using ImageJ. Continuous imaging 
over several minutes led to minor frameshift in some recordings, therefore stacks were aligned 
using the plugin: template matching - align slices in stack. Brightness and contrast were adjusted 
and videos were imported into Matlab software (Mathworks, 2018b), running NETCAL© 
network analysis software (www.itsnetcal.com, ©Javier Orlandi, 2017). Regions of interest (ROI) 
were automatically detected and manually reviewed, and from each ROI a fluorescence trace 
was generated. The data from each trace was exported to Microsoft Excel and GraphPad Prism 
(Version 8) to determine active cells, number of calcium events and bursting frequencies.  
2.5.3.2 Active cell and calcium event classification 






  where F0 is the first frame in a video 
file. A cell was identified as being active if the ΔF/F peak value was greater than three times the 
standard deviation of the baseline noise, which was manually determined for each cell. These 
were regarded as spontaneous events. For synchronised events, cells were regarded as 
synchronous if their initiation was within 1 frame of another spontaneous event within the 
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video. Most recordings were acquired at 0.33 Hz, meaning a gap of one frame is equal to three 
seconds.  
2.5.3.3 Experimental calculations 
To calculate peaks per cell, burst frequency and active cells, each individual trace was manually 
reviewed and the peak values including number of peaks per cell, time of peaks and peaks per 
minute recorded using Microsoft Excel.  
In order to quantify synchrony between cells of the population, the percentage of synchronised 
cells was calculated between active cells. To reduce the possibility of false positive reporting, 
events in which only two neurons were synchronised were dismissed, meaning a minimum of 
three neurons had to display the same response to be described as synchronised (Pirttimaki et 
al., 2017). Additionally, Pearson’s correlation was performed on all individual active cell traces, 
compared to an average population trace (Cornelissen et al., 2013; Kuijlaars et al., 2016).  
2.6 Multi-electrode array (MEA) 
2.6.1 MEA acquisition  
Planar MEA chips were prepared and cells seeded as described in sections 2.1 and 2.2. Cultures 
on MEA chips were recorded on a heated stage (Alpha Med Scientific, Osaka, Japan) whilst in a 
37°C humidified incubator, with 5% CO2, as extracellular MEA activity is sensitive to pH levels 
(maintained by CO2 concentration). Extracellular signals were recorded in all 64 electrodes 
simultaneously at 1 kHz acquisition using MED64 Mobius Toolkit software (Alpha Med Scientific) 
using a ‘basic-recording’ template. Recordings typically lasted for 10 minutes, following a few 
minutes unrecorded initial measurement, to allow cells to recover. Signals detected were 
amplified using an Amadeus 64-channel amplifier (Alpha Med Scientific). Signals were low-pass 
filtered at 100 Hz and sampled at 20 kHz/channel (Odawara et al., 2016b). 
 
2.6.2 MEA analysis 
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For MEA analysis, recordings obtained were ran through Mobius spike detection software 
(Alpha Med Scientific). Thresholds were set at 500 % standard deviation from baseline to ensure 
spikes were detected and not background noise. Extracted spike data was assessed visually for 
each 64 channels to determine whether the recorded data was in fact spike activity, and not 
noise. Once confirmed, frequency analyses, number of spikes/burst and burst duration were 
calculated using Mobius software.  
Parameter values for analysis were set using an active MEA example as a basis for (Table 2.5).  
 Table 2.5: Burst detection parameters for MEA analysis 
 
 
2.7 Statistical analysis 
All statistical analyses were performed using GraphPad Prism Version 8; the author is grateful 
to Professor Alan Nevill (Wolverhampton University, UK) for his advice whilst using this package. 
Bars on graphs and descriptions in-text represent mean values and error bars indicate ± 
standard error of the mean (SEM). For many graphs, box plots were selected to show the 
distribution of data.  
Data-sets were considered un-paired and the Shapiro-Wilk normality test was performed to 
assess the distribution of data, followed by the appropriate statistical test: 1-way and 2-way 
analysis of variance (ANOVA) or student’s T-test, with Tukey’s post hoc test for multiple 
comparisons. The test used is indicated in-text.  
Parameter Value 
Max Interval to start burst (ms) 300 
Max interval to end burst (ms) 350 
Min number of spikes in a burst 3 
Min duration of a burst (ms) 50 
Min interval between bursts (ms) 100 
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Statistical analysis was complicated for percentage of active cell datasets in Figure 3.11 and 
Figure A3, due to an array of unequal sample sizes, combined with the data not satisfying 
Gaussian distribution, even after log transformation. As a result, individual one-way ANOVAs 
were performed (Appendix A3) and non-parametric t-tests of individual timepoints (Figure 
3.11). 
For non-normally distributed data undergoing 2-way ANOVA, the data was first log transformed 
to satisfy the requirements of normality. Datasets which underwent transformations are 
indicated in text.  
For quantitative synchronised calcium-mediated activity, a Pearson’s correlation was performed 
as described in 2.4.3. However, to generate an average R value for each experiment, a Fisher’s 
z-transformation was applied to each individual R value. The mean of the z values was then 
calculated and this number back-transformed using Fisher’s back-transformation. This provided 
an average R value for the experiment.  
N numbers reported in figure legends refer to the number of biological differentiations, whereas 
those in text refer to the total number of technical repeats from all biological differentiations.  
Statistical significance depicted in figures was reported as: *p < 0.05, **p <0.01, ***p <0.001, 











3: MORPHOLOGICAL AND FUNCTIONAL CHARACTERISATION OF 
SPONTANEOUSLY DIFFERENTIATED NEURAL CULTURES 
3.1 Introduction 
The human brain is a bewilderingly complex structure, comprised of a remarkable number of 
two principle cell types: neurons and glia. The cerebral cortex is the executive computational 
centre of the mammalian CNS, containing dozens of neuronal subtypes (Anderson & 
Vanderhaeghen, 2014). Neurons are electrically excitable cells, arranged in the cortex in six 
distinct layers and their extensive interconnectivity provides the processing capability that 
governs all physiological and psychological processes that we experience. Of particular 
relevance to this thesis is a basic feature of the cerebral cortex, which is how it is prone to 
generating synchronous, large bursts of activity which facilitates seizurogenesis (Bromfield et 
al., 2006). The role of glia and their various subtypes (namely astrocytes) has been markedly 
under-investigated, despite the brain being unable to function without both cell types. This 
forms the basis of the investigation in this Chapter.  
3.1.1 In vitro and in vivo neurogenesis 
An incredible and unique quality of iPSCs is their ability to form human neural cells in a relatively 
efficient and non-invasive manner (Takahashi & Yamanaka, 2006). The process of converting 
iPSCs to neural precursor stem cells (NPCs) is referred to as ‘neuralisation’. Several neural 
differentiation protocols exist, which ultimately enables the production of neural subtypes 
(Chambers et al., 2009; Shi et al., 2012a;2012b). Each method has subtle differences, but largely 
the same outcome: functional, morphological human neural subtypes.   
For an iPSC-derived model to fully recapitulate in vivo neurogenesis, there must be a degree of 
similarity and developmental processes in the in vitro environment. Shi et al., (2012a) 
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demonstrated that iPSCs follow an extended period of cortical neurogenesis (lasting several 
weeks) – that is more representative of the human in vivo environment cf rodent neurogenesis, 
which occurs over a matter of days.  For example, during human development, neurulation 
involves the formation of the neural tube, which develops in utero into the brain and spinal cord 
(Sadler, 2005). The development of radially organised columnar epithelial cells in vitro gives rise 
to the characteristic cortical neural rosettes, which mirrors this neurulation process (Elkabetz & 
Studer, 2008).   
In addition to distinctive morphology, cells undergoing in vitro cortical neurogenesis should 
contain markers for neural progenitor transcription factors (Shi et al., 2012a) and the generation 
of cortical neuronal layers (Pasca et al., 2015). Upper and lower cortical layer transcription 
factors have been identified during in vitro development, with the emergence of lower layer 
neurons occurring first and the layers developing in an ‘inside-out’ manner (Anderson & 
Vanderrhaeghen, 2014). This correlates with mammalian neocortical development, wherein 
NPCs sequentially give rise to lower layer and upper layer neurons during embryonic stages 
(Bansod et al., 2017). 
Further characterisation of the temporal development of neural subtypes can also be 
monitored, particularly as radial glia form quite readily, followed by neuronal subtypes, before 
a switch from neurogenesis to gliogenesis. In vivo, the switch from neurogenesis to gliogenesis 
occurs at the perinatal states, and a delayed arrival of astrocytes is also observed in vitro (Shi et 
al., 2012a; Bansod et al., 2017). Consequently, the late arrival of astrocytes after neurons is a 
reliable indicator of cortical differentiation. As mentioned above, in vivo neural activity is 
dependent upon both neurons and astrocytes. However, protocols exist for the generation of 
individual neural subtypes, including neurons and astrocytes. Shaltouki et al, (2013) showed the 




3.1.2 Functional considerations 
Whilst monitoring the emergence of and assessing for the presence of neural subtypes during 
cortical differentiation is an invaluable tool, these results alone are of little or no indication of 
cell function. Many cells in culture may morphologically resemble cells in vivo, but that is not an 
accurate assessment of their identity. As neurons are electrically excitable cells and indeed, 
astrocytes are capable of functional activity, the best assessment of a successful neural 
differentiation is to verify the functional capability of the cells.  
In vivo, neurons are active cells, firing AP and eliciting neurotransmission. This functionality 
arises due to a difference in ionic potential that exists between the intracellular and extracellular 
spaces. To replicate in vivo activity, human iPSC-derived cultures should be able to generate AP 
in vitro and respond to neurotransmitters, as happens in the intact brain. 
3.1.3 Growth medium considerations 
The first stage of any project intended to develop a reliable protocol for applying iPSCs to use in 
neural models, is to optimise the basic conditions for growth and differentiation, as these 
conditions can influence the above structural and functional endpoints. Growth media is the 
most important determinant of these outcomes, as culture conditions for stem cell-derived 
neurons do not necessarily mirror those observed in vivo (Rocktäschel et al., 2019). Evidently, 
as the cell culture itself should be as representative of the in vivo state as possible, all integrated 
factors such as the media should also aim to mimic in vivo compositions. Multiple companies 
and institutions are now producing their own media formulations and whilst often based on 
neurobasal/DMEM recipes, the added supplements and factors has led to great variation within 
the field.  
Interestingly, very high concentrations of glucose (up to 25 mM) are commonly observed in 
culture media compositions, where this value should be closer to 5 mM to be physiologically 
relevant and promote translatability of stem cell models (Rocktäschel et al., 2019). A specialised 
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neuronal medium was developed in 2015 which serves to mimic human in vivo compositions as 
closely as possible (Bardy et al., 2015). Indeed, they recognised the hyperglycaemic condition of 
many neurobasal/DMEM recipes and amended theirs to prevent abnormal glucose homeostasis 
affecting the cultures, as has been shown with several brain disorders (Mergenthaler et al., 
2013). Moreover, It has been shown that concentrations of salts (in particular, NaCl) and the 
presence of serum may directly influence certain electrical activity (Bardy et al., 2015), which 
creates another issue for functional studies, as groups are testing their cells using different fluid 
compositions. In addition to glucose, salts and osmolarity, the neuronal supplements used for 
growth media have also been assessed (Sünwoldt et al., 2017). Commonly used supplements 
including B27 and N2 were found to elicit variable effects on neuronal cultures and negatively 
alter glucose metabolism, respectively. B27 is serum-free and highly dense in nutrients and 
hormones, ranging from insulin to progesterone. B27 in many cases is neuroprotective, 
contributing to neuronal growth and neurite extension (Chen et al., 2008). However, the advent 
of serum-free media compositions intended to reduce the variability which can occur from 
serum-containing solutions and indeed, modifications to B27 recipes have resulted in an 
optimised, more physiological supplement (NS21) (Chen et al., 2008). N2 supplement is a 
widely-used, chemically defined serum-free supplement recommended for growth of post-
mitotic neurons; however, the modern alternative (GS21) was found to positively affect energy 
metabolism in neuronal cultures (Sunwoldt et al., 2017).  
Artificial cerebrospinal fluid (aCSF) is a mimic of the fluid surrounding the brain in vivo and whilst 
devoid of neuromodulators found in human CSF, it contains the necessary salts and pH to 
function as a perfusate and bathing solution (Wickham et al., 2020). Indeed, aCSF is widely used 
for ex vivo slice assays and primary cultures and for inducing and assessing epileptiform activity. 
Due to the range of medium available for iPSC culture, it may be that a defined aCSF formulation 
should be used for functional studies to create a standard protocol for iPSC-derived neural 
toxicity testing. Despite its widespread use as a perfusate in rodent in vivo, in vitro and human 
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in vitro models, aCSF does not promote neuronal survival for longer than a few days and hence, 
is an unsuitable medium for maintaining cells long-term (Bardy et al., 2015).  
As the role of growth medium is so influential, the effects of two different commercially 
available growth media (Axol Biosciences: Axol Neural Maintenance medium; Shi et al., 2012b 
and StemCell Technologies: BrainPhys™; Bardy et al., 2015) have been compared in this chapter, 
to assess the differences in their ability to generate morphologically and functionally matured 
neural cultures. 
 
The aims of this Chapter are to: 
1) Assess the morphological expression of spontaneously differentiated neural cultures 
via cell specific biomarkers of: neural progenitors, cortical layers, excitatory and 
inhibitory neurons and glia; using fluorescence microscopy 
2) Determine the functional capability of spontaneously differentiated cultures, 
including the ability to fire action potentials and respond to neurotransmitters, using 
fluorescent calcium imaging and multi-electrode array recordings 
3) Compare the effects of Axol and SCT media on their respective abilities to generate 










3.2.1 Characterisation of spontaneous differentiation 
Human iPSC-derived NPCs were spontaneously differentiated in Axol and SCT over 18 weeks in 
vitro (WIV). In order to determine whether neural cultures can generate expected neural 
subtypes, immunocytochemistry (ICC) and qualitative polymerase chain reaction (qPCR) were 
performed over 18 WIV.  18 WIV was designated as a cut-off point, as the viability of SCT cells 
post W18 were severely impacted. Indeed, widespread detachment of fasciculated neurons was 
observed in all W18 SCT cultures (Appendix Figure A1). Whilst cells were cultured past 21 WIV, 
experimentation became highly problematic, with large reductions in activity and very poor 
resolution from microscopy. 
Cells in both media conditions produced morphologically distinctive neural cortical rosettes by 
1 WIV, positive for both Pax6 and Sox2 neural progenitor markers, which were distributed in a 
radial fashion (Figure 3.1, n=9 coverslips (cs)). Pax6 and Sox2 gene expression was assessed 
using qPCR. Results indicate that Pax6 expression was significantly upregulated in Axol media at 
4 WIV (p= 0.046, Figure 3.2A). Whilst SCT observed a difference in values of Pax6 expression, 
relative to control, these did not attain statistical significance. The expression of Sox2 was 
significantly downregulated in SCT media at W4 and W8 compared to control (p<0.0001, Figure 
3.2B) but Sox2 was significantly upregulated at W12, compared with earlier experimental 
timepoints (ΔΔCt W12: 1.87 ± 0.64; W4: 5.31 ± 0.47, p= 0.0008, W8: 4.20 ± 0.19, p= 0.0278). 
To monitor the emergence of distinct neural subtypes, neuron-specific class III β-tubulin (Tuj1) 
and calcium-binding protein S100β were used to stain neurons and astrocytes, respectively. At 
4 WIV, both conditions were negative for S100β staining (Figure 3.3B), however, both displayed 
an interconnected array of Tuj1+ neurons, developing by 8 WIV to aggregated clusters of 
neuronal cell bodies (Figure 3.3C, n=9 cs). By 8 WIV, both Axol and SCT displayed S100β+ staining, 
however, the staining was localised to the soma, correlating with the DAPI+ nuclei also observed 
























Figure 3.1: Spontaneously differentiated neural precursor cells (NPC’s) form cortical 
rosettes in Axol and SCT media. iPSC-derived neural precursors were differentiated in Axol 
or SCT media over 1 week and immunocytochemistry was performed to assess the presence 
of neural progenitor markers. (A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, 
emission λ 455 nm). (B) Pax6 neural progenitor staining (Grey, excitation λ 495 nm, emission 
λ 519 nm). (C) Sox2 neural progenitor staining (Red, excitation λ 588 nm, emission λ 648 nm). 























At 12 WIV, morphologically distinct S100β+ astrocytes were observed in both conditions (Figure 
3.4C, n=9 cs. In addition, by 12 WIV, the staining appeared to show an even distribution of 
astrocytes and neurons, closely intertwined in both media conditions, with more astrocytes 
visible by 18 WIV (Figure 3.4). Furthermore, the size of astrocytes in the Axol cultured cells’ field 
of view at 18 WIV were more comparable to those of the SCT astrocytes. The discrepancy 
between sizes of astrocytes was observed in both media conditions at 12 and 18 WIV, showing 
that different types and sizes of astrocytes were generated throughout the spontaneous 
differentiation (n=9 cs). In addition, there were several regions of each W18 coverslip where the 
cultures appeared entirely astrocytic (Appendix Figure A2).
A 
B 
Figure 3.2: Spontaneously differentiated NPCs express Pax6 and Sox2 progenitor genes in 
Axol and SCT media. iPSC-derived neural precursors were differentiated in Axol or SCT media 
over 12 weeks and qPCR was performed to assess the expression of genes associated with 
neural progenitors. (A) Fold change in Pax6 expression over 12 WIV relative to control 
expression at W0 (not indicated on graph). (B) Fold change in Sox2 expression over 12 WIV. 
Data is displayed as mean ± SEM. N=3 separate biological differentiations. *p< 0.05, 2-way 















Figure 3.3: Astrocytes emerge following 8 WIV spontaneous differentiation of human iPSC-derived neural precursors. Neural cultures were 
differentiated in either Axol legacy or SCT BrainPhys media over 8 weeks and immunocytochemistry was performed to assess the emergence of 
neurons (Tuj1) and astrocytes (S100β). (A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, emission λ 455 nm). (B) S100β astrocytic staining 
(Grey, excitation λ 495 nm, emission λ 519 nm). (C) Tuj1 neuronal staining (Red, excitation λ 588 nm, emission λ 649 nm). (D) Merged image of 
A,B,C. N=3. Scale bar: 100 μm. 






















































Figure 3.4: Human iPSC-derived NPCs form neurons and morphologically distinct astrocytes by 12 WIV.  Neural cultures were differentiated in 
either Axol legacy or SCT BrainPhys media over 18 weeks and immunocytochemistry was performed to assess the emergence of neurons (Tuj1) and 
astrocytes (S100β). (A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, emission λ 455 nm). (B) S100β astrocytic staining (Grey, excitation λ 495 






















There was no significant difference in TUBB3 expression (gene encoding Tuj1) at any timepoint 
in both Axol and SCT media compared to control (Figure 3.5A). In contrast, at W4 fold S100β 
expression in both Axol and SCT was significantly increased cf control (Axol: p= 0.0192, SCT: p= 
0.0193, Figure 3.5B). 
Roughly 80% of the mammalian cerebral cortex is comprised of excitatory neurons (Marik et al., 
2010). The presence of excitatory vesicles (VGlut1) was therefore of great importance. Figure 
3.6 shows that both Axol and SCT at 4 WIV generated characteristic punctate synaptic staining.  
B 
Figure 3.5: Spontaneously differentiated NPCs express TUBB3 and S100β over 12 WIV in 
Axol and SCT media. iPSC-derived neural precursors were differentiated in Axol or SCT media 
over 12 weeks and qPCR performed to assess the expression of genes associated with 
neurons (TUBB3) and astrocytes (S100β). (A) Fold change in TUBB3 expression over 12 WIV 
relative to control expression at W0 (not indicated on graph). B) Fold change in S100β 
expression over 12 WIV. Data is displayed as mean ± SEM. N=3. *p< 0.05, 2-way ANOVA with 




















The absence of DAPI+ cells (Figure 3.6A,E) is due to the magnification used. Using the 63x 
objective, DAPI+ nuclei covered most of the field of view, therefore a region of interest was 
selected where no DAPI signal was obtained. Vesicular glutamate transporter-1 (VGlut1) is 
associated with membranes of synaptic vesicles and preferentially transports glutamate. VGlut1 









































Figure 3.6: Spontaneously differentiated NPCs form excitatory, but not inhibitory synapses 
in Axol and SCT media. iPSC-derived NPCs were differentiated over 4 weeks and 
immunocytochemistry performed to assess excitatory and inhibitory synapse formation. (A-D) 
Cultures differentiated in Axol media. (E-H) Cultures differentiated in SCT media. (A,E) Nuclei 
stained with DAPI (Blue, excitation λ 345 nm, emission λ 455 nm). (B,F) VGlut1 excitatory vesicle 
staining (Grey, excitation λ 495 nm, emission λ 519 nm). (C,G) GAD67 inhibitory staining (Red, 












In contrast, glutamic acid decarboxylase 67 kDa (GAD67) is an enzyme catalysing the 
decarboxylation of glutamate to GABA, widely expressed in GABAergic neuronal populations 
(Rudy et al., 2011). GAD67 was therefore used as a marker for inhibitory neuronal populations.  
Figure 3.6C,G shows a complete absence of GAD67+ staining at 4 WIV. Staining for GAD67 was 
also performed at W8, W12 and W18 and GAD67+ staining was consistently absent in both 
conditions (data not shown). As synaptic vesicular staining is a sensitive process, the ICC results 
of GAD67 were supplemented with qPCR analysis of a secondary gene (SLC32A1) encoding the 
vesicular inhibitory amino acid transporter vGAT, which is highly concentrated in the nerve 
terminals of GABAergic neurons (Chaudhry et al., 1998). Figure 3.7 shows a significant increase 
in fold vGAT expression at 4 and 12 WIV in Axol cf control (W4: p= 0.0043, W12: p= 0.0267). 
There was no significant change in expression of vGAT at any point in time during differentiation 
in SCT media. 
Figure 3.7: Spontaneously differentiated NPCs express vGAT over 12 WIV in Axol and SCT 
media. iPSC-derived neural precursors were differentiated in Axol or SCT media over 12 
weeks and qPCR performed to assess the expression of inhibitory amino acid transporter 
vGAT. Fold change in vGAT expression over 12 WIV relative to control expression at W0 (not 
indicated on graph).. Data is displayed as mean ± SEM. N=3. *p< 0.05, **p< 0.01, 2-way 



































Figure 3.8: Human iPSC-derived NPCs form upper and lower cortical neurons when spontaneously differentiated after 4 weeks.  Neural cultures 
were differentiated in either Axol legacy or SCT BrainPhys media over 8 weeks and immunocytochemistry was performed to assess the emergence 
of lower layer cortical neurons (Tbr1) and upper layer cortical neurons (SatB2). (A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, emission λ 
455 nm). (B) Lower layer cortical neurons (Grey, excitation λ 495 nm, emission λ 519 nm). (C) Upper layer cortical neurons (Red, excitation λ 588 
nm, emission λ 649 nm). (D) Merged image of A,B,C. N=3. Scale bar: 100 μm. 
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Alongside neurons and astrocytes, the intention for spontaneous differentiation was to commit 
to cortical neurogenesis. To test this, immunocytochemistry (ICC) was done to assess for the 
emergence of cortical layer markers. Transcription factors T-box brain-1 (Tbr1) and special AT-
rich sequence-binding protein-2 (SatB2) encode lower and upper layer cortical neurons, 
respectively. In both conditions, the level of Tbr1 expression appeared constant at all 
timepoints. Images from W4 and W8 are displayed, as the resolution of W12 onwards decreased 
considerably as the density of cultures increased. W4 Axol appears to show a greater proportion 
of SatB2+ cells, compared to W4 SCT (Figure 3.8). In addition, SatB2 expression between W4 and 
W8 Axol appears the same, whereas there appears to be an increase in SatB2 expression 
between W4 and W8 SCT (n=9 cs). 
3.2.2 Functional calcium activity in spontaneously differentiated cultures 
Having performed experiments to assess the presence of morphologically relevant neural 
subtypes and cortical markers, the next important question was whether the cells could display 
functional activity and basic drug responses. This question was addressed via single-wavelength 
fluorescent calcium imaging using Fluo4-AM and multi-electrode array (MEA) analysis. 
Spontaneous cultures were cultured as described (Chapter 2) for the above ICC/qPCR studies 
and assessed at the same timepoints for their functional properties.  
A standard principle in electrophysiology is the use of artificial cerebrospinal fluid for functional 
studies. However, as Bardy et al., (2015) claim their media is superior for functional studies, the 
effect of each respective media as a perfusate on electrical activity was considered (Figure 3.9). 
There was no significant difference between the use of Axol and SCT media as perfusates (n=5/6 
cs, p= 0.99). However, the use of both medias induced a significantly lower percentage of active 
cells compared with the same cultures perfused with aCSF (Axol Media: 4.08 ± 1.75%, n=6 cs, 
Axol aCSF: 11.77 ± 1.60%, n=9 cs, p= 0.03; SCT Media: 3.86 ± 1.18%, n=5 cs, SCT aCSF: 14.48 ± 




Following the assessment of perfusates, aCSF was selected to continue functional studies. The 
responses of W8 cultures to 1 µM tetrodotoxin (TTX) and 100 µM glutamate are shown in Figure 
3.10 and Video 3.1. In both instances, the cultures were spontaneously active in all randomly 
selected example cells. The addition of TTX is an established method for blocking Na+ channels 
and preventing the subsequent sodium-mediated depolarisations necessary for action potential 
generation (Wasserstrom & Salata, 1988). In both cultures, TTX addition inactivated the baseline 
spontaneous calcium responses. This spontaneous calcium activity was then recovered by the 
addition of the excitatory neurotransmitter glutamate, with representative cells responding 
with large amplitude fluorescence increases of ≥0.5 ΔF/F in 8/10 traces for SCT and 7/10 traces 
for Axol. In all experiments, spontaneously active cells were inactivated by the addition of TTX 
and excited by glutamate (n=9 cs). In the representative example in Figure 3.10, the average 
Figure: 3.9 Artificial cerebrospinal fluid is the optimal perfusate for fluorescent (Fluo4-AM) 
calcium imaging of neural cultures. Human iPSC-derived neural cultures were spontaneously 
differentiated over 8 weeks in either Axol or SCT media. Cultures were then fluorescently 
calcium imaged in respective growth media and in artificial cerebrospinal fluid. The percentage 
of active cells calculated as those with ≥ one peak of calcium activity. Data is displayed as mean 




change in fluorescence during spontaneous recordings were 107.95 ΔF/F and 125.29 ΔF/F for 
Axol and SCT, respectively.  
 
Treatment with TTX reduced the average fluorescence amplitude values of Axol to 90.77 ΔF/F 
and SCT to 121.24 ΔF/F, with glutamate causing large increases in fluorescence value to 140.24 
ΔF/F and 155.11 ΔF/F, respectively.  
Following initial investigation of functional calcium activity/responses, spontaneously 
differentiated cultures were assessed at each timepoint for baseline calcium activity. SCT had 
no significant effect on the percentage of active neurons at any timepoint (p= 0.1016, Appendix 
Figure A3). In contrast, Axol cells were significantly more active at 18 WIV compared with every 
other timepoint (W4: 3.40 ± 0.58%, n=18 cs,  p< 0.0001; W8: 14.57 ± 1.77%, n=27, p= 0.0013; 
W12: 7.59 ± 0.75%, n=36 cs, p< 0.0001; W18: 26.76 ± 4.93%, n=18, Appendix Figure A3). At 4 
WIV, cultures differentiated in SCT displayed significantly more active cells than Axol cultures 
(Axol: 3.399 ± 0.58%, SCT: 11.22 ± 1.27%, n=18 cs, p< 0.0001, Figure 3.11A). However, at 8 WIV, 
there was no significant difference observed between media groups (n=27 cs, p=0.36, Figure 
Figure 3.10: Responses of Axol and SCT spontaneously differentiated cultures to 1 μM 
tetrodotoxin (TTX) and 100 μM glutamate. Human iPSC-derived neural cultures were 
spontaneously differentiated over 8 weeks in either Axol (Blue; left) or SCT (Red; right) media. 
Cultures were then fluorescently calcium imaged using Fluo4-AM in aCSF to record baseline 
activity, then treated with TTX and glutamate. N= ≥6 coverslips from ≥2 biological 
differentiations. Solid black bar indicates the addition of respective condition.  
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3.11B). Figure 3.11C shows that SCT was significantly more active than Axol at W12 (Axol: 7.59 
± 0.75%, n=36 cs, p< 0.0001). In contrast, W18 displayed no significant difference between 
















Figure: 3.11 Comparisons of spontaneously differentiated cultures over 18 WIV. Human iPSC-
derived spontaneous neural cultures were differentiated over 12 weeks. Cultures were then 
fluorescently calcium imaged in aCSF to record baseline activity. Active cells were determined 
as those with a minimum of one peak of calcium-mediated activity (peak > 3x s.d baseline 
noise). (A) W4 Axol and SCT. (B) W8 Axol and SCT. (C) W12 Axol and SCT. (D) W18 Axol and SCT. 





3.2.3 Multi-electrode array recordings 
Whilst fluorescent calcium imaging is an invaluable optical method for monitoring cellular 
activity and responses to drug treatments, multi-electrode arrays (MEA) are a non-invasive, real-
time, multi-point measurement of putative action potentials and moreover, they yield an 
impression of network activity. Combined with calcium imaging, this gives a strong indication of 
the true responses of cultured cells. Spontaneous cultures were plated onto MEAs and their 
adherence monitored over time.  
Cells detached at various timepoints in every repeat (n=>40 MEA chips), with cells forming 
aggregates and fasciculation of neurites over extended periods in culture. Interestingly, the cells 
appeared to migrate back over the electrodes at some timepoints after initially detaching; 
however, there was a marked reduction in the number of electrodes underneath cultured 
neurons. Figure 3.12 shows that at 2 WIV, all 64 electrodes were covered, reducing to 21 
electrodes by 4 WIV. By 8 WIV this number had increased to 53 electrodes, however by 12 WIV, 
the entire culture had detached, with 0 electrodes covered. To combat the issue of adherence, 
two different MEA chips were purchased: carbon-based and platinum-based. 
In addition, MEAs were coated with several biological substrates: polyethyleneimine (PEI), poly-
d-L-ornithine (PDLO) and poly-L-ornithine (PORN) (Amin et al., 2016), on both chip types. Cells 
were seeded and differentiated over time. PORN on carbon-based MEA chips was found to be 
the most adherent coating substrate and this was used for all future experiments (data not 
shown). Despite the adherent properties of PORN cf PEI and PDLO, cell activity could only be 
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10 WIV 12 WIV 
Figure 3.12: Spontaneously differentiated NPCs over 12 WIV on planar MEA chips. 
Representative phase contrast images display the same cultured 64 carbon-coated 
electrodes over 12 weeks. WIV refers to number of weeks in vitro differentiation. N=10. Scale 






































































Figure 3.13: Spontaneous multi-electrode array responses of Axol and SCT- cultured cells at 
4 and 8 WIV. Cells were seeded and differentiated on carbon MEA chips over 8 weeks and 
baseline activity assessed using MEA analysis. (A) Traces of spiking activity, -0.015 mV was the 
minimum potential to denote action potential activity, whilst red lines above/below show 5 x 
standard deviation threshold. (B) Clustered activity relating to traces in A. (Left: Axol, Right: 
SCT). (C) Number of active electrodes where spikes recorded. (D) Average number of bursts 
per active electrode. (E) Duration of burst in each electrode. F) Average number of 




In this Chapter, the morphological and functional characterisation of iPSC-derived 
spontaneously differentiated cultures has been achieved through ICC, qPCR, fluorescent calcium 
imaging and MEA analysis.  
Spontaneously differentiated cultures generate neurons, astrocytes, cortical cells and 
excitatory synapses 
The decision to present only qualitative ICC data arose from the realisation that as cultures 
matured, they became extremely dense. This culminated in the formation of large 3-
dimensional aggregates which were impossible to image using available fluorescent and 
confocal imaging (Appendix Figure A4). This is a common theme within this field and throughout 
our laboratory (Personal communication, Dr. Eric Hill). Only qualitative results for iPSC neuronal 
differentiations are usually presented (Odawara et al., 2014). Quantitation was possible for 
some early timepoints with some staining, but the results from one timepoint were of very little 
value, as comparisons with later timepoints was not possible. To maintain consistency 
throughout ICC experiments, a qualitative, rather than quantitative approach was preferred.  
The formation of distinctive neural rosettes in Axol and SCT media shows the potential of each 
media for neural differentiation and serves as a reliable indicator that cells have committed to 
a cortical, neuronal lineage (Shi et al., 2012a). Pax6 controls cortical development and is a 
reliable marker of cortical neurogenesis (Manuel et al., 2015), whereas Sox2 regulates iPSCs 
neural commitment and is highly expressed in proliferating neural progenitor cells (Zhang, 
2014). Whilst the ICC results show the relatively equal staining of both neural progenitors, 
differences were observed in the expression of Pax6 at W4, with Axol expressing significantly 
increased levels cf control, using qPCR. The expression of Sox2 decreased over 8 WIV compared 
to control in both conditions, consistent with the expectation that as cultures mature and cells 
terminally differentiate, the pool of progenitor stem cells should reduce from the earliest 
timepoints. Indeed, it has been demonstrated that constitutive expression of Sox2 results in the 
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maintenance of progenitor characteristics and inhibits neuronal differentiation (Graham et al., 
2003; Packard et al., 2016). An increase in Sox2 expression was observed with both growth 
medium at W12, which is likely due to the presence of matured astrocytes, as astrocytes are 
known to express Sox2 (Niu et al., 2015). There also exists the possibility that Pax6 expression 
in SCT was lower only at the timepoints recorded; Pax6 expression could have been higher 
between W0-W4, then reduced before levels were measured at W4. In either scenario, the 
expression of progenitors in both conditions, coupled with the positive ICC markers and cortical 
rosette formation, are strong indicators of a cortical neural differentiation.  
Cortical fate was confirmed with ICC of cortical layer markers. The presence of both Tbr1+ and 
SatB2+ cells complemented the results seen for early cortical neurogenesis. Whilst the 
qualitative results appear to show an increase in SatB2 expression for SCT, by W8, both cultures 
appear to have a similar expression of cortical layers. This suggests that both conditions can 
generate distinctive cortical cells as seen in vivo and agrees with the timeframes reported in 
vitro (Kuijlaars et al., 2016; Shi et al., 2012a) 
Despite the differences in neural progenitor expression in both media, it appears to have no 
effect on neuronal differentiation. Both media generated Tuj1+ neurons by 4 WIV, irrespective 
of their progenitor expression. qPCR indicates a reduction over time in TUBB3 expression, which 
could correlate with the emergence of neurons early in development. In both instances, Tuj1+ 
cells were observed from W4 throughout, displaying characteristic connective arrangements. 
Whilst DAPI+ nuclei can be observed throughout the culture, they occupy a very small area of 
the field of view, compared with the neurite extensions. It was not possible to assign a neural 
process to a cell body, particularly as the interconnectivity displayed made it impractical to 
distinguish between neurites of different cells.  
It is understood that gliogenesis occurs following neurogenesis in vivo (Tchieu et al., 2019) and 
this has been recapitulated in vitro (Shi et al., 2012a). For this reason, it was expected that the 
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emergence of S100β+ astrocytes would occur later than neurons. S100β expression is associated 
with a matured developmental stage in astrocyte development (Raponi et al., 2007), which is 
desirable in these cultures, as the endpoint is a mature neural culture. The results demonstrate 
an absence of astrocytes at W4, with the emergence of immature astrocytes at W8. The 
immaturity was confirmed by a lack of characteristic astrocytic morphology. Astrocytes are large 
cells, with distinctive processes, however, prior to W12, all S100β+ staining was localised to the 
nucleus, with no processes visible. By 12 WIV, both cultures were generating morphologically 
matured S100β+ astrocytes, which agrees with the results reported for spontaneous neural 
differentiations (Gunhanlar et al., 2017; Kuijlaars et al., 2016; Shi et al., 2012a). A significant 
increase in both Axol and SCT at 4 WIV for S100β expression could be suggestive of the cultures 
preparing for gliogenesis. This could also explain why the values decrease by W8, when 
immature astrocytes are beginning to be expressed. It was concluded that prior to W8, the 
cultures were morphologically immature as only neurons were present. 
Both cultures formed VGlut1+ excitatory synaptic vesicles within 4 weeks and continued to do 
so over the timepoints tested. It is understood that inhibitory GABAergic and glycinergic 
synaptogenesis precedes excitatory synaptogenesis in vivo (Soto et al., 2011) and GAD67 and 
vGAT were used to determine whether cultures expressed inhibitory cell types. Interneurons 
have been reported in spontaneously differentiated cortical cultures, albeit in small amounts 
(Gunhanlar et al., 2017; Kirwan et al., 2015; Shi et al., 2012a). The presence of interneurons in 
this instance is a paradoxical result, as interneurons do not develop in the cortex in vivo, but 
rather migrate in from the medial ganglionic eminence during neural development (Martini et 
al., 2009). As the 2D culture environment lacks any external brain region input, the presence of 
representative quantities of GABAergic cell types was not anticipated. In this instance, cultures 
were GAD67 negative for ICC at all timepoints, however, the qPCR expression data does suggest 
the presence of inhibitory subtypes, with statistical significance, which could be accounted for 
by the cellular system preparing for inhibitory synaptogenesis and the fact that excitatory 
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neurons can still express functional GABA receptors (Kirwan et al., 2015). It has been shown that 
if interneurons are present following spontaneous differentiation, they develop following 
excitatory neurons (Gunhanlar et al., 2017). However, interneurons may typically develop 
during extended periods of culture, or arrive and die out in the intermediate timepoints 
between the experiments in this Chapter. Indeed, increases in vGAT expression over time were 
observed and in addition, supplementary experiments were performed at 18 WIV, with only one 
repeat, due to apparatus failure. These preliminary expression results of Axol W18 were >5-fold 
higher than all other timepoints (Appendix Figure A5), suggesting the development of 
interneurons occurs at later timepoints in culture.   
A key parameter for assessing which media is superior was the emergence of different neural 
development markers, particularly matured astrocytes, as these appear at later stages of 
differentiation in vivo. However, the data conclusively shows that both Axol and SCT media 
differentiate cells into all expected cell subtypes at the same timepoints and that the absence 
of astrocytes in these cultures would constitute an immature system, prior to 8 WIV. Whilst ICC 
can qualitatively suggest the presence and morphology of cell types, it offers no consideration 
of functionality. Development of this assay requires cells which not only resemble their in vivo 
counterparts, but demonstrate functional activity and drug responses also. 
Both Axol and SCT media produced functionally active cultures 
Calcium imaging and MEA analysis were used to assess functional responses. Both conditions 
displayed more spontaneous activity when perfused with aCSF, therefore aCSF was chosen as 
the perfusate for all subsequent calcium imaging studies. These results disagree with those 
reported by Bardy et al., (2015), and further reflects the differences between cells in different 
culture systems. Whilst cells appeared responsive, eliciting asynchronous calcium-mediated 
activity, there was no evidence that the activity was electrical. In order to test this, TTX was 
added to the cultures, resulting in the immediate cessation of spontaneous activity.  
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Collectively, these results suggest that the activity observed which was blocked by TTX is a 
secondary effect of sodium-dependent action potentials, and confirms the cells are functionally 
active (Hill et al., 2012). Whilst these results give insight into the electrical ability of the cells, 
they provide no information on the receptors which the cultures may be expressing. Glutamate 
is the principal excitatory neurotransmitter in the mammalian CNS, with a wide range of 
ionotropic and metabotropic targets (Goodwani et al., 2017). Application of glutamate resulted 
in large fluorescence increases, indicating that the cultures became excited in response and 
hence, they express functional glutamatergic receptors. It was beyond the scope of this 
investigation to determine precisely which receptors were expressed.  
Having established that both cell conditions respond to different classes of pharmacological 
agent, the assessment of spontaneous activity over W4 to W18 was initiated, to determine if 
this identified an optimal differentiation medium. SCT-differentiated cultures were found to be 
significantly more active at W4 and W12, indicating a potential for SCT to be the better choice 
of growth medium.  
Optimisation of MEA experiments was a challenge, with different electrodes and coating 
reagents tested. Unfortunately, in every condition, the cells detached and recordings were not 
possible after early timepoints. As laminin is a component of the extracellular matrix and is 
necessary for cell adhesion and differentiation (Baur et al., 1995), various concentrations of 
laminin were also tested to see if adherence could be improved. Preliminary studies assessed 
functional responses when cultures were dense (WIV 1-3), although, as expected there was a 
lack of activity, probably due to cell immaturity (data not shown).  
The single successful recordings completed at W4 and W8 showed a lack of activity with Axol 
and low activity with SCT, even at W8, which is not in agreement with the literature. Odawara 
et al., (2014) showed that responses of iPSC-derived neurons increased from 3 WIV, with robust 
activity observed from 4 WIV. However, as only one repeat was successful, this was very 
91 
 
preliminary. It is important to clarify that MEA experiments were not performed in aCSF, but 
rather, in the respective growth medium. In contrast to calcium imaging experiments, for MEA 
studies, the same chips can be assessed over time, as the recordings are made in the incubator, 
in a sterile atmosphere and the technique is completely non-invasive. As the cells were still 
differentiating and MEA recordings were done at multiple timepoints, the sterile growth 
medium was chosen to study activity, rather than aCSF, which would have required filter 
sterilisation and would have posed a risk to culture sterility. Bardy et al., (2015) showed that 
SCT media was superior to standard media recipes for functional analyses, potentially due to 
physiologically-relevant concentrations of salts and factors as discussed above. Their work 
suggested neurobasal and DMEM recipes did not have representative concentrations of such 
components, and hence, produced weaker functional responses. Whilst the data generated 
here is very preliminary, it could be inferred that SCT might hold more promise than Axol 
medium for MEA recordings.  
PORN was found to be the ideal coating reagent for adherence and differentiation of iPSC-
derived NPCs. It was also preferable to use the same coating conditions as were used for calcium 
imaging, for consistency. As there was no issue with detachment of cells on glass coverslips, or 
on culture ware, it was concluded that the issue with MEA adherence was highly likely to be due 
to the MEA chips themselves. Indeed, a supplementary experiment was performed wherein 
MEA chips for a different MEA system were obtained and cultures were more adherent in this 
instance. These results differ to those of Amin et al., (2016), who found PDLO was the ideal 
substrate for MEA adherence. However, the results agree with the observation that PORN 
results in aggregation and fasciculation of neural cells over time (Amin et al., 2016).  
As the difference in medium was only presented following measurements of functionality, it 
was decided that the data required to determine a better medium needed to be more robust 
than just the morphological and basic functional results generated in this Chapter. Although SCT 
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MEA measurements appeared superior, only one experiment could be conducted. For these 
reasons, it could not be concluded with confidence which medium was better for spontaneous 
neural differentiation. In Chapter 4, a side-by-side comparison was performed to determine 
which condition led to more responsive cultures, and hence, which media would be an ideal 
option for development of the assay.  
The results of this chapter indicate that two leading growth media can successful generate 
excitatory cortical culture cells over 12 WIV differentiation. Moreover, as both conditions 
elicited action potential-dependent activity and excitatory neurotransmission, they were both 























4. INVESTIGATING THE ABILITY OF SPONTANEOUSLY DIFFERENTIATED 
iPSC-DERIVED NEURAL CULTURES TO GENERATE EPILEPTIFORM ACTIVITY 
4.1 Introduction 
Existing assays used to study epileptiform activity and seizure-like events (SLE) manipulate 
cellular processes in otherwise healthy tissue, in order to initiate seizurogenesis and generate 
SLE (Chapter 1.5). The induction of SLE is well-established in primary rodent in vitro models and 
brain slice assays, using agents which alter ion flux, neurotransmission and affect the whole 
electrical network (Accardi et al., 2018; Debanne et al., 2006; Easter et al., 2007; Gabriel et al., 
2004; Gonzalez-Sulser et al., 2011; Igelström et al., 2011; Pena & Tapia, 2000; Yaari et al., 1983, 
1986). In order to generate SLE, the system must form receptors/drug targets for the pro-
ictogenic conditions to exert their effects. In this Chapter, responses to a variety of ionic and 
pharmacological manipulations frequently used in rodent in vitro epilepsy studies were used to 
assess whether the system could respond to these conditions, as well as displaying ‘normal’ 
baseline activity.  
4.1.1 Manipulating cell excitability via ion flux  
Neuronal excitability is controlled by ion gradients (Chapter 1). The manipulation of ion levels in 
neurons can result in increased activity, leading to SLE. Changes to potassium (K+) and 
magnesium (Mg2+) levels are typically achieved by modulation of the bathing solution used to 
perfuse the cell/tissue for the experiment. In these studies, aCSF was the most appropriate 
perfusate for all conditions (Chapter 3).  
Elevated extracellular potassium concentrations ([K+]e) can lead to depolarisation, increased 
firing and burst-firing, all of which facilitate seizurogenesis. Furthermore, during seizure, [K+]e 
increases and extracellular sodium and calcium ([Na+]e/[Ca2+]e) decreases, due to neuronal 
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release and uptake, respectively (Raimondo et al., 2015). This can create a cycle of 
depolarisation, promoting further action potential discharge. Increasing potassium levels is an 
established method for generating SLE in vitro (Traynelis & Dingledine, 1988; Yaari et al., 1986). 
In addition, it has been demonstrated that iPSC-derived neurons can respond to high potassium 
solutions, with increased calcium-mediated activity (Tukker et al., 2016).  
Lowering the concentration of Mg2+ can affect the system at the network level, leading to 
recurrent SLE (Igelström et al., 2011; Pacico & Meur, 2014). ‘Normal’ matured activity is 
asynchronous, so for seizures to occur, multiple neurons need to be recruited in an unusually 
hypersynchronous manner (Jiruska et al., 2013; Vaughan & Delanty, 2003). Bursts are generated 
by sustained recurrent excitation, elicited by clusters of glutamatergic pyramidal neurons in the 
cortex, and followed by a period of hyperpolarisation. Recurrent excitation via NMDA and non-
NMDA glutamatergic receptor activation can further recruit and synchronise neurons into the 
seizurogenic activity (Debanne et al., 2006; McCormick & Contreras, 2001). This sequence of 
events is termed the paroxysmal depolarising shift (PDS). Normally, Mg2+ blocks the pore of the 
NMDA receptor. During the PDS, the membrane becomes depolarised to the point where the 
voltage-dependent Mg2+ block of NMDA receptors is released. When Mg2+ is lowered, NMDA 
receptors become permeable to Ca2+ which, alongside voltage-gated Na+ activation, induces 
long-lasting potentiation of glutamatergic transmission at pyramidal cell synapses (Staley & 
Dudek, 2006). Activation of multiple NMDA receptors further depolarises the cell and promotes 
increased Ca2+ influx (Vaughan & Delanty, 2003). Indeed, NMDA and AMPA receptor antagonists 
are known to suppress seizurogenesis (Rogawski, 1992). In this Chapter, magnesium was 







4.1.2 Pharmacological induction of SLE  
SLE can also be induced pharmacologically in rodent seizure models, with chemical and 
biological agents promoting increased bursts of activity from release of excitatory and inhibitory 
neurotransmitters, as discussed in Chapter 1.  
4.1.2.1  4-aminopyridine 
An agent now used in the therapy of multiple sclerosis, 4-aminopyridine (4-AP), is also an 
experimental compound widely used to induce SLE and increase neuronal activity in rodent 
models, however the mechanism of action is not entirely understood (Accardi et al., 2018; 
Bradley et al., 2018; Easter et al., 2007; Gonzalez-Sulser et al., 2011; Hongo et al., 2015; Kreir et 
al., 2018; Pena & Tapia, 2000). In addition, 4-AP has been shown to elicit recurrent 
depolarisations in human iPSC-derived networks (Matsuda et al., 2018; Pruunsild et al., 2017).  
Proposed mechanisms of 4-AP are all based on the evidence that it blocks transient K+ currents 
via antagonism of potassium channels. More specifically, 4-AP enters the Shaker family of 
potassium channels and will then only exit when the activation gate is open (Loboda & 
Armstrong, 2001). However, when 4-AP is inside the channel, its primary effect is to bias the 
activation gate towards the closed conformation, thus blocking the movement of K+ currents 
and prolonging action potentials by inhibiting repolarisation. The consequence of this is 
increased release of glutamate from nerve endings, causing overactivation of glutamate 
receptors. Paradoxically, under these conditions, GABA-mediated transmission may increase 
excitation and consequently, generate epileptiform activity (Pena & Tapia, 2000)  
This mechanism can also affect interneuronal populations. The K+-interneuron accumulation 
hypothesis (Perreault & Avoli, 1991) suggests that the firing of interneurons transiently 
increases the [K+]e, via K+ repolarising conductances. However, this extracellular change will 
cause other interneurons to fire AP, with increased K+e accumulation enhancing the excitability 
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of neighbouring interneurons. This promotes a cycle of positive feedback, the result of which is 
increased neuronal discharges (González et al., 2018).  
4.1.2.2 Picrotoxin 
GABA antagonism is a major mechanism of seizurogenesis, as the inhibition of GABA’s inhibitory 
mode of action results in increased excitation (Olsen & DeLorey, 2012). A variety of GABAA 
receptor antagonists can be selected to cause SLE. Commonly used are: gabazine, picrotoxin 
(PTX), bicuculline and pentylenetetrazol (Bradley et al., 2018; Easter et al., 2007; Fan et al., 2019; 
Hongo et al., 2015). Although mainly used to induce SLE in vivo, pentylenetetrazol is also used 
in vitro (Easter et al., 2009). Gabazine is a competitive antagonist of GABA receptors (Ueno et 
al., 1997) and has also been used in iPSC-derived neural cultures to assess network activity 
(Kuijlaars et al., 2016) and to generate epileptiform activity (Ishii et al., 2017). Although several 
GABA antagonists with pro-ictogenic effects exist, not all mechanisms are understood. In this 
study, PTX was selected for GABA antagonism, as it has a well-understood mode of action: non-
competitive GABAA receptor chloride antagonism, binding preferentially to an agonist bound 
state (open/closed or both conformations) (Newland & Cull‐Candy, 1992). In addition, PTX has 
been shown to elicit increased activity in iPSC cultures (Kuijlaars et al., 2016; Tukker et al., 2018; 
Verheyen et al., 2015; Zhang et al., 2016) and as such, provided an ideal antagonist for 
comparison in the iPSC-derived cultures in this thesis.    
4.1.3 Proposal for a panel of agents for seizure-liability testing  
As the fundamental aim of iPSC-derived seizure liability models (including the work of this 
thesis), is to provide a suitable addition to pre-clinical toxicity testing, a validatory panel of 
agents, which should be considered for all methods attempting to test seizure-liability, is 
proposed (Table 4.1). This panel is based on previous neurotoxicity screening studies performed 




The panel chosen reflects commonly used compounds for inducing SLE and to the author’s  
knowledge, no iPSC-derived models have been tested and have responded to all of these 
conditions. It would also be advantageous to determine the effects of ionic manipulation on 
cultures, particularly as these are widely used for in vitro seizure studies, however, these are 
not routinely used in drug screening.  
In support of the inclusion of human models in the battery of pre-clinical safety pharmacology 
tests, all models should be able to generate epileptiform activity in response to these drugs as 
a minimum attribute, as has been shown reproducibly in several validated rodent systems.  
Table 4.1: Proposed panel of seizurogenic drugs for validation of iPSC-derived seizure-liability 
testing platforms. VG = voltage-gated. The exact mechanism of action of PTZ is unknown, 
however it has been shown to act upon GABA receptors (Bradley et al., 2018). 
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The aims of this Chapter are to: 
1)  Assess whether iPSC-derived spontaneously differentiated neural cultures respond to 
4-aminopyridine, picrotoxin and zero magnesium/high potassium aCSF with increased 
and synchronised activity, using fluorescent calcium imaging. 





The results of Chapter 3 indicate that spontaneously differentiated human iPSC-derived neural 
cultures in Axol and SCT media are capable of generating various neural subtypes, which elicit 
basic functional responses to the excitatory neurotransmitter glutamate and also display action 
potential-dependent activity, as demonstrated by TTX addition. In order to determine whether 
these cultures were capable of epileptiform activity, cells were spontaneously differentiated 
over 18 weeks in vitro (WIV) and assessed periodically at the same timepoints as Chapter 3, as 
the results of Chapter 3 indicated cultures differentiated in both Axol and SCT media generated 
excitatory synapses and displayed functional calcium-mediated activity by 4 WIV. Fluorescent 
calcium imaging was chosen as the technique of assessing seizure induction, as far as can be 
determined, this is a novel approach to testing seizure-like activity in human iPSC-derived 
cultures.   
At each time point, cultures were perfused with different pro-ictogenic conditions of diverse 
mechanisms of action (as per Chapter 4.1). For all timepoints and drug conditions, the data is 
displayed in the same way, comprising a representative fluorescently-stained snapshot of the 
cultures with associated regions of interest (ROI), example traces from the ROI, raster plots of 
example spike data and various other parameters of epileptiform activity.   
4.2.1 4 WIV Testing 
Cells cultured in Axol medium did not respond significantly to 100 µM 4-aminopyridine (4-AP) 
in percentage active cells, peaks per cell, burst frequency, percentage synchronised elevations 
or R value (Figure 4.1). However, the percentage of responding cells of SCT-differentiated 
cultures to 100 µM 4-AP was significantly increased (Control: 14.17 ± 1.61%, 4-AP: 23.85 ± 
4.29%, n=9 coverslips from 3 differentiations (cs), p= 0.0395). In addition, there was an increase 





Figure 4.1: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to 4-aminopyridine at 4 WIV. (A) Cells cultured in either Axol 
(upper, blue throughout) or SCT (lower, red throughout) media were loaded with 5 µM Fluo4-
AM for imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures 
showing 10 example, random fluorescent traces related to yellow regions of interest in (A). (C) 
Representative Raster plot. Spikes were identified manually and plotted over time to identify 
synchronised events. (D) Responding cells were determined as those with ≥ one peak of calcium 
activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) 
Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value 
was calculated by performing a Pearson’s correlation of the spike data generated for (C), then 
performing a Fisher’s z-transformation. Data in D-H is displayed as mean ± SEM from N=3 
separate neural differentiations. *p< 0.05, 2-way ANOVA with Tukey’s multiple comparisons 





Figure 4.2: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to zero-magnesium aCSF perfusion at 4 WIV. (A) Cells cultured 
in either Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) 
Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. (E) 
Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value of the 
spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=3. *p< 0.05, ****p< 
0.0001, 2-way ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid black bar 





Indeed, the percentage of responding cells in SCT was statistically greater than that of cells 
cultured in Axol media (Axol: 3.07 ± 0.98%; SCT: 14.17 ± 1.61%, n=9 cs, p= 0.0145, Figure 4.1D). 
Moreover, whilst largely statistically insignificant, the average responses of Axol and SCT to 4-
AP increased in every instance, with the exception of burst frequency, where a non-significant 
decrease was observed in both conditions (Figure 4.1F). The control values for each parameter 
were consistently higher in SCT than that of Axol and in addition, the response to drug was 
higher in SCT than that of Axol (Figure 4.1D-H).  
Axol and SCT cultures displayed a significant increase in percentage of responding cells to zero-
magnesium aCSF perfusion (0 Mg) (Axol Control: 3.73 ± 0.68, 0 Mg: 11.27 ± 2.56, n=9 cs, p= 
0.0459; SCT Control: 8.26 ±1.44, 0 Mg: 17.18 ± 2.46, n=9 cs, p= 0.0138, Figure 4.2D). 0 Mg aCSF 
perfusion also significantly increased the number of peaks per cell for SCT at 4 WIV (Control: 
1.43 ± 0.13, 0Mg: 2.39 ± 0.33, n=9 cs, p= 0.0063, Figure 4.2E) and both conditions presented a 
highly significant reduction in burst frequency, despite the increase in other markers of activity 
(Axol Control: 0.23 ± 0.01, 0 Mg: 0.11 ± 0.01, n=9 cs, p = <0.0001; SCT Control: 0.30 ± 0.02, 0 Mg:  
0.16 ± 0.02, n=9 cs, p< 0.0001, Figure 4.2F).  
4.2.2 8 WIV Testing 
Similarly to 4 WIV, at 8 WIV Axol cultures did not present any significant response to 4-AP, 
despite increases compared with control in all metrics of activity except burst frequency, which 
again decreased (Figure 4.3D-H). In contrast, SCT cultures displayed a significant increase in 
number of peaks per cell (Control: 1.61 ± 0.16, 4-AP: 2.86 ± 0.42, n=9 cs, p= 0.005, Figure 4.3E).  
SCT culture responses to 0 Mg also resulted in significant increases in the percentage of 
responding cells (Control: 17.00 ± 4.14, 0Mg: 34.04 ± 2.58, n=9 cs, p= 0.004, Figure 4.4D) and 









Figure 4.3: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to 4-aminopyridine perfusion at 8 WIV. (A) Cells cultured in 
either Axol (upper) or SCT (lower) media were loaded with Fluo4-AM for imaging. (B) Time-
lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. 
(E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) 
Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R 
value of the spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=3. **p< 
0.01, 2-way ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid black bar 





Figure 4.4: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to zero-magnesium aCSF perfusion at 8 WIV. (A) Cells cultured 
in either Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) 
Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. (E) 
Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value of the 
spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=3. **p< 0.01, 2-way 
ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid black bar in B-C indicates 






Figure 4.5: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to picrotoxin at 8 WIV. (A) Cells cultured in either Axol (upper) 
or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) Time-lapse videos were 
recorded at 0.33 Hz, with representative figures showing 10 example, random fluorescent 
traces related to yellow regions of interest in (A). (C) Representative Raster plot. Spikes were 
identified manually and plotted over time to identify synchronised events. (D) Responding cells 
were determined as those with ≥ one peak of calcium activity. (E) Calcium peaks per active 
cell. (F) Frequency of calcium events per minute. (G-H) Quantitative measures of synchrony. 
(G) % synchronised cells relating to (C). (H) Average R value of the spike data generated for (C). 
Data in D-H is displayed as mean ± SEM. N=3. *p< 0.05, **p< 0.01, 2-way ANOVA with Tukey’s 




The addition of 100 μM picrotoxin (PTX) at 8 WIV increased the number of peaks per cell in both 
conditions (Axol control: 0.01 ± 0.02, PTX: 0.29 ± 0.02, n=9 cs, p= 0.005; SCT control: 0.21 ± 0.04, 
PTX: 0.41 ± 0.06, n=9 cs, p= 0.0034, Figure 4.5E). Additionally, SCT control displayed a significant 
increase in burst frequency compared to Axol control (Axol: 0.25 ± 0.01, SCT: 0.33 ± 0.03, n=9 
cs, p= 0.043, Figure 4.5F).  
Neither condition significantly increased synchronised activity in any ictogenic conditions tested 
at 8 WIV (Figures 4.3-5). R values for all Axol control and 4-AP repeats were zero (Figure 4.3H). 
In addition, the burst frequency response for all conditions at 8 WIV was not statistically 
different (Figures 4.3/4/5H). 
4.2.3 12 WIV Testing 
4-AP treatment at 12 WIV resulted in an increase in peaks per cell for SCT (Control: 1.61 ± 0.19, 
4-AP: 2.75 ± 0.46, n=9 cs, p= 0.017, Figure 4.6E), whereas the only significant effect on Axol 
cultures was the reduction in burst frequency compared wth control (Control: -0.67 ± 0.02, 4-
AP: -0.86 ± 0.03, n=9 cs, p= 0.024, Figure 4.6F).  
Axol cultures responded significantly to 0 Mg aCSF with an increase in percentage of responding 
cells (Control: 0.93 ± 0.09%, 0Mg: 1.29 ± 0.11%, n=9 cs, p= 0.05, Figure 4.7D). Neither culture 
displayed significant increases in percentage of synchronised elevations (Figure 4.7G), however 
SCT produced a significant increase in log R value (Control: -1.35 ± 0.05, 0Mg: -0.32 ± 0.13, n=9 
cs, p= 0.001, Figure 4.7H).  
PTX elicited a significant response in percentage of responding cells from Axol (Control: 6.83 ± 
1.31%, PTX: 18.19 ± 2.21%, n=9 cs, p= 0.01, Figure 4.8D). In contrast, SCT showed no significant 
response to PTX, with the exception of a signficant reduction in burst frequency (Control: 0.29 
± 0.03, PTX: 0.17 ± 0.02, n=9 cs, p= 0.002, Figure 4.8F). 
High potassium aCSF perfusion (>K+) was chosen as an additional test for 12 WIV, intended to 
excite the morphologically matured system, as Chapter 3 indicated all cellular subtypes were 
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present by this stage. Whilst the only statistically significant result from >K+ perfusion was the 
percentage of responding cells in Axol (Control: 0.89 ± 0.10%, >K+: 1.37 ± 0.03%, n=9 cs, p= 
0.0014, Figure 4.9D), >K+ resulted in the greatest percentage of synchronised cells and peaks 
per cell values seen throughout W12 testing (Figures 4.6-9). Of particular importance is the 
distribution of data observed throughout Figure 4.9D-H for SCT cultures. For all studies, 
(excluding log-tranformed data in E), the distribution shows an isolated ‘anomalous’ value 
higher than the normal distribution. This is discussed in section 4.2.5.  
Continuing the trend of W4 and W8, SCT controls were higher than those of Axol controls 
throughout all W12 treatments, with the sole exception of the R values generated in >K+ (Figure 






Figure 4.6: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to 4-aminopyridine at 12 WIV. (A) Cells cultured in either Axol 
(upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) Time-lapse 
videos were recorded at 0.33 Hz, with representative figures showing 10 example, random 
fluorescent traces related to yellow regions of interest in (A). (C) Representative Raster plot. 
Spikes were identified manually and plotted over time to identify synchronised events. (D) 
Responding cells were determined as those with ≥ one peak of calcium activity. (E) Calcium 
peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value of the 
spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=3.*p< 0.05, 2-way 
ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid black bar in B-C 




Figure 4.7: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to zero-magnesium aCSF perfusion at 12 WIV. (A) Cells cultured 
in either Axol (upper) or SCT (lower) media were loaded with Fluo4-AM for imaging. (B) Time-
lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. (E) 
Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value of the 
spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=3. *p< 0.05, **p  
<0.01, ***p< 0.001, 2-way ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. 
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Figure 4.8: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to picrotoxin at 12 WIV. (A) Cells cultured in either Axol 
(upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) Time-lapse 
videos were recorded at 0.33 Hz, with representative figures showing 10 example, random 
fluorescent traces related to yellow regions of interest in (A). (C) Representative Raster plot. 
Spikes were identified manually and plotted over time to identify synchronised events. (D) 
Responding cells were determined as those with ≥ one peak of calcium activity. (E) Calcium 
peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value was of 
the spike data generated for (C). N=3. **p< 0.01, 2-way ANOVA with Tukey’s multiple 





Figure 4.9: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to high potassium (>K
+
) aCSF perfusion at 12 WIV. (A) Cells 
cultured in either Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for 
imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 
10 example, random fluorescent traces related to yellow regions of interest in (A). (C) 
Representative Raster plot. Spikes were identified manually and plotted over time to identify 
synchronised events. (D) Responding cells were determined as those with ≥ one peak of 
calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. 
(G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average 
R value was calculated by performing a Pearson’s correlation of the spike data generated for 
(C). Data in D-H is displayed as mean ± SEM. N=3. **p< 0.01, 2-way ANOVA with Tukey’s 




4.2.4 18 WIV Testing 
18 WIV cultures did not display statistically significant responses to 4-AP, however in both media 
conditions, a significant decrease in burst frequency was observed (Axol control: 0.29 ± 0.03, 4-
AP: 0.16 ± 0.02, n=9 cs, p= 0.0007; SCT control: 0.27 ± 0.02, n=9 cs, 4-AP: 0.16 ± 0.02, n=9 cs, p= 
0.0041, Figure 4.10F). Interestingly, the SCT culture control values were all lower cf Axol culture 
control values, except for R value (Figure 4.10D-H), which was different to all previous 
experiments.  
0 Mg elicited significant responses in percentage responding cells (Control: 14.69 ± 3.5%, 0Mg: 
32.08 ± 5.85%, n=6 cs, p= 0.037, Figure 4.11D) and peaks per cell (Control: 1.23 ± 0.08, 0Mg: 
1.75 ± 0.9, n=6 cs, p= 0.032, Figure 4.11E) for Axol cultures, whilst SCT did not display any 
significant increases. Interestingly, both cultures significantly decreased bursting frequency 
whilst in drug (Axol Control: 0.25 ± 0.02, 0Mg: 0.15 ± 0.02, n=6 cs, p= 0.03; SCT Control: 0.3 ± 
0.03, 0Mg: 0.14 ± 0.02, n=6 cs, p= 0.0006, Figure 4.11F). 
When PTX was perfused to W18 cultures, peaks per cell were significantly increased for SCT 
cultures (Control: 1.4 ± 0.17, PTX: 2.21 ± 0.26, n=6 cs, p= 0.001, Figure 4.12E), and significant 
decreases observed for burst frequency in Axol (Control: 0.23 ± 0.01, PTX: 0.12 ± 0.01, n=6 cs, 
p= 0.03, Figure 4.12F). Both cultures displayed a lack of synchronised activity. Axol control and 




Figure 4.10: Fluorescent calcium imaging responses of spontaneously differentiated human 
iPSC-derived neural cultures to 4-aminopyridine perfusion at 18 WIV. (A) Cells cultured in 
either Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) 
Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. (E) 
Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value of the 
spike data generated for (C). Data in D-H is displayed as mean ± SEM from N=2 separate neural 
differentiations. **p< 0.01, ***p< 0.001, 2-way ANOVA with Tukey’s multiple comparisons 




Figure 4.11: Fluorescent calcium imaging responses of spontaneously differentiated 
human iPSC-derived neural cultures to zero-magnesium aCSF perfusion at 18 WIV. (A) Cells 
cultured in either Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for 
imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures 
showing 10 example, random fluorescent traces related to yellow regions of interest in (A). 
(C) Representative Raster plot. Spikes were identified manually and plotted over time to 
identify synchronised events. (D) Responding cells were determined as those with ≥ one 
peak of calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events 
per minute. (G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to 
(C). (H) Average R value of the spike data generated for (C). Data in D-H is displayed as mean 
± SEM. N=2. *p< 0.05, ***p< 0.001, 2-way ANOVA with Tukey’s multiple comparisons test. 







Figure 4.12: Fluorescent calcium imaging responses of spontaneously differentiated 
human iPSC-derived neural cultures to picrotoxin at 18 WIV. (A) Cells cultured in either 
Axol (upper) or SCT (lower) media were loaded with 5 µM Fluo4-AM for imaging. (B) Time-
lapse videos were recorded at 0.33 Hz, with representative figures showing 10 example, 
random fluorescent traces related to yellow regions of interest in (A). (C) Representative 
Raster plot. Spikes were identified manually and plotted over time to identify synchronised 
events. (D) Responding cells were determined as those with ≥ one peak of calcium activity. 
(E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) 
Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R 
value of the spike data generated for (C). Data in D-H is displayed as mean ± SEM. N=2. *p< 
0.05, **p< 0.01, 2-way ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid 




4.2.5 ‘Anomalous’ result from 12 WIV elevated potassium 
As mentioned previously, a particular culture appeared to display a greater response in activity 
than the others tested. This result warranted an individual presentation of analysis, due to its 
obvious highly active, synchronised response to >K+ aCSF. As this was an isolated culture, 
statistical analysis was not possible, however, due to the nature of the activity, a plethora of 
additional analyses fitting of epileptiform activity could be performed (Hongo et al., 2015). This 
culture can be found as ‘Video 4.1’ in the supplementary video files. 
Figure 4.13B shows a clear increase in activity, with each randomly sampled ROI displaying 
elevations >1ΔF/F. The spike raster plot in Figure 4.13C also indicates a clear synchronisation 
amongst the cells in culture. Sparse activity is observed prior to >K+ perfusion, then all cells 
display synchronised activity, depicted by the solid vertical lines.  
In contrast to every other culture and condition, every single parameter saw an increased 
response from this culture. Of particular note is the burst frequency (Figure 4.13F), which 
displayed a 2.6-fold increase, which was not observed in any other culture tested. 94% of cells 
responded to the drug (Figure 4.13D), with 98% of these cells in the field of view displaying 
highly synchronised activity; further confirmed by an R value of 1.0 (Figure 4.13G-H).  
More complex analysis was possible for this culture, given the magnitude of the responses. The 
area calcium events occupied and their amplitudes were both increased over 3-fold and 11-fold 
from control, respectively (Figure 4.13I-J). Moreover, duration of bursts decreased in the 
presence of >K+ and the inter-burst-interval (IBI) ie, the time between events, was also 






Figure 4.13 – Epileptiform response of SCT-cultured cells to >K
+
 perfusion at 12 WIV. (A) Cells 
were cultured in SCT media for 12 weeks and loaded with 5 μM Fluo4-AM for fluorescent 
calcium imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures 
showing 10 example, random fluorescent traces related to yellow regions of interest in (A). (C) 
Representative Raster plot. Spikes were identified manually and plotted over time to identify 
synchronised events. (D) Responding cells were determined as those with ≥ one peak of 
calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. 
(G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average 
R Value. (I) Area calcium event occupied. (J) Amplitude of calcium events. (K) Duration of 
calcium events. (L) Time between calcium events. N=1. Scale bar: 5 μm. Solid black bar in B-C 




The aim of this chapter was to determine whether spontaneously differentiated human neural 
precursor stem cells were capable of responding to pro-ictogenic conditions. The endpoints of 
the study assessed hyperexcitability, hypersynchrony and bursting: the hallmarks of 
epileptiform activity (Avoli & Jefferys, 2016). The use of fluorescent calcium imaging to test this 
presented an added benefit of enabling the visualisation of potential synchronised responses 
and interconnectivity of neural networks. 
Cultures were tested from 4 to 18 WIV, as iPSC-derived cultures can fire AP as early as 3 WIV 
(Odawara et al., 2014) and indeed, functional calcium-mediated activity was observed in these 
cultures at 4 WIV (Chapter 3). For this reason, cultures and their responses to seizurogenic 
treatments were assessed from 4 WIV. From the outset, it was suspected that the responses 
would not be significant, due to an immature neuronal culture (Amin et al., 2016). Particularly 
for Axol cells, as 4 WIV was found to have significantly lower levels of activity cf later timepoints 
(Appendix Figure A3). Despite those suspicions, SCT cultured cells did display significant 
responses to both 4-AP and 0 Mg, albeit only in one parameter. As the criteria determined for 
epileptiform responses were both increased activity and synchrony, these responses were not, 
therefore, categorised as ictal.  
Picrotoxin was not selected for experiments at 4 WIV. This decision was based on results of 
Chapter 3 indicating the total absence of GAD67+ interneurons and the results of Gunhanlar et 
al., (2017), who reported the generation of GAD67+ synapses from their spontaneous 
differentiation, but not until 6-8 WIV. This means that even if the spontaneous cultures did 
generate interneuronal populations, as has been reported in several instances (Gunhanlar et al., 
2017; Kirwan et al., 2015; Shi et al., 2012a), 4 WIV would be too soon to see a response. Indeed, 
PTX did not generate epileptiform activity at any timepoint in either condition, which is likely 
due to the absence of GABAergic interneurons and inhibitory circuits; the primary target of PTX 
(Avoli & Jeffreys, 2016). 
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4-AP was selected for study due to its use as an epileptic agent (Avoli & Jeffreys, 2016). As the 
target of 4-AP is neuronal potassium channels, testing 4-AP from 4 WIV was decided, as 
theoretically, the cellular targets should have been present with the emergence of neurons. 
Over the 18 weeks, several isolated significant increases in parameters were observed,  but no 
timepoint or media produced significant responses across the panel of endpoints. In fact, the 
only culture which appeared to respond with increased synchrony and increased activity metrics 
to 4-AP was 4 WIV SCT cultures. However, the number of peaks per cell and percentage of 
synchronised cells were not found to be significant, which would be expected from a highly 
active, synchronous culture displaying epileptiform activity. The slight discrepancy in values 
could be explained by the fact that more cells became active in the presence of 4-AP, but only 
displayed a single or very few peaks. This could account for the number of peaks not significantly 
increasing. Furthermore, the significance reported in R values could be an increase in synchrony 
between these few new peaks in the presence of drug. The absence of significant increases in 
percentage synchronised cells suggests that the newly active cells were displaying peaks 
randomly, not typical of epileptiform activity. Of interest was that the bursting frequency was 
reduced, which would not be expected in an epileptiform culture, as the bursts should be more 
frequent compared with control. Taken together, these results do confirm that SCT at 4 WIV 
responds to 4-AP, but not with epileptiform activity. This is most likely due to the immaturity of 
the culture and lack of refined synaptic circuits, which is a pre-requisite for synchronised 
epileptiform activity (Ishii et al., 2017).  
0 Mg aCSF was selected as a pro-ictogenic condition, owed to its role in NMDA receptor-
mediated excitation of cultures (Isaev et al., 2012). Similarly to 4-AP, some cultures and 
timepoints responded significantly to 0 Mg perfusion, but significant increases were not 
observed in all assessment endpoints in any experiment. Again, only one condition produced 
significant responses in activity and synchrony, which was Axol W18. Despite significant 
increases observed in peaks per cell, percentage responding cells and R value, the burst 
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frequency was significantly decreased, suggesting that whilst a response to 0 Mg was observed, 
epileptiform activity was not. 0 Mg acts on NMDA receptors, which are integral in functional 
excitatory synaptic transmission (Lutzu & Castillo, 2020). In human in vivo studies, synapse 
formation is believed to commence around week 9 (de Graaf-Peters & Hadders-Algra, 2006) and 
as NMDA receptor-mediated transmission is essential for the 0 Mg model, these results could 
suggest undeveloped synapses. This also explains why the condition which did respond to 0 Mg 
with increased activity and synchrony was 18 WIV. 
The lack of epileptiform responses at W4 and W8 in particular, is potentially due to the absence 
of astrocytes in culture, as confirmed by immunostaining in Chapter 3. Astrocyte dysfunction is 
observed in epilepsy and seizure activity, the non-appearance of which prior to 8 WIV could 
provide an explanation as to why widespread synchrony was not observed (Tian et al., 2005; 
Wetherington et al., 2008). Furthermore, astrocytes are involved in establishment of neural 
circuitry and synaptogenesis (Christopherson et al., 2005). The lack of formation of a complete 
synaptically-connected network may explain the inability to form synchronous responses.  
Interestingly, despite the conditions where significant responses in activity and synchrony were 
observed, for 11/12 experiments, the bursting frequency was lower in drug treatment cf 
controls, suggesting non-epileptiform activity. Furthermore, the reduction in burst frequency of 
7 of these 11 conditions was significant. This is not consistent with epileptiform activity; bursting 
should actually increase as this is a characteristic response (Bradley et al., 2018). These results 
strengthen the argument that despite some experiments displaying increased activity and 
synchrony, this fundamental parameter indicates that activity in those responsive cultures was 
not epileptiform.  
In addition, neither media at any timepoint or drug treatment elicited significant increases in 
the percentage of synchronised cells. This would be expected for ictal activity, as seizures 
synchronise populations of cells (Badea et al., 2001).   
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Whilst responses for many experiments were not statistically significant, the cultures did appear 
to respond to the various seizurogenic conditions, suggested by the mean drug response values 
increasing in almost every condition. It could be argued that more repeats could determine 
whether a significant response occurs, yet, the experimental design involved three repeats 
performed for three separate biological differentiations (total of 9 coverslips). However, the 
experimental design and sample size provided a reasonable opportunity for the cultures to 
display epileptiform activity and largely, they did not. The experimental design was applied 
consistently and results obtained at W4, W8 and W12 were considered indicative of the 
capability of the cultures. However, due to an equipment failure outside of the author’s control, 
final biological repeats at W18 were lost, hence only 2 biological differentiations were perfomed 
(total of 6 coverslips). Therefore, 18 WIV experiments would benefit from an increased sample 
size. For this reason, the results at 18 WIV were not considered conclusive.  
As the literature suggested 12 WIV is the point at which spontaneous cultures can display 
matured activity, high potassium aCSF perfusion (>K+) was selected as an additional test for 12 
WIV (Gunhanlar et al., 2017; Kirwan et al., 2015; Odawara et al., 2014, 2016b; Shi et al., 2012). 
Several repeats were also performed at week 18 (data not shown) with >K+ aCSF, but due to 
time constraints and apparatus failure, insufficient repeats for statistical anaysis were obtained, 
and consequently, week 12 was preferentially chosen to ensure all repeats with >K+ could be 
generated.  
The single example presented shows that spontaneously differentiated cultures do possess the 
capacity to respond in a hypersynchronous and hyperexcited manner. As a result this culture 
was defined as having displayed epileptiform activity in response to >K+ perfusion. However, 
this is isolated and hence, not robust or reliable. An R value of 1 indicates complete correlation 
and this was observed, alongside obvious increases in all other parameters of activity and 
synchrony. Whilst it can be concluded that spontaneously differentiated cultures can, therefore, 
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elicit epileptiform activity, 1 repeat of 18 different >K+ aCSF experiments is not a clear indication 
that the cultures can respond in this way routinely and is not statistically significant. The ability 
for one culture to respond likely arises from the differences in cell densities and subtypes when 
cultures are allowed to differentiate spontaneously and without control. Despite careful seeding 
densities, cultures did vary coverslip to coverslip and batch to batch. It is this variation which 
probably precluded any successful and sustained observation of spontaneously differentiated 
cultures displaying repetitive seizure-like activity. This is also supported by the decision to 
present individual datapoints; which highlighted the large variance in the distribution of data, 
further confirming that spontaneous differentiation is unreliable as a method for generating 
consistent drug response data. 
In conclusion, the experiments in this chapter support the contention that whilst spontaneously 
differentiated neural cultures in Axol and SCT media have the potential to respond to >K+ aCSF 
perfusion with large increases in activity, synchrony and bursting, this is not a reliable or 
reproducible method for generating such activity. Furthermore, no epileptiform response was 
observed with 4-AP, PTX or 0 Mg aCSF– all of which routinely generate seizure-like events in 
rodent in vivo and in vitro models. The results suggest either an absence of relevant 
receptors/cell types or an immature neural network formation.  
Regarding the question posed in Chapter 3, that was which growth medium (Axol or SCT) was 
more suitable to eliciting functional responses to these conditions, SCT appeared to create the 
superior culture conditions, due to significantly higher control percentages in several conditions, 
combined with the results of Chapter 3. This decision was strengthened  by the observation that 
the only culture appearing to respond in an epileptiform manner was cultured in SCT medium.  
The revelation that spontaneous differentiation is not suitable for seizure-liability led to the 
development of alternate culture models in the following chapters. Additionally, as SCT proved 





5: OPTIMISATION OF HUMAN IPSC-DERIVED NEURONS AND ASTROCYTES 
IN A CO-CULTURE MODEL 
5.1 Introduction  
To the author’s knowledge, no study has attempted to use spontaneous differentiation as a 
method for generating neural cultures for the express purposes of seizure-liability testing; as 
was demonstrated in Chapter 4. The results from Chapter 4, coupled with consideration of two 
commercially available growth media are suggestive of an immature neural network function, 
with limited ability to respond to pro-ictogenic pharmacological and ionic manipulations. A 
major limitation of spontaneous differentiation is the time taken for cultures to mature, both in 
terms of morphology (with emergence of astrocytes not occurring until 8 WIV) and functionality 
(Chapter 4.2, Shi et al., 2012a). Indeed, electrophysiological studies of spontaneously 
differentiated cultures suggest that neurons may take up to 23 WIV to reach maturity (Amin et 
al., 2016; Kirwan et al., 2015). In addition, variation was observed between cultures, with 
astrocytic overgrowth and high-density aggregation observed throughout in both growth media 
(Chapter 4.2, Appendix Figures A2/4). 
5.1.1 Co-cultures of neurons and astrocytes 
In contrast to a spontaneous differentiation protocol, many protocols exist for the co-culturing 
of rodent neurons with other cell types; predominantly astrocytes (Aebersold et al., 2018; El et 
al., 2018; Herzog et al., 2011; Jones et al., 2012). There have also been recent investigations 
which have attempted the seeding of human neurons and astrocytes together, in a neural ‘co-
culture’. Initial co-culture models seeded human iPSC-derived neurons with rodent astrocytes, 
or rodent astrocyte-conditioned media (Odawara et al., 2014, 2016a; Tang et al., 2013). 
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Odawara et al., (2014) showed that the co-culturing of human iPSC-derived neurons with rodent 
astrocytes results in greater, more rapid, functional and morphological maturity cf cultures 
without astrocytes. In an attempt to move to a more human-relevant system, with no inter-
species extrapolation, an increasing number of studies have seeded iPSC-derived neurons with 
human iPSC-derived astrocytes in both short-term (de Rus Jacquet, 2019; Kayama et al., 2018; 
Matsuda et al., 2018; Tukker et al., 2016, 2018, 2019) and long-term cultures (Odawara et al., 
2016b) and iPSC-derived neurons with primary human astrocytes (Kuijlaars et al., 2016).  
Amongst their many functions, astrocytes are highly involved in the formation and maturation 
of excitatory and inhibitory synapses in the CNS, and also their degradation and removal to 
refine neural circuits  (Nguyen et al., 2011). For example, rodent retinal ganglion cells form very 
few synapses when cultured alone, but the number is increased tenfold in the presence of 
astrocytes or astrocyte-conditioned media (ACM) (Pfrieger & Barres, 1997). The differences 
between rodent and human astrocytes are quite considerable, ranging from their size and 
function, to the presence of morphologically distinct astrocyte subtypes within the human brain 
and the cerebral cortex in particular (Oberheim et al., 2009). Despite these interspecies 
differences, studies using human iPSC-neurons and rodent astrocytes highlighted the 
importance of including astrocytes in culture. Human-neuronal and rodent-astrocytic co-
cultures demonstrated enhanced and more rapid functional maturation, spiking activity and 
maintenance of long-term electrical activity cf neurons alone (Lischka et al., 2018; Odawara et 
al., 2014; Tang et al., 2013).  
In addition, several recent studies have used co-culture protocols with a specific focus on 
seizure-liability testing (Ishii et al., 2017; Odawara et al., 2018; Tukker et al., 2019). These studies 
have shown that iPSC-derived neural co-cultures are capable of generating epileptiform activity 
in response to convulsants. This activity was achieved in 8 weeks, facilitated by the inclusion of 
iPSC-derived astrocytes, which is a far more rapid and practical developmental timeframe than 
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observed with spontaneously differentiated models, both in the literature (Gunhanlar et al., 
2017; Kirwan et al., 2015; Shi, et al., 2012b) and in Chapters 3 and 4 of this thesis. An added 
benefit of the co-culture method cf spontaneous differentiation is that the seeding densities of 
each cell type can be precisely controlled, to promote the generation of a heterogenous neural 
model, with reduced variation between cultures.  
Despite the obvious advantage of controlling cell ratios and the commercial availability of cells 
which have already been differentiated and karyotyped, a particular issue in the field is the 
tendancy for each group to use their own protocol, which differs widely with other literature. 
As such, there is no ‘standard’ as there is for rodent in vitro studies. Furthermore, commercial 
intellectual property issues prevent disclosure of precise media formulations and hence, neural 
induction methods used in the generation of the cells, and donors of the parent iPSC can be 
from a wide variety of patients. The methods used to generate iPSC derived co-cultures are 
diverse (Table 5.1). Differences in the supply of cells, ratios of subtypes, growth medium and 
surface coating reagent are considerable. 
5.1.2 Monocultures of neurons and astrocytes 
In order to generate a co-culture protocol, monocultures of neurons and astrocytes first had to 
be developed. In addition, the author is unaware of any group who have attempted seizure-
liability studies on iPSC-derived astrocyte monocultures.  
To generate neuronal monocultures, the small molecule DAPT was used. DAPT is an inhibitor of 
the γ-secretase complex, which is a key target of Notch (Nelson et al., 2007). Notch signalling 
plays a key role in neural connectivity, axon migration, synapse formation and synaptic 
maturation (Giniger, 2012) and maintains the progenitor pool in differentiating neural cultures; 
hence its inhibition leads to the progenitor pool exiting the cell cycle simultaneously. Indeed, 
DAPT has been used previously in iPSC-derived cultures to synchronise the differentiation of 
NPCs to generate enriched neuronal monocultures (Elkabetz & Studer, 2008; Kuijlaars et al., 
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2016; Rhee et al., 2019; Wong et al., 2017), albeit at different concentrations and durations of 
treatment.  
As discussed above, astrocytes are an integral component of neural cultures and indeed,  
experiments with stem cell-derived astrocytes have demonstrated that these cells are capable 
of exhibiting many of the functions of human in vivo astrocytes. These include: facilitating 
synaptic maturation, gliotransmission, protection of neurons from excitotoxicity and stress and 
astrocytic calcium activity (Hill et al., 2016). The recent emergence of this co-culture method 
was largely due to the advent of protocols for the exclusive generation of astrocytes from 
human iPSCs (Perriot et al., 2018; Serio et al., 2013; Shaltouki et al., 2013; Soubannier et al., 
2019; TCW et al., 2017) and the recent commercial availability of iPSC-derived astrocytes.  
The first efficient, relatively rapid protocol for astrocyte generation from iPSC was reported by 
Shaltouki et al., (2013). Astrocyte development can occur via two lineage pathways: via an 
intermediate precursor which expresses CD44 and an indirect pathway involving glial precursors 
which differentiate exclusively into astrocytes and oligodendrocytes (Shaltouki et al., 2013). 
Astrocytes can be generated from iPSC-derived NPCs, via the use of a defined differentiation 
medium. In this instance, treatment with the growth factors BMP2 and ciliary neurotrophic 
factor (CNTF) directs differentiation of NPCs to astrocytes (Shaltouki et al., 2013). BMPs can 
cause selective astroglial lineage from progenitor cells (Gross et al., 1996) and activation of the 
CNTF receptor has been shown to promote differentiation of cortical precursors into astrocytes 
and prevents cells committing to a neuronal lineage (Bonni et al., 1997). However, it was the 
inclusion of a splice variant of neuregulin known as ‘heregulin’ which was found to promote the 
highest efficiency of astrocyte differentiation. Neuregulins are cell adhesion molecules which 
act on the epidermal growth factor (EGFR) family of receptor tyrosine kinases to promote neural 
development. Heregulin has been shown to act in both paracrine and autocrine fashion, 
stimulating EGFR to activate downstream signalling pathways including the phosphatidylinositol 
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3-kinase/AKT pathway, important in regulating cell cycle and, involved with differentiation of
stem cells to neurons and astrocytes (Otaegi et al., 2006). Astrocytes used in this Chapter have 
been differentiated using this method of defined differentiation medium (Shaltouki et al., 2013). 
The aim of this Chapter was to compare different co-culture and monoculture methods using 
human iPSC-derived neurons and astrocytes, on their ability to respond to seizurogenic 
conditions with epileptiform activity.. The methods in this Chapter are represented in Figure 
5.0. 
Figure 5.0: Representation of culture methods tested in Chapter 5. The monocultures and 
co-cultures highlighted in red text indicate those to be tested in this Chapter. 
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Table 5.1: Co-culture models of human iPSC-derived neural cells. Including seeding ratios of neurons to astrocytes, growth medium and method of co-
culturing.
Neurons Astrocytes Ratio Coating 
Reagent 
Co-culture method Culture Medium Reference 




4:1 PORN-laminin Together N2/B27 with cAMP, BDNF, GDNF 
Kuijlaars et al., 
2016 
iCell® iCell 3:1 PORN-laminin 
Neurons for 40 
minutes, then 
astrocytes on top 
iCell maintenance Tukker et al., 2016 
iCell® glutaneurons/ 
iCell® neurons 
iCell 1:1 PEI-laminin Together SCT BrainPhys™ Tukker et al., 2018 
iCell®/Synfire® iCell 6:1 PEI-laminin Together 
SCT BrainPhys™ 
Neuro.4U® 




3:1 PEI-laminin Together 
iCell neuron maintenance and 
ScienCell astrocyte 
Ishii et al., 2017 
XCell Science cortical XCell Science 10:1 PEI-laminin 
Neurons for 8 days, 
then astrocytes 
SCT BrainPhys™, removing 
BDNF/GDNF after astrocyte 
addition 
Kayama et al., 2018 
XCell Science cortical XCell Science 10:1 PEI-laminin 
Neurons for 8 days, 
then astrocytes 
XCell neural maturation with SCT 
SM1 supplement 
Odawara et al., 
2018 
XCell Science cortical 






Neurons for 8 days, 
then astrocytes 
SCT BrainPhys™, removing 
BDNF/GDNF after astrocyte 
addition 




The aims of this chapter are to: 
1) Establish a suitable method for DAPT-synchronisation of iPSC-derived neurons using 
fluorescence microscopy 
2) Assess the ability for cultures of astrocytes-only and neurons-only to form respective 
subtypes via immunostaining 
3) Determine whether cultures of neurons and astrocytes-only can display epileptiform 
responses to 4-aminopyridine, picrotoxin and zero-magnesium aCSF, using 
fluorescent calcium imaging 
4) Compare different co-culture methods to produce functional, robust cultures 
5) Determine the ability for different co-culture methods to produce functional synapses 





















5.2.1 Neuron and Astrocyte Monocultures 
In order to determine the optimal method of synchronising human iPSC-derived neural stem 
cells (NPCs) to produce a pure neuronal population, NPCs were treated with the Notch signalling 
inhibitor DAPT over 7 days and the percentage of proliferating cells assessed via 
immunocytochemistry (ICC) using Ki67 – a nuclear protein necessary for and indicative of, 
cellular proliferation (Sun & Kaufman, 2018). This was supplemented in SCT medium, as 
previous results had shown SCT more effective for NPC differentiation than Axol neural 
maintenance medium (Chapters 3/4).   
At all timepoints tested, DAPT-treated cells had a significantly lower percentage of Ki67-positive 
nuclei cf untreated cells: (D5: Control: 69.74 ± 6.46%, DAPT: 8.23 ± 4.25%, p= 0.0001; D6: 
Control: 63.21 ± 6.28%, DAPT: 7.97 ± 3.18%, p= 0.0003; D7: Control: 66.44 ± 9.20%, DAPT: 9.34 
± 4.90%, p= 0.0002, all n=9). The difference between DAPT treatments at Days 5-7 were not 
significant, with the largest difference being 1.37% between D5-D7. Whilst D7 had the highest 
percentage of Ki67+ cells in DAPT, it did not have the highest number of proliferating cells in 
total (66.44%) which was lower than that of D5 (69.74%) (Figure 5.1A).  
Alongside the duration of DAPT treatment, the initial seeding density was considered. 
Spontaneously differentiating cells in Chapter 3 were seeded at a density of 50,000 cells/cm2, 
which was a sufficient protocol for spontaneous differentiation. However, as the proliferation 
of NPCs in DAPT-treated cultures were expected to be inhibited, a higher initial seeding density 




Despite a 1.5-fold increase in cells cf spontaneous, a seeding density of 75,000 cells/cm2 
produced sparse cultures with poor viability; these showed extensive fasciculation of neurites 
and detachment from the culture surface by D7 (Figure 5.1B, n=3). The seeding density was 
subsequently increased to 100,000 cells/cm2 and cells adopted an adhered, 2-dimensional 
orientation, with neurite extensions visible and reduced cell death (Figure 5.1C). 100,000 
A 
B C 
Figure 5.1: Determining optimal time course and seeding density for DAPT treatment of NPCs. 
Human iPSC-derived neural precursor stem cells were plated and allowed to recover for 24 
hours, before being treated with 10 µM DAPT. (A) Cells were differentiated over 7 days with or 
without DAPT supplementation. Immunocytochemistry was performed and cells were stained 
for the cell proliferation marker Ki67. The percentage of Ki67+ cells was determined from the 
total DAPI stained cells. (B-C) Representative phase contrast images of Day 7 DAPT seeding 
densities of 75,000 and 100,000 cells/cm2, respectively. N=3. ***p< 0.001, 2-way ANOVA with 
Tukey’s test. Scale bar: 100 µm. 
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cells/cm2 was selected as the optimal seeding density for cultures containing synchronised 
neurons.  
Following establishment of an optimised synchronisation protocol, human iPSC-derived neurons 
and 11 WIV astrocytes were differentiated over 4 weeks and their morphology characterised via 
ICC (Figure 5.2-3). As per Chapter 3, neuron-specific class III β-tubulin (Tuj1) and calcium-binding 
protein S100β were used to label neurons and astrocytes, respectively. Results in this Chapter 
indicated that synchronised NPCs formed neural rosettes at 1 WIV, as with spontaneous 
differentiations (Figure 5.2, n=6 cs). Moreover, sync-neuron cultures generated Tuj1+ neurons 
and were S100β negative (Figure 5.3, n=6 cs). In addition, the neurons presented a low degree 
of fasciculation, which remained constant throughout phase contrast monitoring (data not 
shown).  
Figure 5.2: DAPT-synchronised NPCs form cortical rosettes at 1 WIV. iPSC-derived neural 
precursors were treated for 7 days with 10 µM DAPT and immunocytochemistry performed to 
assess the presence of neural progenitor markers. (A) Nuclei stained with DAPI (Blue, excitation 
λ 345 nm, emission λ 455 nm). (B) Pax6 neural progenitor staining (Green, excitation λ 495 nm, 
emission λ 519 nm). (C) Sox2 neural progenitor staining (Red, excitation λ 588 nm, emission λ 



























Figure 5.3: DAPT-treated NPCs do not generate S100β+ astrocytes and iPSC-derived astrocytes 
alone do not contain Tuj1+ neurons. iPSC-derived neural precursors were synchronously 
differentiated in SCT media with 10 µM DAPT (Left column) and 11-week old cryostored iPSC-
derived astrocytes were cultured in ScienCell™ astrocyte media over 4 weeks. 
Immunocytochemistry performed to assess the presence of neuronal and astrocytic markers. 
(A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, emission λ 455 nm). (B) S100β astrocytic 
staining (Grey, excitation λ 495 nm, emission λ 519 nm). (C) Tuj1 neuronal staining (Red, 
excitation λ 588 nm, emission λ 649 nm). (D) Merged image of A,B,C. N=3. Scale bar: 100 μm.  
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Sync-neuron cultures did not survive past ~7 WIV in any biological differentiation (Appendix 
Figure A6). In contrast, astrocyte-only cultures were S100β+ by 4 WIV (Figure 5.3B, n=6 cs) and 
did not contain Tuj1+ cells (n=6 cs). The relative size of the human iPSC-derived astrocytes were 
approximately 50-fold that of the neuronal cells (~100 µm versus ~2 µm).  
5.2.2 Induction of epileptiform activity in monocultures 
Having established a suitable synchronisation protocol and characterised the morphology of 
different culture types, respective cultures were perfused with a series of pro-ictogenic 
conditions as described in Chapter 4.  Synchronised-neuronal monocultures at 4 WIV and 15 
WIV astrocyte monocultures displayed no significant response in activity to 4-AP, 0 Mg2+ aCSF 
or PTX perfusion (Figures 5.4-6). 
The peaks per cell values increased in all pro-ictogenic treatment (Figure 5.4-6F), however, this 
did not attain statistical significance. As with peaks per cell values, sync neurons exhibited higher 
control values cf astrocytes. For all treatments, the representative Fluo4-AM-loaded images 
supported the results of ICC in Figure 5.3, showing large (>100 µm) astrocytes and considerably 
smaller neurons (~2  µm) (5.4-6A,B). 
Alongside metrics for activity, measures of synchrony were used to determine whether cultures 
of neurons and astrocytes alone could produce this characteristic epileptiform response. 
Neither neuron or astrocyte monocultures presented a significant response in terms of the  
percentage of synchronised cells (Figure 5.6G-I). However, in every instance, neuronal cultures 
showed an increase in percentage of synchronised elevations. Whilst astrocyte cultures also 
showed increases in synchronised elevations with 4-AP and 0 Mg perfusion, no synchronised 
events were detected in PTX (Figure 5.7I). Moreover, the R values reported for astrocyte 
cultures were all zero (Figure 5.7J-L). R values for neuronal cultures were also zero in each 
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Figure 5.4: Human iPSC-derived astrocyte and neuron monocultures do not respond to 4-
aminopyridine perfusion. (A,B) Astrocyte cultures (A) and neuronal cultures (B) were loaded 
with 5 µM Fluo4-AM for fluorescent calcium imaging, with time lapse videos recorded at 0.33 
Hz. (C-D) Representative figures showing 10 example, random fluorescent traces related to 
yellow regions of interest in (A,B). (E) Responding cells were determined as those with ≥ one 
peak of calcium activity. (F) Calcium peaks per active cell. (G) Frequency of calcium events per 
minute. Data in E-G is displayed as mean ± SEM from N=3 separate differentiations. 2-way 
ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 µm. Solid black bar in C-D refers 
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Figure 5.5: Human iPSC-derived astrocyte and neuron monocultures do not respond to zero-
magnesium aCSF perfusion. (A,B) Astrocyte cultures (A) and neuronal cultures (B) were loaded 
with 5 µM Fluo4-AM for fluorescent calcium imaging, with time lapse videos recorded at 0.33 
Hz. (C-D) Representative figures showing 10 example, random fluorescent traces related to 
yellow regions of interest in (A,B). (E) Responding cells were determined as those with ≥ one 
peak of calcium activity. (F) Calcium peaks per active cell. (G) Frequency of calcium events per 
minute. Data in E-G is displayed as mean ± SEM. N=3. 2-way ANOVA with Tukey’s multiple 
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Figure 5.6: Human iPSC-derived astrocyte and neuron monocultures do not respond to 
picrotoxin perfusion. (A,B) Astrocyte cultures (A) and neuronal cultures (B) were loaded with 
5 µM Fluo4-AM for fluorescent calcium imaging, with time lapse videos recorded at 0.33 Hz. 
(C-D) Representative figures showing 10 example, random fluorescent traces related to yellow 
regions of interest in (A,B). (E) Responding cells were determined as those with ≥ one peak of 
calcium activity. (F) Calcium peaks per active cell. (G) Frequency of calcium events per minute. 
Data in E-G is displayed as mean ± SEM. N=3. 2-way ANOVA with Tukey’s multiple comparisons 





Figure 5.7: Astrocyte and neuron monocultures do not display synchronous activity in 
response to pro-ictal conditions. (A-C) Representative raster plots of astrocytic-only cultures 
in response to pro-ictal conditions. Spikes were manually identified and plotted over time to 
identify synchronised events. (D-F) Representative raster plots of neuron-only cultures. A,D: 
response to 100 µM 4-aminopyridine, B,E: zero-magnesium aCSF perfusion, C,F: 100 µM 
picrotoxin. (G-I) % synchronised cells of total active cells, relating to (A-F). (J-L) Average R value 
was calculated by performing a Pearson’s correlation of the spike data generated for (G-I), 
then performing a Fishers-z transformation. Data in G-L is displayed as mean ± SEM. N=3. 2-
way ANOVA with Tukey’s multiple comparisons test. Solid black bar in A-F refers to addition 
of pro-ictal condition.  
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5.2.3 Co-culturing human iPSC-derived neurons and astrocytes together 
Following studies with isolated cultures of neurons and astrocytes, the potential of co-cultured 
cells to display epileptiform responses when cultured together was attempted, as has been 
reported with other co-culture systems (Ishii et al., 2017; Matsuda et al., 2018; Odawara et al., 
2018; Tukker et al., 2019). Initial co-culture experiments were performed using 0 Mg-aCSF 
perfusion, to assess whether synapse maturation and network functionality occurred more 
rapidly than spontaneously differentiated cultures. In order to determine this, several co-culture 
methods were assessed. Co-cultures were designated ‘spontaneous’ or ‘synchronised’, referring 
to the methods applied in the co-culture generation. Spontaneous co-cultures (Spon CC) 
comprised iPSC-derived NPCs and iPSC-derived astrocytes and synchronised co-cultures (Sync 
CC) comprised DAPT-synchronised iPSC-derived NPCs and iPSC-derived astrocytes (Figure 5.0).  
Figure 5.8 shows that in both co-culture conditions, cells did not display significant increases in 
synchrony or activity when perfused with 0 Mg aCSF. Example traces from Spon CC indicate 
increased activity, with large fluorescence amplitude increases, compared with Sync CC (Figure 
5.8B). The control values for percentage responding cells in Spon CC were higher than those for 
Sync CC, albeit not significantly (Spon CC: 15.47 ± 6.01, Sync CC: 10.54 ± 2.70; n=6 cs, p= 0.99). 
This was also true for peaks per cell, burst frequency and percentage of synchronised elevations, 
where the control values for Spon CC were not significantly higher than those for Sync CC.  
Whilst Spon CC presented an increased response in responding cells and peaks, (Figure 5.8D,E), 
burst frequency and synchronised elevations decreased (Figure 5.8F,G), however none of these 




Figure 5.8: Spontaneous and synchronous co-cultures responses to zero-magnesium aCSF 
perfusion. (A) Upper: Spontaneously differentiated iPSC-derived neurons were cultured with 
iPSC-derived astrocytes over 8 weeks. Lower: Synchronously differentiated iPSC-derived 
neurons were cultured with iPSC-derived astrocytes over 8 weeks. Cultures were loaded with 
5 µM Fluo4-AM for fluorescent calcium imaging. (B) Time-lapse videos were recorded at 0.33 
Hz. Representative figures show 10 example, random fluorescent traces related to yellow 
regions of interest in (A). (C) Representative Raster plot. Spikes were identified manually and 
plotted over time to identify synchronised events. (D) Responding cells were determined as 
those with ≥ one peak of calcium activity. (E) Calcium peaks per active cell. (F) Frequency of 
calcium events. (G-H) Quantitative measures of synchrony. (G) % synchronised cells relating 
to (C). (H) Average R value was calculated by performing a Pearson’s correlation of the spike 
data generated for (C), then performing a Fishers-z transformation. Data in D-H is displayed 
as mean ± SEM from N=3 separate co-cultures. 2-way ANOVA with Tukey’s multiple 
comparisons test. Scale bar: 5 µm. Solid black bar in B-C indicates addition of zero-magnesium 
aCSF. 






In addition, in each assessment parameter, one Spon CC experiment skewed the distribution of 
data, with values considerably higher than others presented. This datapoint was analysed 
individually and is presented in Figure 5.10. 
The responses of co-cultures to 0 Mg was also assessed at 18 WIV (Appendix Figure A7). Neither 
co-culture method displayed significantly increased responses to 0 Mg in any parameter. 
Furthermore, the values for responding cells and peaks per cell in both CC were lower at W18 
than W8. In each parameter, the response to 0 Mg did not significantly increase, except for burst 
frequency, which displayed a significant decrease in value in Spon CC (Control: -0.38 ± 0.13, 0 
Mg: -0.99 ± 0.02; n=3, p= 0.005). In addition, the morphology of both Spon CC and Sync CC at 
W18 appeared astrocytic, with approximately 5-fold increased soma diameter than other cells 
in culture (Appendix Figure A8). 
Despite a lack of consistent response in spontaneously differentiated cultures in Chapter 3, MEA 
analysis was attempted for co-culture models, as the literature showed various groups had 
achieved adherent and active iPSC-derived co-cultures on MEAs (Ishii et al., 2017; Kayama et al., 
2018; Matsuda et al., 2018; Odawara et al., 2018; Tukker et al., 2016, 2018, 2019). In contrast 
to the issues presented in Chapter 3, widespread detachment of cultures from MEAs was not 
observed in either co-culture model. Despite this, no activity was recorded in any of 9 MEA chips 
at W4, W12 and W18 for Spon CC cultures. At 8 WIV, a single MEA displayed activity in Sync CC, 
shown in Figure 5.9. As with previous MEA findings, statistical analysis was not possible as only 
one MEA of 9 showed electrophysiological activity. Again, although successful in adherence and 
recording activity, only 33 of 64 electrodes recorded signals which satisfied the minimum action 
potential classification of -0.015 mV potential (Figure 5.9B,C). The number of bursts per 




































Figure 5.9: Multi-electrode array responses from spontaneous and synchronous co-culture 
models at 8 WIV. Co-cultures were differentiated on carbon MEA chips over 8 weeks and 
baseline activity assessed using MEA analysis. (A) Example snapshot of spiking activity, -
0.015 mV was the minimum potential to denote action potential activity, whilst white lines 
above and below illustrate the standard deviation threshold. Vertical red lines which cross 
the threshold are detected signals. (B) Clustered spike analysis of all signals which reached 
the minimum potential for action potential classification, relating to the spikes from A. (C) 
Number of active electrodes where spikes were recorded. (D) Average number of bursts per 
active electrode. (E) Duration of bursts detected. (F) Average number of spikes/burst. N=1.  
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5.2.4 Individual datapoint from Spon CC 
As presented above, the distribution of data for Spon CC was skewed by a single experiment 
(Figure 5.8). As seen with a previous isolated culture in Chapter 4, observation of this culture 
warranted an individual presentation of data alongside additional epileptiform analysis metrics 
(Hongo et al., 2015). This culture is represented as supplementary video file ‘Video 5.1’.  
Figure 5.10 shows the effects of 0 Mg perfusion on a Spon CC. Figure 5.10A shows that whilst 
many cells are visible in the field of view, cells are not overly dense and no aggregation can be 
seen. The example traces all show highly synchronised and increased activity when perfused 
with 0 Mg aCSF, each random trace displaying fluorescence amplitude increases of over 0.5ΔF/F 
compared with baseline (Figure 5.10B).  
The percentage of responding cells increased over 4-fold in 0 Mg, from 24.39% to 100% of cells 
responding in the field of view (Figure 5.10D). Alongside this measurement of activity, peaks per 
cell increased 10-fold to 24.87 peaks per cell and the frequency of bursts was twice that of 
baseline (Control: 0.9 bursts per min, 0 Mg: 1.99 bursts per min) (Figure 5.10E,F). 
The raster plot in Figure 5.10C very clearly shows the extent of synchronisation during perfusion 
with 0 Mg aCSF, beginning with asynchronous baseline activity. Indeed, the values of 
synchronised elevations indicate that 93.3% of cells in the field of view were synchronised in 0 
Mg, compared to 0% at baseline (Figure 5.10G) and the R value of these active cells was 1 (Figure 
5.10H).  
Additional analyses of epileptiform activity revealed the amplitude and duration of bursts 
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Figure 5.10 – Epileptiform response of spontaneous co-culture to zero-magnesium 
perfusion at 7 WIV. (A) Cultures were loaded with 5 μM Fluo4-AM for fluorescent calcium 
imaging. (B) Time-lapse videos were recorded at 1 Hz, with representative figures showing 
10 example, random fluorescent traces related to yellow regions of interest in (A). (C) 
Representative Raster plot. Spikes were identified manually and plotted over time to identify 
synchronised events. (D) Responding cells were determined as those with ≥ one peak of 
calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. 
(G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) 
Average R Value. (I) Amplitude of calcium events. (J) Duration of calcium events. (K) Time 
between calcium events. (L) Area calcium event occupied. N=1. Scale bar: 5 μm. Solid black 




As mentioned in 5.1, various methods exist for the co-culturing of neurons and astrocytes and 
this chapter sought to identify a standard method for producing co-cultures with this particular 
cellular system. It is important to note that there is a lack of literature agreement in terms of 
successful protocols for particular cell lines, so standardisation in human iPSC-derived models 
can be particularly difficult to achieve.  
Monocultures do not display epileptiform activity 
Firstly, individual cultures of the components which comprise mature co-culture systems were 
attempted (Chapter 5.2.1). As described in Chapters 3 and 4, spontaneous differentiation of 
NPCs generates co-cultures of both neurons and astrocytes over 8 WIV. However, overgrowth 
and extensive aggregation of cells was observed throughout spontaneous differentiation, 
alongside considerably more S100β+ astrocytes present over time (Appendix Figure A2, Chapter 
3). For this reason, to generate neuronal monocultures, DAPT-synchronisation was utilised to 
force progenitors to exit the cell cycle simultaneously and differentiate solely into neurons. 
However, there is great variation in the application of DAPT for the purposes of neuronal 
synchronisation (Jun Rhee et al., 2019; Kuijlaars et al, 2016). As such, the densities of cells and 
concentration of DAPT used was carefully considered, to determine the most suitable conditions 
to generate pure neurons using this system.  
Whilst the percentage of proliferating cells were lowest at 6 days in vitro (DIV), 7 DIV DAPT 
treatment was selected as the optimal method for use in co-cultures. In addition, the 
percentage of proliferating cells in the control condition at D7 indicated that by this point cells 
had begun to differentiate, as the value was lower than that of D6. As cells were already 
beginning their differentiation process, cells were treated with DAPT for the full duration of 7 
days. Importantly, it has been observed in this cellular system and those within our laboratory 
(personal communications: Miss Marianne King, Mr James Crowe) that DAPT-synchronisation 
(and mitotic inhibition in general) does not target 100% of the cell population. As the emergence 
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of neurites was visible at D7, this suggests that DAPT had inhibited a significant proportion of 
the culture and that those cells had ceased proliferation and committed to a neural 
differentiation. Therefore, by treating the cells with DAPT as long as possible, it was assumed 
that this would target a higher percentage of total cells in culture, thereby producing the 
greatest response to Notch signalling inhibition. 
It was tentatively assumed that as a result of NPCs exiting the progenitor pool and 
differentiating early in culture, maturity would occur more rapidly than seen for spontaneously 
differentiated cultures. However, the key morphological developmental timepoints were the 
same as seen in spontaneous differentiation (cortical rosettes present by 1 WIV, Tuj1+ neurons 
present by 4 WIV), and the appearance of the neurons themselves was similar, with a low degree 
of fasciculation at 4 WIV. As expected, neuron-only cultures did not form astrocytes, due to the 
pool of progenitors being synchronised for terminal neuronal differentiation. Interestingly, low 
fasciculation of neurites continued throughout the following weeks, which was opposite to the 
aggregation observed in spontaneously differentiated cultures as they developed. It is likely, 
therefore, that the pool of progenitors at different stages of the cell cycle is likely the causative 
factor in fasciculation, aggregation and detachment observed previously (Chapter 3).  
The proposed experimental protocol aimed to differentiate the neuronal monocultures over 8 
weeks, to provide a secondary timepoint for comparison with the results of spontaneous 
differentiation in Chapters 3 and 4. This was achieved for astrocyte-only cultures, which were 
already 11 WIV at the time of initial seeding. The cells were GFAP and S100β+ with characteristic 
astrocyte morphology by 4 WIV (personal communication; Marianne King, James Crowe). In 
addition, ICC data indicates that the control cultures were exclusively comprised of respective 
neural subtypes, with neuronal cultures S100β negative and astrocyte cultures Tuj1 negative 
throughout (Figure 5.3). Due to time constraints, qPCR was not performed on monocultures, 
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however, these cells were tested within the laboratory and expressed appropriate neuronal 
(TUBB3) and astrocytic markers (GFAP, S100β, ALDH) (personal communication, Marianne King).  
Whilst monocultures of astrocytes survived indefinitely, this did not occur for neuronal 
monocultures, as complete detachment and cell death was observed around 7 WIV in all repeats 
(Appendix Figure A6, n=3). This is likely due to the absence of astrocytes and the protective 
functions they impart, including the prevention of neuronal cell death following insults including 
excitotoxicity and oxidative stress (Dhandapani et al., 2003). Whilst SCT medium was used to 
culture the cells, this media contained trophic factors BDNF and GDNF, which are secreted by 
astrocytes (Toyomoto et al., 2005; Wu et al., 2008). These results suggest that despite the 
growth medium containing astrocytic factors such as GDNF, the physical presence of astrocytes 
may be necessary to maintain neuronal viability. Indeed, it has been shown that physical contact 
between neurons and astrocytes is necessary for extended culture periods and that lack of 
physical contact between these cell types results in poor neuronal viability over time (Odawara 
et al., 2014). As the release of neurotrophic factors from astrocytes exerts protective effects on 
neurons in a paracrine fashion (Liu et al., 2017), the results in this chapter support those 
previously reported, i.e. that physical contact and paracrine signalling is necessary for neuronal 
viability, rather than solely the presence of growth factors.  
From a morphological perspective, the emergence of neuronal markers was not affected by the 
absence of astrocytes in culture. In terms of functionality, neuronal monocultures displayed 
lower baseline activity than that of spontaneously differentiated cultures and furthermore, no 
significant responses were observed following treatment with pro-ictogenic conditions. This 
finding is supported by Odawara et al., (2014), who concluded that the presence of astrocytes 
in culture (whether human or rodent) is necessary for functional maturation of neurons. This is 
also further supported by numerous studies, which reported that neuronal monocultures are 
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an inferior model system for functional activity to those in contact with astrocytes (Ishii et al., 
2017; Kuijlaars et al., 2016).  
It is established that astrocytes, whilst not electrically excitable cells, communicate via 
intracellular calcium release and show both spontaneous and synchronous calcium-mediated 
activity (Carmignoto & Haydon, 2012; Parri & Crunelli, 2003; Pirttimaki et al., 2017; Volterra et 
al., 2014). In addition, no significant response was observed to any pro-ictogenic condition in 
astrocyte monocultures. These cultures also lacked synchronous activity. Interestingly, baseline 
activity of responding astrocytes was higher than that of neuronal monocultures, however this 
did not attain statistical significance. These results confirm the requirement of co-culture 
methods for long-term culture (Odawara et al., 2016a)  
To the author’s knowledge, this is the first study that has assessed the ability of monocultures 
of human iPSC-derived astrocytes to generate seizure-like activity in vitro. The data in this 
chapter confirms that separate cultures of neurons and astrocytes are much less robust models 
than those derived from spontaneous differentiation and fundamentally, they are an 
inappropriate model for seizure-liability testing.  
Co-culturing neurons and astrocytes can produce epileptiform activity 
Having established that monocultures are unsuitable models, initial co-culture models were 
attempted using methods reported in the literature, to assess whether this model system can 
be induced to generate seizure-like activity (Table 5.1). In comparison to monocultures, co-
culturing of human iPSC-derived neurons and astrocytes produces viable, adherent cultures 
over time, as previously reported (Kayama et al., 2018; Kuijlaars et al., 2016; Matsuda et al., 
2018; Odawara et al., 2016b; Tukker et al., 2016) and importantly, they possess the capability 
of epileptiform responses (Ishii et al., 2017; Odawara et al., 2018; Tukker et al., 2018, 2019). 
The co-culture methods employed in this chapter were based on those previously described 
(Ishii et al., 2017; Matsuda et al., 2018), which assessed seizure-liability of co-cultures, wherein 
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both cell types were seeded simultaneously. Neither spontaneous or synchronised co-cultures 
showed significant responses to 0 Mg aCSF perfusion at timepoints tested. However, one 
spontaneous co-culture displayed a hypersynchronous and hyperexcitable response to 0 Mg. As 
with spontaneous differentiation in Chapter 4, the epileptiform response was an isolated non-
repeatable experiment. As previously discussed, the high heterogeneity of response seen in 
spontaneously differentiating cultures could provide an explanation for this culture type being 
the responsive model out of the two tested.  
Astrocytic overgrowth in long-term co-cultures 
Calcium imaging results at W18 demonstrated very large cells, with typical astrocytic 
morphologies. Several video snapshots from each co-culture method displayed what appeared 
to be astrocytes throughout the entire culture (Appendix Figure A8). Whilst it is not possible to 
determine the cell type retrospectively, the low control calcium-mediated activity in these 
particular examples, coupled with visual identification of many cells with astrocytic appearance 
is suggestive of a large prepondrance of astrocytes observed in these cultures over time. This is 
despite the initial seeding ratio of neurons to astrocytes being in favour of neurons. As such, 
there exists the possibility that the pool of progenitors could be influenced by the higher initial 
number of astrocytes present from Day 1 with co-culture models, thus influencing the 
progenitor cell fate. Indeed, the fate of NPCs has been shown to be influenced by cytokine 
release from astrocytes (Gonzalez-Perez et al., 2012; Wang et al., 2011).  
To further compare the co-culture methods, MEA recordings were attempted, as the cultures 
appeared considerably more adherent on MEAs than previously observed with spontaneous 
cultures (Figure 5.9). This could be due to astrocytes preferentially adhering to the culture 
surface as opposed to neurons. Indeed, studies using primary rodent models typically seed 
neurons on top of a layer of matured astrocytes to promote survival and adherence (Lange et 
al., 2012). Despite the adherence of the cultures, only one MEA recording displayed measurable 
spiking activity. The absence of activity could be explained by multiple reasons: firstly, astrocytes 
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themselves would not be detected by MEAs as they do not fire action potentials and secondly, 
even if neurons were present, by seeding simultaneously, there was an equal likelihood of 
astrocytes adhering on the recording electrodes, hence blocking signals from firing neurons. 
Indeed, when considering the development of astrocytes over time (Chapter 3), at earlier 
timepoints when MEA activity was successfully recorded in a synchronised co-culture, the 
astrocytes would not have overtaken neuronal proliferation to the same extent as they would 
have at 18 WIV. The increased astrocyte densities at 18 WIV compared to 8 WIV could explain 
the absence of detectable electrical activity over time.   
Astrocyte proliferation in co-cultures 
In collaboration with James Crowe (Parri Group, Aston University), it was shown that 
synchronous co-culture methods produced more active cells by 10 WIV when neuronal cells 
were seeded prior to astrocytes (Kayama et al,, 2018;  Matsuda et al., 2018; Odawara et al., 
2018) In this chapter, synchronised neurons and astrocytes were simultaneously seeded to 
generate co-cultures, as literature assessing seizure-liability of iPSC-derived co-cultures used 
this approach (Ishii et al., 2017; Kuijlaars et al., 2016; Tukker et al., 2016, 2019). Moreover, the 
astrocytes used in the co-culture tested by James Crowe were more matured than those in 
previous studies (Table 5.1). This approach was based on the evidence that mature astrocytes 
better support neuronal maturation (Hedegaard, 2019). As the differentiation process is very 
time-consuming, the use of matured astrocytes to hasten neuronal maturation is beneficial, 
both in terms of time and cost.  
As seen in Chapter 3, astrocytic overgrowth was observed in each co-culture method in this 
chapter, and methods attempted by other members of the group (personal communication, 
James Crowe). The conclusions drawn from this chapter regarding the overgrowth of NPCs and 
astrocytes suggest that further refinement of the protocol was required. As such, the co-culture 
method selected for the final experimental chapter was based on the co-culture of 
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synchronously differentiated neurons and matured astrocytes, with careful consideration of the 































6: INDUCTION OF EPILEPTIFORM ACTIVITY IN CO-CULTURES OF IPSC-
DERIVED SYNCHRONISED NEURONS AND ASTROCYTES 
6.1 Introduction 
Results presented in Chapter 5, demonstrated that an increase in initial cell seeding density of 
NPCs and co-culturing with astrocytes was required to generate consistently functional cultures. 
Furthermore, the proliferative potential of NPCs and astrocytes was highlighted and suggested 
the need for further refinement of culture conditions to manage astrocytic overgrowth, 
especially as uncommitted cells can be influenced by the cell types in their surroundings 
(Gonzalez-Perez et al., 2012; Wang et al., 2011). Overgrowth of astrocytes in culture was 
observed for spontaneous differentiation (Chapter 3/4) and synchronous/spontaneous co-
culture protocols (Chapter 5) and as such, methods to inhibit the proliferation of astrocytes 
were a focus of this chapter.  
Cytosine arabinoside (AraC) has been previously used to control cellular proliferation of both 
neuronal and non-neuronal iPSC-derived and other human cells (Table 6.1). AraC incorporates 
into DNA, forming cleavage complexes and inhibiting replication. The formation of cleavage 
complexes results in DNA fragmentation and furthermore, AraC inhibits DNA polymerase, 
further decreasing DNA replication and repair of fragmentation (Sampath et al., 2006). AraC-
induced mitotic inhibition has been found to be toxic to post-mitotic neurons (Martin et al., 
1990). Hence, whilst AraC treatment would be unnecessarily toxic towards neurons, it was likely 
to be more effective than Notch signalling inhibition in potentially containing the growth of the 
highly proliferative astrocytes, although DAPT has also been used to inhibit proliferation of glial 
populations (Ma et al., 2019; Nagao et al., 2007). 
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There is no standard protocol for the use of AraC to inhibit astrocyte proliferation (Table 6.1). 
In agreement, De Rus Jacquet (2019) also stated that effective AraC treatment should be 
optimised for each cell line. 
Table 6.1: Overview of human iPSC-derived and human primary cell types inhibited with AraC 
from recent literature.  




NPCs – Neurons 5 2 (Cheng et al., 2017) 
Induced neurons 2 >10 (Pak et al., 2018) 
NPCs – Glia 4 1 
(Schwartzentruber et al., 
2017) 
Schwann Cells – Fibroblasts 5-10 Undisclosed (Clark et al., 2017) 
NPCs – Glia 5-8 1 (de Rus Jacquet, 2019) 
Foetal brain tissue -  
all dividing cells 




The co-culturing of neurons and astrocytes has been widely reported in in vitro primary and 
iPSC-derived models (Chapter 1/5). Whilst many of these cultures consist of excitatory neurons 
and astrocytes, the inclusion of inhibitory neuronal populations was less common (Tukker et al., 
2016, 2018, 2019). Interneurons are essential for forming a complete neural network and play 
an integral role in seizure activity (Magloire et al., 2019). Immunostaining results from 
spontaneous differentiation (Chapter 3-4) were GAD67- at all timepoints and no significant 
response to the GABA-antagonist picrotoxin was observed. However, significant levels of vGAT 
expression were observed – consistent with the notion that interneurons may indeed be 
present, but in low numbers (Gunhanlar et al., 2017; Kirwan et al., 2015). 
As previously discussed, there are several protocols for the generation of interneurons from 
iPSC (Chapter 1.3.6). Initially, the work of Shi et al., (2012a) demonstrated the presence of 
ventrally and caudally expressed transcription factors associated with the development of 
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GABAergic interneurons (GIN), which was confirmed with immunostaining of GAD67 inhibitory 
synapses. This was demonstrated only in the presence of the ‘Sonic Hedgehog’ (SHH) agonist 
purmorphamine (Shi et al., 2012b). SHH is a morphogen, critical in development of distinct brain 
regions (Rash & Grove, 2007) and mediates differentiation and maintenance of ventral GIN 
during neurogenesis (Xu et al., 2005, 2010).  
Liu et al., (2013) then published a protocol for the direct differentiation of pure (~90%) 
populations of GIN, again using purmorphamine. They also found that early treatment with 
purmorphamine increased the efficiency of GIN induction (Liu et al., 2013). Subsequent 
protocols also used agonism of SHH signalling for GIN generation (Maroof et al., 2013; Nicholas 
et al., 2013; Tyson et al., 2015).  
Despite several protocols for the generation of GIN, at the time of writing, the author was 
unaware of any group generating their own interneurons from iPSC/NPC to co-culture and for 
seizure-liability testing. Moreover, as several commercially available products have become 
available including excitatory and inhibitory neurons, at ratios representative of the in vivo 
environment, the need for generating components individually and ‘assembling’ the cultures, 
was apparently reduced. Most importantly, the addition of an inhibitory neuronal component 
to the system generates a heterogenous culture, wherein all main neural subtypes are present, 
thus generating a culture reflective of the intact cerebral cortex (Azzarelli et al., 2015). The 
generation of such a platform provides the potential for assessing seizure-liability of existing 
and novel compounds and also delivers a system for assessing existing and novel anti-epileptic 






6.1.2 Sodium Valproate as an anti-epileptic 
As outlined in Chapter 1, many anti-epileptic compounds exist with diverse mechanisms of 
action (Shih et al., 2013). Of these, one of the most widely prescribed anti-epileptic treatments 
is sodium valproate (VPA) (Chang et al., 2012). VPA is a preferential treatment in paediatric 
epilepsy, owing to its acceptable safety profile and broad mechanism of action (Ghodke-Puranik 
et al., 2013).  
6.1.2.1 Effect of VPA on GABA and Neurotransmission 
As discussed in Chapter 1, the synthesis and degradation of GABA is a multi-step process 
involving several enzymes. VPA has been shown to inhibit several enzymes involved in the 
degradation of GABA: GABA transaminase, succinic semialdehyde dehydrogenase and α-
ketoglutarate dehydrogenase (Johannessen & Johannessen, 2003) and enhancement of those 
synthesising GABA such as GABA decarboxylase (Löscher, 1981). As a result, the levels of GABA 
in the brain increase and inhibition of activity is promoted.  
6.1.2.2 Effect of VPA on Ion Channels 
The blockade of ion channels prevents the hyperexcitability of neurons observed in seizures. 
Valproate is reported to block sodium channels (Englund et al., 2011; Rogawski et al., 2016), 
reducing the inward flow of Na+ and preventing repetitive action potential firing. More recent 
evidence suggests it can also play a role in inhibiting low-threshold T-type calcium channels, 
inhibiting Ca2+ entry into the cell and hence, reducing neurotransmission (Broicher et al., 2007; 
Löscher, 2002). There is also evidence for VPA acting on potassium channels to reduce K+ 
conductance and excitability, albeit only at higher drug concentrations than those used 
therapeutically (Franceschetti et al., 1986; Johannessen & Johannessen, 2003). 
6.1.2.3 Effect of VPA on Histone deacetylases (HDACs) 
In order for exceptionally long sequences of eukaryotic DNA to fit into the relatively small 
nucleus, the DNA structure has to be tightly packaged around histone proteins to form a 
structure called the nucleosome – the fundamental subunit of chromatin. Histone deacetylases 
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are a class of enzymes responsible for the regulation of gene expression via hydrolysis of 
acetylated lysines in the histone proteins which surround DNA. Histone modification is 
considered a major epigenetic mechanism for remodelling the chromatin structure – leading to 
alterations in gene expression, without direct modification to the genetic sequence (Xu et al., 
2007). VPA has been identified as a class I HDAC inhibitor (Göttlicher et al., 2001) and with 
particular relevance to seizurogenesis, upregulation of BDNF and GDNF (which exerts 
neuroprotective effects) has been observed with VPA addition (Chen et al., 2006).  
6.1.2.4 Effect of VPA on Phosphatidylinositol (3,4,5)-trisphosphate (PIP3) 
PIP3 is formed as a result of tyrosine kinase signalling and PIP3 kinase phosphorylation. PIP3 
functions as a second messenger to activate AKT to induce cellular proliferation and apoptosis 
(Wolff et al., 2014). With respect to neurons, PIP3 regulates synaptic transmission (Chang et al., 
2014) and the PIP3/AKT pathway is implicated in seizure generation and epilepsy (Schick et al., 
2006; Zhang & Wong, 2012). Depletion of PIP3 occurs during seizure, and can generate a positive 
feedback loop, promoting further seizure-like activity (Chang et al, 2014). VPA has been shown 
to reverse depletion of PIP3 following seizure, exerting a therapeutic effect (Chang et al., 2014).  
The exact mechanism of action of VPA is still unclear, although several hypotheses have been 
published on the possible multi-factorial pharmacodynamics of VPA. This, alongside its use as a 
frontline treatment and its previous use in iPSC-derived neuronal cultures (Darville et al., 2016) 








The aims of this chapter are to: 
1) Identify the optimal concentration of cytosine arabinoside for synchronisation of 
astrocytes, via the MTT cytotoxicity assay and measurements of cellular proliferation 
2) Assess the ability for co-cultures of synchronised neurons and astrocytes to display 
epileptiform responses to 4-aminopyridine, high potassium aCSF and zero-magnesium 
aCSF conditions using fluorescent calcium imaging 
3) Perform provisional experiments to determine whether the inclusion of commercially 
available iPSC-derived interneurons influences the ability of co-cultures to respond to 






















6.2.1 Synchronisation and Characterisation of co-cultures 
The conclusions drawn from Chapter 5 indicated that astrocytic overgrowth exerted undesirable 
effects on the viability and function of neuronal co-cultures. Therefore, the first stage of this 
Chapter was to establish a suitable protocol for the mitotic inhibition of astrocytes. Cytosine 
arabinoside (AraC) was used for its ability to arrest growth of proliferating cells in iPSC-derived 
systems. Serial dilutions of AraC were tested for their effects on proliferation and cell viability. 
At each concentration tested, the percentage of Ki67+ cells significantly decreased, with 10 µM 
AraC reducing proliferation furthest (Control: 32.26 ± 8.96%, 10 µM: 3.50 ± 1.42%, n=4, p= 
0.0056, Figure 6.1). AraC did not significantly affect cell viability at any concentration tested 
(Figure 6.1B).  
Following the establishment of protocols for the synchronisation of NPCs (Chapter 5) and 
astrocytes (Figure 6.1), these cells were co-cultured and differentiated over 10 weeks. Their 
morphology was characterised by ICC (Figure 6.2). Tuj1+ neurons were observed in all cultures, 
with a low degree of fasciculation and aggregation compared with spontaneous differentiation 
(Figure 3.3/4, n=12 cs). Astrocytes in co-cultures displayed typical morphology and were S100β+ 
throughout (n=12 cs). Importantly, the ratios of cell types appeared consistent throughout 
differentiation.  
qPCR was used to assess the expression of neuronal-associated genes with cultures (Appendix 
Figure A9). There was no significant difference in the expression of neuronal TUBB3 and vGAT, 
when compared to control values of NPCs at Day 0. Expression of astrocytic S100β was 
significantly increased cf control (Control: 0.0004 ± 0.05; S100β: 1.71 ± 0.29, n=3, p= 0.046).  
In addition, the baseline activity of this co-culture method was compared to previous models 
throughout this thesis. In every instance, this co-culture protocol elicited significantly increased 








Figure 6.1: Mitotic inhibition of human astrocytes using AraC. Human iPSC-derived astrocytes 
were plated and incubated for 24 hours, before being treated with 1.25, 2.5, 5 and 10 µM 
cytosine arabinoside (AraC) for 24 hours. (A) Immunocytochemistry was performed to assess 
for the presence of proliferating astrocytes, using the cell proliferation marker Ki67. (B) MTT 
assay for cell survival to assess the effects of mitotic inhibition on cell survival. N=4. *p< 0.05, 






6.2.2 Network connectivity 
A prerequisite of in vivo neural activity is the formation of a synaptically-matured neural 
network (Hill et al., 2012) and indeed, this is especially important for synchronising and eliciting 
bursts of action potentials in epileptiform activity (Abarbanel, et al., 1996). To this end, the 
formation of a network using this co-culture method was assessed via the use of 0 Mg and >K+ 
aCSF. The rapid propagation of calcium activity was observed in both conditions, in every 
coverslip tested (Figure 6.3/4, n=24). The representative examples presented clearly indicate an 
origin wherein the calcium signals propagated throughout the culture, stimulating distant cells 






















Figure 6.2: Synchronously differentiated co-cultures form morphologically matured 
astrocytes and neurons. iPSC-derived NPCs were differentiated in SCT media with 10 µM DAPT 
and co-cultured with AraC-synchronised astrocytes over 10 weeks. Cells were fixed and 
immunocytochemistry was performed to assess the presence of neural markers. (A) Nuclei 
stained with DAPI (Blue, excitation λ 345 nm, emission λ 455 nm). (B) S100β astrocytic staining 
(Grey, excitation λ 495 nm, emission λ 519 nm). (C) Tuj1 neuronal staining (Red, excitation λ 





Figure 6.3: Representative example of rapid propagation of calcium waves throughout network during zero-magnesium aCSF perfusion. (A) Large image 
shows fluorescently stained neural cultures, with 4 example somas labelled numerically in yellow at baseline (no calcium activity). (B) Calcium waves 

















Figure 6.4: Representative example of rapid propagation of calcium waves throughout network during high potassium aCSF perfusion. (A) Large image 
shows fluorescently stained neural cultures, with 4 example somas labelled numerically in yellow at baseline (no calcium activity). (B) Calcium waves 
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6.2.3 Induction of epileptiform activity in co-cultures 
Having determined that spontaneously differentiated cultures and spontaneous co-cultures can 
produce epileptiform responses (albeit, not reproducibly) to >K+ and 0 Mg aCSF perfusion 
respectively, these ionic manipulations were selected as the basis for epileptiform experiments. 
Previously attempted spontaneous and co-culture methods did not elicit epileptiform responses 
to 4-AP (Chapter 4,5). Furthermore, due to the absence of inhibitory cells, PTX was not tested. 
In this Chapter, ionic manipulation, followed by the addition of 4-AP was used. This combined 
method has previously been reported for epileptiform studies (Hongo et al., 2015; Ross et al., 
1998, 2000).   
The addition of 0 Mg appeared to cause oscillatory activity in some cells within cultures, with 
large calcium elevations occurring in regular intervals (representative Figure 6.5B). Moreover, 
perfusion of 0 Mg generated a significant increase in the percentage of active cells (Control: 
47.35 ± 9.38%, 0 Mg: 78.25 ± 6.13%, n=12 cs, p= 0.0085, Figure 6.5D), with a further slightly 
increased response when both 0 Mg aCSF and 100 µM 4-AP were added, compared to control 
(79.74 ± 3.89%, p= 0.0057, Figure 6.5D). The perfusion of 0 Mg aCSF with 100 µM 4-AP also 
significantly increased the number of peaks per cell (Control: 1.81 ± 0.27, 0 Mg-4-AP: 2.90 ± 
0.25, n=12 cs, p= 0.0072, Figure 6.5E) and R value (Control: 0.24 ± 0.11, 0 Mg-4-AP: 0.59 ± 0.09, 
n=12 cs, p= 0.0461, Figure 6.5H) However, burst frequency and percentage of synchronised 







+ 0 Mg + 4-AP 
Figure 6.5: Fluorescent calcium imaging responses of co-cultures of human iPSC-derived 
neurons and astrocytes to zero-magnesium aCSF and 4-aminopyridine perfusion. Neurons and 
astrocytes were synchronised and cultured independently, before co-culturing at 13 DIV, 
followed by 10 weeks differentiation. (A) Co-cultures were loaded with 5 μM Fluo4-AM for 
imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 
10 example, random fluorescent traces related to yellow regions of interest in (A). (C) 
Representative Raster plot. Spikes were identified manually and plotted over time to identify 
synchronised events. (D) Responding cells were determined as those with ≥ one peak of calcium 
activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per minute. (G-H) 
Quantitative measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value. 
(I) Amplitude of calcium events. (J) Duration of calcium events. (K) Time between calcium events. 
N=3.*p< 0.05, **p< 0.01, ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 μm. Solid 
black bars in B-C indicate addition of 0 Mg
2+ 
aCSF and 100 µM 4-AP.  
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+ 4-AP + 4-AP 
Figure 6.6: Fluorescent calcium imaging responses of co-cultures of human iPSC-derived 
neurons and astrocytes to elevated potassium aCSF and 4-aminopyridine perfusion. 
Neurons and astrocytes were synchronised and cultured independently, before co-culturing 
at 13 DIV, followed by 10 weeks differentiation. (A) Co-cultures were loaded with 5 μM Fluo4-
AM for imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative figures 
showing 10 example, random fluorescent traces related to yellow regions of interest in (A). 
(C) Representative Raster plot. Spikes were identified manually and plotted over time to 
identify synchronised events. (D) Responding cells were determined as those with ≥ one peak 
of calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per 
minute. (G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to (C). 
(H) Average R value. (I) Amplitude of calcium events. (J) Duration of calcium events. (K) Time 
between calcium events. N=3. *p< 0.05, **p< 0.01, ***p< 0.001, ANOVA with Tukey’s 
multiple comparisons test. Scale bar: 5 μm. Solid black bars in B-C indicate addition of >K
+
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The increased cellular and network activity observed from the recordings satisfied the 
requirements for expanding the range of analyses that could be performed. Burst analysis 
metrics were all non-significant, however, the duration of a burst and the inter-burst-interval 
values indicated that perfusion of both manipulations did increase bursting activity to a greater 
extent that 0 Mg alone (Figures 6.5J-K).  
Representative traces from perfusion with high potassium aCSF did not appear to generate 
oscillatory activity as was seen with perfusion of 0 Mg (Figure 6.6.B). Cellular activity increased 
in 8/10 traces to produce fluorescence amplitude responses of >0.5ΔF/F and increased spiking 
activity was also observed (representative, Figure 6.6C). >K+ aCSF significantly increased the 
percentage of active cells (Control: 49.95 ± 8.35%, >K+: 76.36 ± 4.83%, n=12 cs, p= 0.0077, Figure 
6.6.D) and peaks per cell (Control: 1.72 ± 0.26, >K+: 2.74 ± 0.29, n=12 cs, p= 0.0343, Figure 6.6.E). 
The addition of 100 µM 4-AP elicited significant responses in percentage of responding cells 
(>K+-4-AP: 83.31 ± 2.73%, n=12 cs, p= 0.0008), peaks per cell (>K+-4-AP: 3.24 ± 0.28, n=12 cs, p= 
0.0012) and R value (>K+-4-AP: 0.56 ± 0.11, n=12 cs, p= 0.039). However, there was no significant 
increase in bursting.  
6.2.4 Astrocytic or neuronal calcium activity? 
As the co-cultures contained two principal cell types which can both display calcium signalling, 
further experiments were performed to determine which cell type was responsible for the 
activity observed. Tetrodotoxin (TTX) was applied to several cultures and its effects are shown 
in Figure 6.7. TTX significantly reduced the percentage of active cells in all manipulations cf 
baseline control activity (Table 6.2/Figure 6.6B). The peaks per cell values were significantly 
reduced also (Table 6.6/Figure 6.6C). However, the frequency of bursts did not significantly 
decrease. Indeed, no significant effects of TTX on burst activity, bursting amplitude and inter-





Table 6.2: Overview of statistical results from one-way ANOVA comparing the effects of TTX 









Table 6.3: Overview of statistical results from one-way ANOVA comparing the effects of TTX 
addition on peaks per cell. ns = not significant. N=7 coverslips from 3 differentiations. 
 
Alongside TTX studies, the addition of VPA was hypothesised to reduce levels of activity, whilst 
also giving an indication of the mechanism by which the cultures were eliciting this increased 
activity. VPA did not produce significant reductions in activity in any metric (Figure 6.8), despite 
a decrease in percentage of responding cells, peaks per cell and burst frequency, compared with 
experimental manipulations. Additionally, no significant effect of VPA on burst activity was 
observed, although a reduction in burst amplitude, increased IBI and decreased burst duration 
were all observed (Appendix Figure 11A).  
 
 
Condition Mean ±  Std. Error P value 
0 Mg Control 44.22 ± 14.09 Ns 
0 Mg 82.29 ± 8.18 0.015 
0 Mg-4-AP 77.75 ± 6.03 0.033 
0 Mg-4-AP-TTX 39.62 ± 5.80 - 
>K+ Control 59.60 ± 7.33 Ns 
>K+ 82.11 ± 4.67 0.028 
>K+-4-AP 80.22 ± 3.78 0.034 
>K+-4-AP-TTX 56.09 ± 8.43 - 
Condition Mean ±  Std. Error P value Post hoc Test 
0 Mg Control 1.67 ± 0.26 ns 
Dunn’s 
0 Mg 2.29 ± 0.21 ns 
0 Mg-4-AP 2.86 ± 0.35 0.0049 
0 Mg-4-AP-TTX 1.38 ± 0.11 - 
>K+ Control 1.57 ± 0.13 ns 
Tukey’s 
>K+ 3.06 ± 0.31 0.0029 
>K+-4-AP 3.45 ± 0.38 0.0002 
















Figure 6.7: Effects of tetrodotoxin perfusion on fluorescent calcium activity of co-cultures of 
neurons and astrocytes exposed to different pro-ictogenic conditions. Human iPSC-derived 
neuronal and astrocytic co-cultures were cultured over 10 WIV and treated with various pro-
ictogenic perfusions to elicit increased activity, followed by tetrodotoxin (TTX). (A) Time-lapse 
videos were recorded at 0.33 Hz, with representative figures showing 15 example, random 
fluorescent traces. (B) Responding cells were determined as those with ≥ one peak of calcium 
activity. (C) Calcium peaks per active cell. (D) Frequency of calcium events per minute. N=3. *p< 
0.05, **p< 0.01, ***p< 0.001, ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 μm. 
Solid black bars in A indicate addition of zero magnesium/high potassium aCSF, 100 µM 4-AP 









Figure 6.8: Sodium valproate perfusion does not reduce fluorescent calcium activity of co-
cultures of neurons and astrocytes exposed to different pro-ictogenic conditions. Human 
iPSC-derived neuronal and astrocytic co-cultures were cultured over 10 WIV and treated with 
various pro-ictogenic perfusions to elicit increased activity, followed by valproate (VPA). (A) 
Time-lapse videos were recorded at 0.33 Hz, with representative figures showing 15 example, 
random fluorescent traces. (B) Responding cells were determined as those with ≥ one peak 
of calcium activity. (C) Calcium peaks per active cell. (D) Frequency of calcium events per 
minute. N=3. ANOVA with Tukey’s multiple comparisons test. Scale bar: 5 μm. Solid black bars 











6.2.5 Preliminary characterisation of co-cultures with interneurons 
The final series of experiments in this thesis included the addition of human iPSC-derived 
interneurons to the established co-cultures described (Chapter 6.2). To ensure the survival and 
incorporation of interneurons into the network, ICC was performed at 10 WIV to assess for the 
presence of excitatory and inhibitory synapses following seeding of cells. Figure 6.9 shows 
synaptic puncta of both an excitatory and inhibitory nature (Figure 6.9) which was observed in 
all three repeats (n=3 coverslips, 1 biological differentiation).  
6.2.6 Induction of epileptiform activity in interneuron co-cultures 
As the inclusion of interneurons was a final series of experiments, there was unfortunately 
insufficient time and resources to perform the studies with enough repeats for statistical 
analysis and to optimise the culture system. As the target of PTX is often interneurons, the 
cultures were perfused with PTX to observe any effects. PTX appeared to increase the 
percentage of responding cells, peaks per cell, percentage of synchronised elevations and R 
value (Figure 6.10). Interestingly, the addition of VPA following PTX perfusion appeared to 
decrease all measures of activity and synchrony, whilst extending the interval between bursting.  
Similar to experiments performed on co-cultures earlier in Section 6.2.3, ionic and 
pharmacological manipulation was used simultaneously on interneuron co-cultures. 0 Mg and 
0 Mg-4-AP both increased every single parameter for activity and synchrony, whilst reducing 
the IBI (Figure 6.11). In addition, VPA had no effect on percentage of active cells, but did reduce 
the peaks per cell, bursting frequency and percentage of synchronised elevations. 
Finally, perfusion with >K+ and 4-AP also increased percentage of responding cells, peaks per 
cell and decreased the IBI (Figure 6.12). However, little change was observed for burst 

























Figure 6.9: Interneuron co-cultures demonstrate the presence of inhibitory synapses. iPSC-
derived neural precursors were differentiated in SCT media with 10 µM DAPT and cocultured 
with AraC-synchronised astrocytes and iPSC-derived interneurons over 10 weeks and 
immunocytochemistry performed to assess the presence of excitatory and inhibitory synapses. 
(A) Excitatory synapses stained with VGlut1 (Grey, excitation λ 495 nm, emission λ 519 nm). 
(B) Inhibitory synapses stained with GAD67 (Red, excitation λ 588 nm, emission λ 649 nm). (C) 




Figure 6.10: Fluorescent calcium imaging responses of co-cultures of human iPSC-derived 
neurons, astrocytes and interneurons to picrotoxin perfusion. Neurons and astrocytes were 
synchronised and cultured independently, before co-culturing at 13 DIV alongside addition of 
interneurons, followed by 10 weeks differentiation. (A) Co-cultures were loaded with 5 μM 
Fluo4-AM for imaging. (B) Time-lapse videos were recorded at 0.33 Hz, with representative 
figures showing 10 example, random fluorescent traces related to yellow regions of interest 
in (A). (C) Representative Raster plot. Spikes were identified manually and plotted over time 
to identify synchronised events. (D) Responding cells were determined as those with ≥ one 
peak of calcium activity. (E) Calcium peaks per active cell. (F) Frequency of calcium events per 
minute. (G-H) Quantitative measures of synchrony. (G) % synchronised cells relating to (C). 
(H) Average R value. (I) Amplitude of calcium events. (J) Duration of calcium events. (K) Time 
between calcium events. N=1. Scale bar: 5 μm. Solid black bars in B-C indicate addition of 100 
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Figure 6.11: Fluorescent calcium imaging responses of co-cultures of human iPSC-derived 
neurons, astrocytes and interneurons to zero magnesium aCSF and 4-aminopyridine 
perfusion. Neurons and astrocytes were synchronised and cultured independently, before 
co-culturing at 13 DIV alongside addition of interneurons, followed by 10 weeks 
differentiation. (A) Co-cultures were loaded with 5 μM Fluo4-AM for imaging. (B) Time-lapse 
videos were recorded at 0.33 Hz, with representative figures showing 10 example, random 
fluorescent traces related to yellow regions of interest in (A). (C) Representative Raster plot. 
Spikes were identified manually and plotted over time to identify synchronised events. (D) 
Responding cells were determined as those with ≥ one peak of calcium activity. (E) Calcium 
peaks per active cell. (F) Frequency of calcium events per minute. (G-H) Quantitative 
measures of synchrony. (G) % synchronised cells relating to (C). (H) Average R value. (I) 
Amplitude of calcium events. (J) Duration of calcium events. (K) Time between calcium 
events. N=1. Scale bar: 5 μm. Solid black bars in B-C indicate addition of zero magnesium 
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Figure 6.12: Fluorescent calcium imaging responses of co-cultures of human iPSC-derived 
neurons, astrocytes and interneurons to elevated potassium aCSF and 4-aminopyridine 
perfusion. Neurons and astrocytes were synchronised and cultured independently, before co-
culturing at 13 DIV alongside addition of interneurons, followed by 10 weeks differentiation. (A) 
Co-cultures were loaded with 5 μM Fluo4-AM for imaging. (B) Time-lapse videos were recorded at 
0.33 Hz, with representative figures showing 10 example, random fluorescent traces related to 
yellow regions of interest in (A). (C) Representative Raster plot. Spikes were identified manually 
and plotted over time to identify synchronised events. (D) Responding cells were determined as 
those with ≥ one peak of calcium activity. (E) Calcium peaks per active cell. (F) Frequency of 
calcium events per minute. (G-H) Quantitative measures of synchrony. (G) % synchronised cells 
relating to (C). (H) Average R value. (I) Amplitude of calcium events. (J) Duration of calcium events. 
(K) Time between calcium events. N=1. Scale bar: 5 μm. Solid black bars in B-C indicate addition of 
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In this final experimental chapter, a robust co-culture method has been developed, which 
responds with increased activity and synchrony to different pro-ictogenic conditions within 10 
weeks.  Importantly, the baseline percentage of active cells observed from these co-cultures 
was significantly higher than previously tested models in Chapters 3-5 (Appendix Figure A12).  
AraC is an effective mitotic inhibitor for iPSC-derived astrocytes 
The results from Chapters 3-5 suggested that the proliferative ability of astrocytes in co-culture 
models needed to be inhibited. To this end, the mitotic inhibitor AraC was used to synchronise 
astrocyte cultures and arrest their proliferation (de Rus Jaquet, 2019). As AraC is commonly used 
as a chemotherapeutic drug (Vincelette & Yun, 2014), and considered a potent anti-proliferative 
agent, the effect on cell viability was also considered. As it was anticipated that mitotic inhibition 
could have potentially cytotoxic effects and reduce viability of the astrocytes, a balance had to 
be struck so that the astrocytic growth was contained, with minimal cytotoxicity. The results 
indicated that AraC treatment at 10 µM could be applied to cultures of astrocytes to produce 
the desired effect of containing their growth, as evidence by reduced Ki67 immunostaining, 
without excessive cell attrition. 
Immunostaining was performed throughout differentiation, as for previous Chapters. The 
consistency of astrocytes and neurons throughout differentiation remained constant, which 
gives a further, strong indication that the inhibition was successful. As for ICC results in Chapter 
3.2, quantitation was not possible. Gene expression analysis performed at 10 WIV showed a 
significant increase in S100β expression compared with Week 0, which could suggest an increase 
in numbers of astrocytes themselves, however qualitative visualisation did not indicate that 
astrocytes had overgrown the culture.  
Importantly, an issue observed in spontaneous differentiation, particularly on PORN-laminin 
was the large degree of fasciculation and the tendency for clusters of somas to form ‘hubs’ 
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throughout the culture (Amin et al., 2016). This was not observed using this co-culture model 
and is further evidence that the inhibition of both cell types was effective. Of particular 
significance is that aggregation of previous cultures often resulted in detachment from the 
culture surface and the ultimate loss of cells. Cultures were successfully differentiated over 10 
weeks, demonstrating that co-culturing promotes a more adherent, robust culture, as 
previously reported (Kuijlaars et al., 2016).   
This synchronised co-culture method promotes network formation 
Neural networks are essential for seizure generation and are highly suggestive of a matured, 
connected culture (Spencer, 2002). It has been shown that stored and intracellular calcium are 
involved in neural network activities such as propagation of calcium waves and that these can 
increase the rapidity of the spread of calcium via calcium-induced calcium release (Neymotin et 
al., 2015). As such, calcium imaging was used to determine whether waves of calcium signals 
were evident and whether they could spread throughout the culture. Both ionically manipulated 
perfusate condition elicited large waves of calcium activity, which propagated distally from an 
origin. This provides evidence that the cells in culture had formed an interconnected neural 
network, as opposed to isolated neurons. The reason behind the formation of reproducible 
networks is likely due to the inclusion of matured astrocytes in this co-culture model (Halassa & 
Haydon, 2010). These results agree with those of Kuijlaars et al., (2016) who found co-culture 
of DAPT-synchronised NPCs with primary human astrocytes promotes neural network 
formation. However, this group also use synchronised baseline activity as a metric for networks, 
as it has been demonstrated that developing neural networks exhibit periods of synchronised 
bursts, mediated by excitatory neurons in iPSC-derived systems which lack a physiologically-
relevant interneuronal component (Kirwan et al., 2015). It is important to note, however, that 
Kuijlaars et al., (2016) demonstrated ‘synchronised network activity’ at baseline, yet their aCSF 
recipe did not contain magnesium. This suggests that the activity observed was a result of 
excitatory ionic manipulation and not of true control (i.e. no manipulation) calcium activity. For 
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this reason, the propagation of calcium waves was used to determine network connectivity and 
not synchronised burst activity during development.  
Are calcium signals neuronal or astrocytic? 
As discussed previously, astrocytes display spontaneous and synchronised calcium activity 
(Klapper et al., 2019; Pirttimaki et al., 2017). Due to the co-cultures containing both neurons 
and matured astrocytes, this presented a possibility that the signals observed from calcium 
imaging could be from astrocytes in culture, as opposed to neurons. Indeed, one could make 
the link between astrocytic calcium signals and absence of ‘typical’ electrical activity on MEA 
recordings both in this Chapter and previous Chapters. Indeed, some cultures displayed what 
appeared to be oscillatory activity, but with considerably longer times between the oscillations 
than the wave propagations observed previously. Astrocytes can oscillate and can also influence 
neuronal oscillations in culture systems, often at a slower pace than that of neurons (Pasti et 
al., 2001; James Crowe, unpublished data). 
In order to distinguish between the two cell types, experiments were performed using 
tetrodotoxin (TTX), with the aim to inhibit neuronal action potential-mediated activity, which 
incidentally, provides another metric for assessing network function in vitro (Hill et al., 2012; 
Kasteel & Westerink, 2017). As a result, any signals still observed during TTX application were 
assumed to be astrocyte-mediated. This method contrasts with those used previously, wherein 
glutamate was used to distinguish between neuronal and astrocytic cell types (Pickering et al., 
2008), however as both cell types in culture can respond to glutamate with increased 
intracellular calcium activity, this method is ineffective (Bezzi et al., 1998).  
The application of an action-potential blocker such as TTX should result in a reduction in 
neuronal cell and burst activity, with the exception of IBI, which should increase as the cells 
should fire less often (if at all) (Abe & Terasawa, 2005). It appears that TTX application reduced 
every parameter assessed, with statistically significant results for some assessments. As a result, 
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it is likely that most of the individual and network activity observed and reported is either 
neuronal or is mediated by sodium action potentials, as upon TTX application, propagating 
waves also ceased. With relevance to calcium waves, the synchronised co-culture platform 
demonstrated more rapid propagation than those observed in isolated human astrocytic 
networks (Hill et al., 2012), suggesting that the waves of calcium in this instance, were neuronal. 
In further support, collaboration with various current and former members of Dr. Rhein Parri’s 
lab group (Aston University, personal communications), patch clamp analysis on both 
spontaneously differentiated and synchronised co-cultures revealed the ability for neurons in 
culture to fire action potentials and exhibit electrical activity. The possibility still stands that the 
calcium activity observed could be astrocytic in nature, but this may be a result of neuronal 
firing and consequent neurotransmitter release stimulating astrocytes (Agulhon et al., 2008; 
Fiacco et al., 2007). The inability to effectively distinguish between cell types is a major limitation 
of this experimental design and is discussed in Chapter 7.  
Was activity observed epileptiform? 
The rationale behind combining ionic and pharmacological manipulation in this Chapter was 
that the tendency for previous cultures to appear as if they were reaching a threshold and 
required only a minor increase in stimulation to fire in a hyperexcitable and hypersynchronous 
manner was routinely observed. Despite observing increased activity and synchrony (with 
statistical significance) in each pro-ictogenic condition, a hypersynchronous, hyperactive culture 
like the isolated repeats in Chapters 4 and 5 was not observed with this model. It could be 
argued that this is due to the absence of interneurons and it underlines the significant role they 
play in seizure generation. Irrespective of this, the addition of ionic and pharmacological 
treatments in tandem often resulted in increased values cf ionic manipulation alone and 
significant increases in activity and synchrony cf control. Therefore, the conclusion from this 
method is that combination of pro-ictogenic conditions excites the system to a greater extent 
than individual treatments. Again, this is possibly because inhibitory circuits are not present and 
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thus cannot modulate or mediate the synchronisation typically observed in seizure-like events 
(Grasse et al., 2013). 
Alongside experiments with TTX to attempt to distinguish between neurons and astrocytes, 
sodium valproate (VPA) was also perfused on several cultures to monitor whether activity 
reduced. As reviewed in 6.1, VPA can exert effects on GABAergic neurotransmission and various 
ion channels. VPA appeared to slightly reduce activity, however no parameter assessed was 
statistically significant. The reason for this could be due to the mechanistic action of VPA: if the 
action of VPA is based predominantly on GABAergic transmission, the lack of inhibitory input in 
this system could explain the ineffectiveness of VPA treatment in this instance. 
Co-cultures with interneurons display increased activity 
The generous donation of commercially available interneurons (James Crowe) provided the 
basis for the final experiments in this thesis, however, due to time and cost constraints, no 
repeats could be performed and thus, no statistical analysis. Interneurons were added at a ratio 
of 1:4 with excitatory neurons, as this ratio has been reported in the human in vivo cortex 
(Sahara et al., 2012). Immunostaining of synapses revealed characteristic punctate VGlut1 
excitatory vesicles and GAD67+ inhibitory vesicles, not previously seen. These were localised to 
the soma and along the neurites as previously reported (Gunhanlar et al., 2017).  
Interneuronal co-cultures were perfused with PTX, as it was expected that the receptors and 
cellular targets were now present in the system. Indeed, measures of activity and synchrony 
were all increased in the presence of PTX, however the burst frequency remained unchanged 
and burst parameters indicated an unsuccessful epileptiform result. Interestingly, VPA perfusion 
decreased all measures of activity and synchrony and burst activity, whilst extending IBI, 
suggesting VPA was effective in reducing PTX-induced neuronal activity. This is possibly due to 
the effects of VPA on GABA transmission and interneuronal populations (Lauber et al., 2016; 
Winterer, 2003).  
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The provisional result with 0 Mg and 4-AP perfusion indicates a successful experiment, with 
substantially increased activity, synchrony, and burst measures. This combined with visual 
analysis, the derived traces and the Raster plot were all suggestive of epileptiform activity. 
Moreover, perfusion with VPA also decreased several parameters of activity, synchrony and 
burst characteristics. Whilst >K+ aCSF did increase activity, it displayed no effect on bursting and 
synchrony, indicating a lack of epileptiform activity. However, in this instance, VPA produced a 
decrease in every parameter and increased duration between bursts, suggesting it acted 
successfully upon the culture.  
Whilst the results from these preliminary interneuron co-cultures are very promising, there 
needs to be a significantly increased sample size and appropriate statistical analysis to confirm 
that interneuron inclusion is necessary for epileptiform activity in the human iPSC-derived 
neural cultures presented in this Chapter. Furthermore, there was considerable optimisation of 
ratios, seeding densities and maturation states of the individual cellular components involved 
in co-culturing methods throughout this thesis. Whilst the ratio of interneurons seeded was 
similar to that typically observed in vivo, further refinement and development of the inhibitory 
component of in vitro models will require lengthy and methodical investigation to generate the 












7: GENERAL DISCUSSION AND FUTURE DIRECTIONS 
The main aim of this thesis was to develop and test human iPSC-derived models for preclinical 
seizure-liability testing and integrate this with a suitable, high-throughput analytical technique. 
There is a dearth of standard protocols to assemble these cellular platforms, including 
consideration of growth media, cellular ratios, cell subtypes, donor patients and methods of 
experimentation, making this aim problematic and challenging. This thesis has compared 
methods for generating iPSC-derived neural cultures for preclinical seizure-liability testing and 
has narrowed the choice towards a potentially exciting and productive human culture platform. 
The most common protocols reported in the literature have been considered and their ability 
to produce hypersynchronised and hyperactive responses to well-known seizurogenic 
treatments has been assessed. This Chapter will briefly summarise the experimental findings 
from previous Chapters, whilst providing a general discussion of the collective results. 
Limitations of this study, alongside future directions are also addressed.  
7.1 Summary of experimental findings 
In Chapter 3, it was intended to demonstrate the ability of commercially available neural 
precursor stem cells (NPCs) to differentiate into morphologically and functionally distinct neural 
subtypes over 18 weeks differentiation. The initial spontaneous differentiation protocol was 
based on that of the seminal work of Chambers et al., (2009) and Shi et al., (2012a,b) who 
demonstrated NPCs, in the presence of defined growth medium, could undergo both 
neurogenesis and gliogenesis. This allowed the formation of the key cellular components of the 
cortex, along with the ability to exhibit functional activity. In agreement with the scientific 
literature, spontaneously differentiated cultures displayed developmental markers at the same 
points in time, with the initial emergence of immunostained neural progenitors and cortical 
rosettes, radial glia, neurons by 4 WIV, cortical layer markers and astrocyte emergence around 
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8 WIV, with astrocyte maturation observed post 10 WIV. This was also confirmed by qPCR. These 
results correlate with the in vivo neural development timeline (Mertens et al., 2016), suggestive 
of a successful differentiation protocol. Furthermore, there was an absence of inhibitory 
interneuron immunostaining at all timepoints, despite significant increases in vGAT expression, 
which is further indication of a cortical differentiation.  
An important objective of Chapter 3 was to provide evidence of differences in neural growth 
media, to move closer to standardisation of iPSC protocols for safety pharmacology applications. 
In Chapter 3, two widely available commercial growth media were directly compared on their 
ability to influence cultures to generate the above cell types, the speed at which this could be 
achieved and their subsequent functional activity. The results of this chapter disagree with the 
scientific literature, where it was shown that SCT media was superior to the standard 
electrophysiology perfusate ‘artificial cerebrospinal fluid’ (Bardy et al., 2015). Instead, it was 
discovered that aCSF produces increased functional responses from cultures and hence, was a 
more appropriate perfusate for functional recordings. 
Chapter 4 sought to build on the findings of Chapter 3 and progress the platform development 
towards the possible induction of seizure-like activity in the spontaneously developed cultures, 
using experimental methods which are high-throughput and non-invasive; ideal for toxicity 
screening (Collins et al., 2017). A novel interrogation of spontaneously derived neural cultures 
over 18 weeks differentiation was presented, using fluorescent calcium imaging. At various 
timepoints correlating to key developmental stages (i.e. 4 WIV (arrival of neurons), 8 WIV 
(arrival of astrocytes), 12 WIV (matured astrocytes, matured culture) and 18 WIV (further 
maturation)) the ability for spontaneously differentiated cultures to respond to a panel of 
seizurogenic conditions was explored. Despite many experiments being conducted, in both 
media, the activity was not epileptiform, with the exception of a single SCT culture which 
displayed characteristic synchronised and hyperactive bursting calcium activity; indicative of 
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seizure-like events (Hongo et al., 2015; Pacico & Meur, 2014). However, the overall results of 
Chapters 3 and 4 suggested cells cultured in SCT media exhibited the greatest activity and 
responses to seizurogenic manipulations.  
Following the morphological and functional characterisation of spontaneous differentiation in 
two commercially available growth media, in Chapter 5, the ability of monocultures of neurons 
and astrocytes and co-culture models were investigated, in terms of their responses of 
characteristic epileptiform activity. An optimised protocol for the synchronisation of NPCs was 
developed in this thesis and following synchronisation, individual neuronal cultures were found 
to be relatively inactive. Further evidence strongly supported the requirement of astrocytes and 
neurons to exist in co-culture, in physical contact, as reported previously (Odawara et al., 2014). 
Neither monoculture platform displayed epileptiform activity and therefore, the co-culturing of 
both cell types was attempted using two different methods. Epileptiform activity was observed 
with a spontaneous co-culture model in Chapter 5, albeit not reproducibly; suggesting that co-
culture systems have the potential to be used in toxicity screening. A key observation was 
recorded at this point, with respect to the highly problematic potential for astrocytes to 
overgrow in late cultures, subsequently reducing activity and neuronal drug responses.   
In Chapter 6 methods were evaluated to control astrocyte proliferation and in collaboration 
with PhD students from the Coleman, Hill and Parri groups (Aston University), a refined co-
culture model was generated, based on previous literature (Kayama et al., 2018; Matsuda et al., 
2018; Odawara et al., 2018), wherein the ratios of neurons to astrocytes could be more strictly 
controlled than in previous co-culture models and spontaneously differentiated cultures 
(Chapters 3-5). The results were indicative of a functional, heterogeneous model system, 
although robust epileptiform activity was only episodically observed. Final experiments wherein 
GABAergic interneurons were added to the culture system, yielded a platform with the capacity 
to react to a wider range of compounds, some with elevated measures of synchrony, activity 
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and bursting. In this thesis, evidence for the requirement of astrocytes, neurons and GABAergic 
interneurons to physically co-exist in culture with consideration of subtype ratios is provided. 
7.2 General discussion 
7.2.1 Statistical analysis 
It is estimated that many biological publications contain errors in their statistical analysis 
(García-Berthou & Alcaraz, 2004), and thus, care was taken to consult biostatistics expertise to 
ensure accuracy and reliability. Statistical analysis in this thesis was performed with detailed 
consideration of several multi-factorial study designs. In many instances (particularly Chapter 3 
and 4), it was necessary to perform multiple comparisons, as the primary aim was to compare 
two growth media and their effect on different drug treatments. A 2-way ANOVA is a parametric 
test; appropriate for normally distributed data. Parametric tests have higher statistical power 
than their non-parametric equivalents (Kitchen, 2009), making this a desirable means of 
determining significant results. However, as biological data is seldom normally distributed, 2-
way ANOVA for multiple comparisons presented a challenge. To the author’s knowledge no 
appropriate non-parametric alternative to the 2-way ANOVA is available. The Scheirer-Ray-Hare 
test (Scheirer et al., 1976) has been used in some situations as a non-parametric alternative, 
however this test has low statistical power and if applied to the data in this thesis, there was 
potential to misinterpret the findings. Therefore, non-normally distributed data had to be 
transformed to enable statistical testing with greater statistical power. Transformations are 
commonly used in biology to normalise slightly skewed data, enabling scientists to then perform 
parametric testing (Garcia-Berthou & Alcaraz, 2004). In this thesis, data was transformed using 
logarithmic methods and this was kept constant for all transformations.  
Outliers can be removed from datasets, in the hope that this enables the data to follow a 
Gaussian (normal) distribution and indeed, this practice is commonly followed. However, 
particularly in Chapters 4,5 ‘outliers’ provided the most interesting results, demonstrating the 
cultures’ capability to generate hyperexcitable, hypersynchronous activity. In this instance, 
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removing the outliers would have prevented these important preliminary findings. As a result, 
it was decided to display all data obtained and then, if necessary, perform transformations to 
enable 2-way ANOVA. For datasets where the study design permitted 1-way ANOVA 
(particularly Chapter 6), a suitable non-parametric alternative is allowed, so this data was not 
adjusted in any way.  
7.2.2 What is the ideal culture system for seizure-liability testing? 
7.2.2.1 Spontaneous differentiation 
As previously stated, the main aim of this thesis was to build an optimal culture method for 
neurotoxicity testing. Several approaches were attempted, and all assessed using the same 
broad experimental approach. Spontaneous differentiation revealed the potential for cultures 
to respond in an epileptiform manner to seizurogenic conditions, however, the data indicated 
that this is not a reliable or reproducible method of generating this activity. There are several 
possible explanations for these results. Mature electrical circuits are necessary for normal, 
oscillatory and seizure activity and human cortical neurogenesis occurs over a period of roughly 
100 days (Rabinowicz et al., 1996). Ergo, the neuronal cells and circuits at weeks 4-12 may not 
be fully matured. Indeed, Amin et al., (2016) assessed their spontaneously differentiated 
cultures via patch clamp techniques and found that cells fired immature action potentials even 
at 12 WIV. This is supported by experiments suggesting that the matured network activity of 
spontaneously differentiated cultures occurs between 8-23 WIV (Kirwan et al., 2015). Due to 
time constraints of this project, 18 WIV differentiation was an attainable, but nevertheless long 
duration. However, these reports, combined with the results of Chapter 4, indicate that the 
activity of most of the cultures was still immature at this timepoint. Relating this to the aim of 
this thesis, a high-throughput neurotoxicity model which takes over 18 weeks to develop is 
simply an unrealistic approach (Verstraelen et al., 2014). In agreement, whilst those authors 
suggest embryoid body protocols generate heterogeneous models, this still takes an 
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impractically long amount of time (>12 WIV), so therefore, is unsuitable for the purpose of short 
timeframe toxicity testing (Gunhanlar et al., 2017).   
A recurrent theme throughout this thesis is the supportive, developmental and functional roles 
which astrocytes provide to neurons. In primary rodent cultures, the issue of astrocytic 
overgrowth is frequently observed over time (Foo, 2013) and the data indicated a similar 
process was occurring in iPSC-derived cultures, however this could only be observed visually and 
not quantified. Furthermore, it has been shown in in vitro studies that astrocytes tend to grow 
at the base of culture, invading the culture growth surface, forcing neurons to detach and die 
(Gilad & Gilad, 1987). In addition, throughout spontaneous cultures, a large degree of neuronal 
fasciculation was observed, to the point where cells detached from the culture surface and 
became unstable and ultimately died. In vivo developmental studies have confirmed that 
neuronal fasciculation is a necessary process for providing a scaffold and guide for the migration 
of developing neurons in the CNS (Bak & Fraser, 2003), hence, initial fasciculation of neurites 
was a positive result in terms of alignment with the in vivo environment. However, the extensive 
aggregation observed over time is indicative of an incomplete system, wherein the mechanisms 
behind fasciculation have been able to continue in an uncontrolled manner. It may be that the 
overgrowth of astrocytes led to this fasciculation, following neuronal detachment from the 
culture surface. 
Ultimately, the lack of responsiveness of spontaneously differentiated cultures may have been 
due to the variation in cell ratios and the unregulated cell aggregation and overgrowth, which 
hindered any practical method of determining exactly how many cells of which type were 
present in the cultures over time. For safety pharmacology applications, variation to this extent 
is unacceptable and ideally, a system should have physiological ratios of cell types, which do not 
uncontrollably proliferate or cause the death of neighbouring cells. In conclusion, the author 
contends that astrocytic overgrowth could explain the lack of reactivity to pro-ictogenic 
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conditions and relatively low baseline activity observed in later cultures. In addition, the fact 
that astrocytes do not appear in culture until post W8 differentiation could also provide a reason 
for this reduced activity, as neurons are less mature than if the physical presence of astrocytes 
had occurred from a similar time to the initial neuronal plating in vitro. 
 7.2.2.2 Co-culture differentiation 
Following from the variation observed from spontaneous differentiation, a more controlled 
series of methods were attempted, from individual cultures of cell types, to co-culture models. 
The results from Chapters 3 and 4 indicated that astrocyte overgrowth and neuronal immaturity 
were likely causative factors in the ineffectiveness of spontaneous differentiation to generate 
SLE. As such, co-culture methods were employed which seeded neurons and astrocytes 
together, to provide a supportive, developmental environment for neurons from the initial 
plating.  
To rectify some of the problems with spontaneous differentiation, a synchronisation protocol 
for neurons in this system was developed, wherein the number of neurons could be more 
stringently regulated and fewer NPCs would remain to develop into astrocytes. This provided 
two possibilities for culture systems: firstly, where a defined number of astrocytes would be 
added to these synchronised neurons and secondly, where a defined number of astrocytes 
would be added to spontaneously differentiating neurons. The theory behind both being that 
the presence of astrocytes throughout neuronal development may speed up the maturation 
process and offer tighter regulation of ratios of cell types, compared with that of spontaneous 
differentiation. Additionally, the necessity for astrocytes in culture for seizure activity has been 
reported (Klapper et al., 2019). 
Interestingly, the spontaneous co-culture model generated a large synchronised bursting 
response to >K+ aCSF conditions at 7 WIV, whilst no characteristic epileptiform activity was 
observed in the synchronised neuron – astrocyte co-cultures. Furthermore, the magnitude of 
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the seizure-like activity was far greater than that of the response observed for the epileptiform 
response in the spontaneously differentiated culture (Chapter 4). This suggests that the 
presence of astrocytes throughout neuronal development led to a more rapidly matured 
culture, capable of eliciting epileptiform activity and agrees with the scientific literature for 
rodent (Bradley et al., 2018; Fan et al., 2019) and human iPSC-derived (Ishii et al., 2017; Kuijlaars 
et al., 2016; Odawara et al., 2016a, 2016b; Tukker et al., 2016, 2018) platforms. However, again 
this was not reproducible, likely due to the variation previously observed with spontaneous 
differentiation.  
With regards to both co-culture systems from Chapter 5, astrocytic overgrowth was, again, 
apparent by the end of the differentiation period. Further observation confirmed that the 
cultures were highly astrocytic, presented as a widespread adherent monolayer. These data 
suggest that the cells seen over 18 weeks on the culture-ware and MEA chips were astrocytic 
and that the neurons had diminished to a number which was not compatible with a detectable 
response. This is supported by the absence of detectable MEA signals, despite a completely 
adherent monolayer and is reinforced by the appearance of large, astrocytic morphologies from 
W18 calcium imaging, which can produce calcium responses (Khakh & McCarthy, 2015). Indeed, 
the calcium responses observed in the cultures which appeared heavily astrocytic were slower 
and more repetitive than previously observed neuronal signals, which could provide further 
evidence that the cells being imaged were largely astrocytic; particularly as astrocytic calcium 
activity typically functions more like that of a pacemaker (Hill et al., 2012).  
The experiments with monocultures of neurons and astrocytes have further confirmed reports 
that neurons and astrocytes must co-exist for a heterogeneous, viable culture system (Odawara 
et al., 2014; Stogsdill et al., 2017; Taga et al., 2019), particularly as the absence of physical 
contact with astrocytes (despite neuroprotective growth factors), led to the death of 
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synchronised neuronal monocultures in all repeats. Astrocytic monocultures demonstrated 
sporadic calcium activity, but did survive alone essentially indefinitely.   
In conclusion, despite the co-cultures of astrocytes and neurons showing the ability to produce 
epileptiform activity, this method of culturing presents similar issues observed with 
spontaneous differentiation. This method is still superior to spontaneous differentiation, as 
epileptiform responses were observed at 7 WIV, far more rapidly than those of spontaneous 
differentiation. These results are highly indicative of astrocytes influencing the maturation of 
neurons more rapidly, however, their overgrowth and the continued variation in developing cell 
type ratios ultimately led to the finding that this culture method was not suitable for the purpose 
of this thesis. 
7.2.2.3 Synchronised astrocytes and neurons in co-culture 
The results from Chapters 3-5 indicated that spontaneously differentiating cells are 
unpredictable in their final culture composition and that at later timepoints, astrocytic 
overgrowth became a problematic issue. As such, a method for inhibiting astrocytic proliferation 
in this system was developed, using the chemotherapeutic agent cytosine arabinoside (AraC) 
(Cheng et al., 2017; de Rus Jacquet, 2019; Schwartzentruber et al., 2017). 
This method produced cultures which displayed network activity and significant increases in 
activity and synchrony to conditions tested. Furthermore, immunostaining and visual 
observation suggested that by inhibiting the ratios of cell types, this remained constant 
throughout the differentiation protocol.  
This protocol is an amendment of that published previously (Odawara et al., 2018), but with a 
novel contribution in the inhibition of astrocytes using AraC. Furthermore, the ratio of 
astrocytes finally chosen was optimised for this individual system, from collaboration with Mr 
James Crowe (Parri group, Aston University). In further support for this platform, the baseline 
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activity was significantly increased in synchronised astrocyte-neuronal co-cultures cf every 
preceding model assessed in this thesis (Appendix Figure A12). 
Despite generating a functional, integrated and responsive platform, a number of issues still 
remain. Firstly, the optimisation was performed for this specific cellular model and there is no 
guarantee that this is applicable more widely, as the data in this thesis has indicated. Secondly 
and perhaps most importantly, irrespective of the significant increases in epileptiform criteria, 
statistically significant bursting activity was not observed in this culture system. This is evocative 
of a missing component in the model to generate a truly controlled, reproducible system.  
7.2.3 GABAergic interneurons are vitally important 
The findings in this thesis strongly suggests that GABAergic interneurons are required for a 
heterogeneous, reproducible neural seizure-liability platform.  
As discussed in detail in Chapters 1 and 6, GABAergic interneurons (GIN) play critical roles in 
neural circuits and seizure induction (Sharfman, 2007). Spontaneous differentiation can 
intermittently produce GIN in monolayer systems (Kirwan, et al., 2015; Shi et al., 2012a) and 
embryoid body-based protocols (Gunhanlar et al., 2017), particularly in late timepoints in 
developing cultures. As discussed previously, interneurons do not develop in the cortex, but 
rather migrate in from the medial ganglionic eminence (Martini et al., 2009) and precise 
generation of interneurons from NPC involves the use of specific morphogens such as 
purmorphamine (Liu et al., 2013). As the embryoid-body protocol (Gunhanlar et al., 2017) 
includes no mention of morphogens, if this is routinely observed with this method, it would be 
interesting to determine which processes lead to interneuron generation in non-adherent 
cultures, but unpredictable interneuron generation in adherent cultures. Ultimately, from a 
toxicity screening standpoint, waiting several months for cultures to potentially display 
interneurons is not feasible and renders this differentiation model unsuitable regardless. Due 
to apparatus failure and time constraints, sufficient repeats of spontaneously differentiated 
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cultures at 18 WIV to perform statistical analysis were not possible. vGAT expression in Axol 
cells was considerably higher than control, which could have been indicative of interneuron 
emergence at this late point in development. 
The proportion of interneurons which develop randomly are likely due to spontaneous 
differentiation not being 100% efficient (Chambers et al., 2009; Shi et al., 2012b). As discussed 
above, this presents a problem with variations in cultures in terms of density and final ratios of 
cell types. The reports of the presence of GIN in spontaneously differentiating cultures, coupled 
with the variability of spontaneous cultures could explain why some cultures responded with 
epileptiform activity and most did not. Indeed, the co-culture method which produced a 
hypersynchronous and hyperexcitable response was developed from a spontaneously 
differentiating neuronal protocol. The irregular, uneven generation of interneurons is likely a 
causative factor in the inability for most cultures to produce seizure-like activity. With respect 
to the specific compounds tested, the target of picrotoxin is GABAA receptors on interneurons 
(Davidoff & Aprison, 1969), which explains the lack of response to PTX observed. However, there 
were statistically significant increases in activity in cultures maintained in Axol, in response to 
PTX, which could indicate the presence of GIN in culture, providing a target for the compound. 
With regards to 4-aminopyridine, as per Chapter 4, the mechanism of 4-AP seizure-induction 
includes potassium channel antagonism and interneuronal excitation, via the interneuron-
potassium hypothesis (Perreault & Avoli, 1991). These data show that the absence of seizure 
activity in the presence of 4-AP is also likely to be due to the absence of GIN in this system, and 
that even if they are present as some data suggests, they are not in sufficient concentration to 
be reminiscent of the in vivo cortical environment.  
Furthermore, when considering the bursting parameters for the synchronised astrocytic-
neuronal co-culture method, increases in burst activity did not achieve statistical significance. 
Interneurons are crucial for burst activity (Shin et al., 2010; Velazquez & Carlen, 1999) and their 
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non-appearance could explain why these metrics were not significantly increased. In conclusion, 
the unsuccessful generation of seizure-like activity in cultures from all methods is likely due to 
the absence of GABAergic interneurons, as increased measures of synchrony and activity were 
observed immediately from preliminary interneuron co-culture experiments. Whilst not 
conclusive and not statistically verified, the inclusion of interneurons in the established 
synchronised co-culture protocol in this thesis holds great promise for future seizure-liability 
testing with human iPSC-derived neural platforms.  
7.2.4 Don’t stand so close to me 
Upon closer inspection of the cultures that responded with epileptiform activity, it was revealed 
that these cultures were less dense and aggregated than other cultures (Figures 4.13A/5.10A). 
This was not intentional, and indeed it further highlights the variation in spontaneous culture 
method outcome. It would appear that this arrangement facilitated the widespread seizure-like 
activity. This finding prompted closer examination of other cultures and it was found that those 
with higher activity and drug response were, indeed, less clustered than relatively inactive 
cultures. The reason for this is unclear but may relate to astrocytic overgrowth as mentioned 
above. Nevertheless, the precise control of ratios and mitotic inhibition of components did 
result in less dense co-cultures of synchronised astrocytes and neurons and this discovery most 
certainly warrants further investigation.  
7.3 Limitations of this study and possible solutions  
7.3.1 Morphological characterisation 
As mentioned previously, quantitation from immunostaining is an imprecise method of 
obtaining data on ratios of cell types. In fact, this was a limitation of morphological 
characterisation in Chapters 3-5. The tendency for cultures to aggregate into large 3D hubs 
meant accurate imaging was very difficult. Arguably, 3-dimensional aggregates could be imaged 
using Laser confocal microscopy, to generate high resolution z-stacks and indeed, this was 
explored. Unfortunately, even this approach was found to be unreliable, as there was no 
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consistency to the degree of aggregation between coverslips, and between aggregates within 
the same coverslip. This meant that some aggregates were several times the size of others, and 
in order to generate a fair ratio of antibody-positive cells, each aggregate would have to be 
considered. For the magnitude of the study and the number of technical and biological repeats, 
this was unrealistic and not of significantly greater importance than the qualitative results. 
To supplement the qualitative immunostaining data and circumvent some of its limitations, 
qPCR was used to detect gene expression levels. Unfortunately, and due to time constraints, 18 
WIV qPCR could not be performed for spontaneous studies. As the trend for neuronal gene 
expression indicated a decrease over time, the pattern of S100β expression increased over time, 
after the initial highest timepoint. Perhaps performing additional experiments at W18 would 
confirm whether S100β expression is further increased, coinciding with the high density of 
astrocytes seen in final culture. In contrast, performing different experimental procedures, such 
as single nucleus RNASeq has been used to characterise changing astrocyte phenotypes in 
disease (Al-Dalahmah et al., 2020).  
7.3.2 Multi-electrode array 
Despite the prevalence of modern MEA-based methods for assessing neural activity (Hyvärinen 
et al., 2019; Kayama et al., 2018; Matsuda et al., 2018; Odawara et al., 2018; Taga et al., 2019; 
Tukker et al., 2016, 2018, 2019; Yokoi et al., 2019), there were several problems identified with 
the approach using this cellular system. An issue with the MED64 system is the planar MEA chips 
themselves are considered ‘consumables’ with limited uses. Initially planar chips coated with 
platinum were used, however, this has been demonstrated to be toxic to cells (Wissel et al., 
2018). In the case of the MEA, platinum coatings repel cells and were subsequently advised 
against using (personal communication, Alpha Med Scientific). Following this discovery, carbon-
coated electrodes were obtained which did increase cell adherence, however electrode 
degradation and complete destruction of several MEA chips was observed after multiple uses. 
This signals a product which is not applicable for high-throughput testing applications. Cultures 
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were also attempted on MEA chips from a competitor company and these were far more robust, 
with greater adherence noticed. Another limitation is the cost of the MEAs, which provides a 
significant barrier to the number of cultures that can be attempted before the chips degrade. 
The application of these chips in this context is, in the author’s judgement, not cost effective. 
There is no doubt that MEA analysis has gained popularity for iPSC-derived toxicity testing, 
however, significantly more optimisation was required for it to be a possibility for this type of 
project and due to time constraints, this was not possible. Whilst some experiments were 
successful and data was generated, a significant number of experiments failed, either from 
adherence issues, or a lack of activity reported from astrocytic overgrowth.  
Analysis of MEA data is possible using software packages from respective companies, however, 
as these are relatively recent, there is little guidance and no standardisation on analysis of 
acquired MEA data, meaning there are many subjective analyses published in the scientific 
literature. Despite the final synchronised co-culture method being successfully adhered in 
monolayer over 12 WIV, recordings were noisy and random, making analysis impossible. It was 
hoped that a more standard protocol like the burst analysis protocol developed by Matsuda et 
al., (2018) could be achieved in this thesis. Ultimately, the adherence issue was a huge limitation 
and future studies could attempt one of two improvements: firstly, a different MEA system 
could be used as it may be possible that this cellular system works better with a different 
experimental system and secondly, a more adherent substrate could be utilised to promote 
greater adherence. In this thesis, several surface-treatments were attempted as per Amin et al., 
(2016), however, the use of commercial products were not used, mainly due to the lack of 
transparency on their composition. A promising avenue is the use of a human laminin substrate 
‘laminin 521’ which was recently found to promote iPSC-derived neural differentiation, cortical 
integration and synchronisation of burst activity in developing cultures (Hyvärinen et al., 2019). 
This could bridge the gap between the culture system developed here and the experimental 
analysis process, to produce future successful recordings. 
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7.4 Future Directions  
Having established a suitable co-culture protocol for seizure-liability studies which can respond 
to diverse neuroactive conditions with increased synchrony and activity, there are several 
refinements and future directions to promote the eventual inclusion of this model in pre-clinical 
seizure-liability testing. 
7.4.1 Establishing optimal interneuron ratios 
The development of cultures in this thesis proved the necessity for controlling and optimising 
ratios of neural cell types for the final synchronised co-culture platform. As the interneuronal 
co-culture was preliminary work, the ratio of interneurons selected was 20% of the neuronal 
component, as the in vivo cortical arrangement suggests GABAergic interneurons account for 
20-25% of all cortical neurons (Riedemann, 2019). Extensive optimisation of astrocyte ratios was 
considered in this thesis (data not shown) and it is likely that the ratio of interneurons would 
need to be adjusted to produce the prime platform for the desired functional interrogation in 
future studies.   
7.4.2 Optogenetic methods 
In this thesis, a novel human iPSC-derived culture system has been developed for seizure-liability 
testing, using optical fluorescent calcium imaging. The benefits of calcium imaging are multiple, 
discussed throughout the thesis. Calcium imaging allows for the detection of simultaneous 
neuronal and astrocytic calcium activity across networks of cells and at the single cell resolution 
(Hill et al., 2012; Ikegaya et al., 2005). Furthermore, studies have confirmed that calcium imaging 
is a reliable proxy for seizure activity (Badea et al., 2001; Pacico & Meur, 2014; Smetters et al., 
1999). The ability for calcium imaging to detect both neuronal and astrocytic activity, whilst 
beneficial in many aspects, can also have its limitations. Indeed, the biggest limitation of this 
study was that the principal technique employed could not differentiate between neuronal 
calcium activity and astrocytic calcium activity.  
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Figure 7.1: Visual representation of future directions. After establishment of optimal 2D culture 
protocols, including ratios of neurons, astrocytes and interneurons, the cultures should then 
seek to encompass structural properties of the in vivo cortex. This may be achieved by 2 photon 
polymerisation/scaffolding to form 3D, interconnected cultures which are amenable to high-
throughput optogenetic and electrophysiological assessment. 
Despite experiments performed to selectively stain astrocytes with sulforhodamine, this was 
unsuccessful (data not shown). Sulforhodamine is a widely used astrocyte marker in microscopy 
owed to its low phototoxicity and relatively low cytotoxicity. Interestingly, it has recently been 
demonstrated that sulforhodamine can induce seizure-like events in cortical cultures and as 
such, even if this method had been successful, it may have negatively influenced the culture 
activity (Rasmussen et al., 2016). As previously discussed, some cultures displayed typical 
astrocytic morphology and slow calcium activity, but it is not possible to accurately determine 
whether that astrocyte is isolated, or whether processes surrounding the astrocyte and 
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displaying activity have arisen from associated neurons. Not only would being able to visualise 
each cell type independently show which cells were active and responsive, it would enable 
research into specific network and astrocyte dynamics within the seizure event.  
There now exist several methods to enable this isolation and generate such data. Recent 
advancements in the development of genetically encoded calcium indicators (GECIs) removes 
the need for existing fluorescent dye loading (Saber et al., 2018). GECIs, like their traditional 
counterparts, are non-invasive, but can be targeted to specific neurons or astrocytes, allowing 
longer duration imaging, without the risk of photo-toxicity (Mank & Griesbeck, 2008) or non-
specific cell staining (Rad et al., 2017). Other issues observed with fluorescent dyes such as 
background fluorescence and non-specific dye loading can be overcome with GECI technology 
(Mank & Griesbeck, 2008). In addition to GECI, genetically encoded voltage indicators (GEVI) 
have been in development for decades and allow the recording of membrane potentials and 
can transduce this voltage change to fluorescence intensity measurements. It is a highly 
sensitive technique and provides high resolution measurements of spike activity and synaptic 
communication. Current invasive measurements of membrane potential and voltage imaging 
are slow, limited to very few cells, technically demanding and incredibly sensitive to biochemical 
perturbations, which can be induced from photoexcitation using the technique itself (Bando et 
al., 2019). GEVIs can measure activity in large populations via protein engineering, which 
couples fluorescent proteins to voltage-sensitive domains (VSDs), microbial rhodopsins or 
chemogenetic probes. For example, the first use of a GEVI tethered a green fluorescent protein 
to the VSD of the voltage-gated Shaker potassium channel. As a result, any voltage-dependent 
alterations to the channel induces changes in the probe fluorescence and the signal amplified, 
providing significantly greater resolution and the ability to detect action potentials with 
standard microscopy equipment (Siegel & Isacoff, 1997). Combining these significant 
advancements in optogenetic methods with iPSC-derived models could provide a new 
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dimension to PSL and arguably increase the throughput and efficiency of this technique, whilst 
enabling visualisation of individual cell types in seizure-like activity.  
Despite the ionic manipulation of potassium and magnesium in the aCSF, the direct modification 
of calcium was not explored in this thesis. Lowering the extracellular concentration of Ca2+ can 
induce regular SLE, accompanied by transient decreases in Na+ and increases in K+ in the 
extracellular space (Yaari et al., 1983). Low [Ca2+]e enhances neuronal excitability and can induce 
spontaneous, synchronised bursts of activity, reminiscent of epileptiform discharges. Calcium 
influx occurs via voltage gated-calcium channels and N-methyl-D-aspartate (NMDA) receptors 
and during seizure, the [Ca2+]e decreases far lower than non-convulsing tissue (Blauwblomme et 
al., 2014; Simons, 1988; Somjen, 2002). This decrease is due to calcium influx into neurons 
undergoing the seizure activity, which impairs synaptic transmission as there is too little Ca2+e 
to sustain the calcium influx. Higher Ca2+e can enhance synaptic transmission as calcium is 
available to enter the cell, even though a higher [Ca2+]e reduces excitability (as the cell is not 
depolarised). However, this remains to be observed in iPSC-derived models. 
7.4.3 3D models and induced neural cells 
While human stem cell derived neurons can be routinely produced using well established 
methods (Chambers et al., 2009; Shi et al., 2012b) the reproducibility of these methods is 
variable (Hu et al., 2010). The neurons produced are often slow (2–3 months) to exhibit 
functional properties such as sustained action potential firing and synaptic plasticity. This 
represents a significant limitation in experimental models and screening platforms. Alternative 
approaches such as transdifferentiation allow the direct neuronal cell reprogramming to 
generate different neuronal lineages, termed “induced neurons” (iN; Vierbuchen et al., 2010)) 
or “induced astrocytes” (iA; Caiazzo et al., 2015). Such iN can be generated within 3–5 weeks 
after reprogramming and demonstrate physiological action potential firing (Vierbuchen et al., 
2010). Furthermore, iA can be produced within 2 weeks (Caiazzo et al., 2015). Whilst these 
approaches have reduced the time required to generate functional neuronal subtypes, the 
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efficiency of generating iN cells is often less than 10% (Yang et al., 2011), suggesting that far 
more development is required to produce a reproducible platform for testing.  
A criticism of the use of two-dimensional (2D) human cultures is that they do not reproduce the 
structure and hierarchical connectivity that is seen in three-dimensional (3D) tissue. An 
important route to obtain better structural and morphological relevance is to generate iPSC-
derived 3D co-cultures such as organoids and spheroids (Figure 7.2), which have been shown to 
recapitulate early development of the human cortex (Lancaster et al., 2013; Lancaster & 
Knoblich, 2014a, 2014b; Pasca et al., 2015). While these 3D cultures are useful models for early 
development and diseased states, they are less able to model complex, later stages of 
development and lack vasculature (Sun et al., 2018). The use of scaffolds to ‘train’ cultures to 
develop into defined structures is an exciting avenue for regenerative medicine and has very 
recently been demonstrated in our laboratory (Crowe et al., 2020). Overcoming these issues 
and applying this technology to seizure-liability testing could provide an insight into not only the 
mechanisms of seizure spread between layers of cortical cells, but possibly identify novel targets 
and pharmaceuticals. The advent of matured 3D structures would aim to generate layers of the 
cortex as seen in vivo and provide a robust and relevant platform that resembles a human 
cortex, in terms of both structure and functionality, adding an extra dimension and increased 




Figure 7.2: 3D culture systems. (A) iPSCs can be spontaneously differentiated within 3D 
aggregates. (B) 3D aggregates can be further cultured in 3D to develop a neural/cerebral 
organoid. These organoids recapitulate the developmental processes and structural hierarchy 
seen in the developing brain. (C) Section of the laminated structure formed within the neural 















7.5 Commercial systems 
It could be posited that due to the commercial availability of neural cells from iPSC, the 
generation and co-culturing of individual cell types is redundant. Indeed, there are several 
benefits to using pre-differentiated neural cultures: these include heterogeneity, presence of all 
desired cell subtypes and strict quality controls and industrial standards applied. This obviously 
provides several benefits over the differentiation of cells and batch-to-batch variation that is 
unavoidable in a research setting, particularly a spontaneous differentiation. However, as these 
products are commercial outputs, companies are bound by confidentiality with their 
differentiation methods and methods of mitotic inhibition (if even used). Furthermore, the cost 
of these cultures is considerable, and quite often, the cells are only suitable for one passage, 
meaning expansion of cultures for high-throughput testing is incredibly expensive cf making 
ones own cultures. As several companies produce and sell these cultures, this sadly further 














7.6 Concluding remarks 
In this thesis, several different culture protocols of human iPSC-derived neurons and astrocytes 
have been compared, to provide an optimal method for pre-clinical seizure liability testing, 
which is amenable to high-throughput optical interrogation. It was found that spontaneous 
differentiation can produce cultures capable of eliciting hyperactive and hypersynchronous 
bursting activity, typical of seizure-like events, however this method is unreliable and not 
robust. It was also shown that monocultures of astrocytes and neurons are unsuitable as model 
systems, and that the interaction between both cell types is necessary for functional 
maturation, and the ability to respond to diverse neuroactive treatments.  
This thesis has provided evidence that co-culturing neurons and astrocytes without mitotic 
inhibition leads to an overgrowth of glial cells and consequent reductions in cell activity and 
response to drugs. Therefore, a co-culture model has been produced which controls ratios of 
neurons and astrocytes to ensure the developing cultures remain constant and responsive. 
These co-cultures displayed network connectivity and responded to known pro-convulsant 
conditions with increased activity and synchrony. Preliminary work highlighted the importance 
of GABAergic interneurons and their ability to form a complete and heterogenous system which 
can respond to several pro-ictogenic treatments and these are an absolute requirement for in 
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Figure A1: Representative figures showing detachment of neurons in SCT media at 18 WIV. 
Cells cultured in SCT media formed extensive fasciculation of neurites and detached from 





Figure A2: Spontaneously differentiated cultures at 18 WIV are heavily astrocytic. Neural 
cultures were differentiated in either Axol legacy or SCT BrainPhys media over 18 weeks and 
immunocytochemistry was performed to assess the relative quantities of neurons (Tuj1) and 
astrocytes (S100β in culture). (A) Nuclei stained with DAPI (Blue, excitation λ 345 nm, 
emission λ 455 nm). (B) Tuj1 neuronal staining (Red, excitation λ 588 nm, emission λ 649 
nm). (C) S100β astrocyte staining (Green, excitation λ 495 nm, emission λ 519 nm). (D) 
Merged image of A,B,C. N=3. Scale bar: 100 μm.  
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Figure A3: Activity over time of spontaneously differentiated cultures in Axol and SCT 
differentiation media. Neural cultures were differentiated in either Axol legacy or SCT 
BrainPhys media over 18 weeks and assessed intermittently for functional activity using 
fluorescent (Fluo4-AM) calcium imaging in aCSF perfusion. Active cells were determined as 
those with a minimum of one peak of calcium-mediated activity (peak > 3x s.d. baseline 
noise). (A) Axol-cultured cells over time (Blue). (B) SCT-cultured cells over time (Red). Data 

















Figure A4: Spontaneously differentiated cultures at 18 WIV form large aggregates and 
clustering of cell bodies. Representative image of cultures differentiated over 18 WIV. 
Widespread clumping was observed in both Axol and SCT-cultured cells. N=3, both media 














Figure A5: Spontaneously differentiated cultures in Axol express S100β and vGAT at 18 
WIV.  iPSC-derived neural precursors were differentiated in Axol or SCT media over 18 weeks 
and qPCR performed to assess the expression of neural progenitors Pax and Sox, neuronal 
cells (Tuj1), astrocytes (S100β) and inhibitory amino acid transporter vGAT. Fold change in 
















Figure A6: Representative figures showing detachment of DAPT-synchronised neurons at 7 
WIV. NPCs cultured in sync media formed extensive fasciculation of neurites and detached 












Figure A7: Zero-magnesium aCSF has no effect on 18 WIV co-cultures. Cultures were loaded 
with 5 µM Fluo4-AM for fluorescent calcium imaging. (A) Responding cells were determined 
as those with ≥ one peak of calcium activity. (B) Calcium peaks per active cell. (C) Frequency 
of calcium events per minute. (D) Percentage of synchronised cells of total active cells. N=3. 




Figure A8: Example Synchronised and Spontaneous co-cultures show cells with astrocytic 
morphology. Spontaneous and synchronous co-cultures were differentiated over 18 WIV 
and fluorescent (Fluo4-AM) calcium imaging performed. Images were taken from the loaded 
cultures. (A) Synchronous co-cultures loaded with 5 µM Fluo4-AM appeared to display 
astrocytic processes and morphology. (B) Spontaneous co-cultures show large, characteristic 





Gene Mean S.D. 
GAPDH  18.74 2.114 
Act  16.61 1.110 
YWHAZ 18.73 1.122 
18S 16.05 2.402 
C B 
F E D 
Figure A9: Housekeeping genes for endogenous controls and gene expression analysis of 
synchronised neuronal and astrocytic co-cultures. Top: Four endogenous control genes were 
tested to determine a suitable control for all qPCR analysis within the thesis. (A) Average Ct 
value for each housekeeping gene, with its corresponding mean value and standard deviation. 
Bottom: Co-cultures of synchronised neurons and astrocytes were differentiated over 12 WIV 
and qPCR was performed to assess the expression of progenitor genes Pax6 (B) and Sox2 (C), 
neuronal TUBB3 (D), astrocytic S100β (E) and inhibitory neuronal marker vGAT (F). Data is 




                                                         
A B C 
Figure A10: Tetrodotoxin perfusion effects on bursting activity in co-cultures of neurons and astrocytes exposed to different pro-ictogenic conditions. 
Human iPSC-derived neuronal and astrocytic co-cultures were cultured over 12 WIV and treated with various pro-ictogenic perfusions to elicit increased 
activity, followed by TTX. (A) Amplitude of calcium bursts. (B) Duration of calcium bursts. (C) Time between calcium bursts. N=3. 1-way ANOVA with Tukey’s 
multiple comparisons test.  
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Figure A11: Sodium valproate perfusion effects on bursting activity in co-cultures of neurons and astrocytes exposed to different pro-ictogenic conditions. 
Human iPSC-derived neuronal and astrocytic co-cultures were cultured over 12 WIV and treated with various pro-ictogenic perfusions to elicit increased 
activity, followed by VPA. (A) Amplitude of calcium events. (B) Duration of calcium bursts. (C) Time between calcium bursts. N=3. 1-way ANOVA with Tukey’s 
multiple comparisons. 





Culture Condition % Active Cells 
Mean ± SEM 
P-value from T-test 
Axol W4 Spon 3.4 ± 0.58 <0.0001 
SCT W4 Spon 11.22 ± 1.27 <0.0001 
Axol W8 Spon 14.57 ± 1.77 <0.0001 
SCT W8 Spon 18.25 ± 2.09 <0.0001 
Axol W12 Spon 7.59 ± 0.75 <0.0001 
SCT W12 Spon 18.50 ± 2.14 <0.0001 
Axol W18 Spon 26.76 ± 4.93 0.007 
SCT W18 Spon 20.47 ± 3.77 0.0001 
Astrocyte mono 16.45 ± 4.36 0.0001 
NPC mono 6.15 ± 0.94 <0.0001 
Spon CC 15.07 ±4.27 0.007 
Sync CC 14.19 ± 2.22 0.006 
Sync astrocytes and NPC CC 48.65 ± 6.14 - 
 
Figure 12A: Overall comparison. Percentage of active cells for every culture method tested in 
this thesis. Statistics in the lower table were calculated individually using t-test, purely to 
present the significantly increased activity observed in the co-culture method employed in 
Chapter 6. 
